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SUMMARY
Head injuries are a major cause of morbidity and mortality in western 
society. Despite advances in the detection and management of head injury 
there has been limited improvements in outcome. It is clear that a better 
understanding of the pathophysiology of traumatic brain injury is 
essential. Without this scientific basis, the future for patients sustaining 
severe head injuries remains bleak.
The neuronal cytoskeleton consists of proteins which serve structural and 
functional roles within the neurone. Microtubules are a major component 
of the cytoskeleton and are essential for normal neuronal functioning. 
Specifically, they are intimately involved in the process of fast 
axoplasmic transport in which proteins and organelles are transported 
from the neuronal cell body to synapses. Disruption of this process may 
be important in the pathogenesis of traumatically induced neuronal injury. 
It is hypothesised that alterations in the cytoskeletal framework may 
represent a common final pathway in the mediation of traumatic insults in 
the brain. Therefore, elucidation of the mechanisms involved in this 
process would provide valuable information which could be used in the 
design of future therapeutic strategies.
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Alterations in the microtubule component of the neuronal cytoskeleton
following production of an acute subdural haematoma in the rat.
Immunohistochemistry and Western blot analysis were used to examine 
specific components of the neuronal cytoskeleton at 30 minutes, 2 hours 
and 4 hours following production of an acute subural haematoma in the 
rat. The microtubule associated proteins, MAP 2 and Tau, are 
preferentially localised to dendrites and axons respectively, p-tubulin is 
one of the major constituent polypeptides of microtubules and provided a 
useful marker of microtubules. A series of investigations demonstrated 
that the microtubule component of the neuronal cytoskeleton was 
disrupted following induction of an acute subdural haematoma. There 
was a dramatic loss in MAP 2 immunostaining in the cortex underlying 
the subdural haematoma within 2 hours of production of the haematoma. 
However, there was not uniform loss of MAP 2 immunostaining 
throughout the cortical layers suggesting that certain neurones are less 
susceptible to the mechanisms leading to neuronal cell death. Specific 
alterations in Tau-1 and P-tubulin immunoreactivity were demonstrated 
in both the cerebral cortex and the myelinated fibre tracts of the ipsilateral 
corpus callosum. This important finding demonstrates that traumatically 
induced axonal injury may contribute to the pathogenesis of acute 
subdural haematoma. Quantitative Western blot analysis supported the 
hypothesis that degradation of the neuronal cytoskeleton occurs following 
traumatic brain injury. In addition there were alterations in the 
electrophoretic profile of Tau detected which were consistent with 
changes in the phosphorylation state of the protein.
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To examine the morphological correlate of these alterations, transmission 
electron microscopy was employed in a group of 4 hour animals. There 
was clear evidence of disruption of the dendritic and axonal 
cytoskeletons. Specifically, following induction of an acute subdural 
haematoma, the dendritic microtubules demonstrated an abnormal helical 
configuration compared to the normal linear arrangement. Transverse 
sections from myelinated fibres in the corpus callosum demonstrated loss 
of microtubules and compaction of neurofilaments.
Overall, this series of investigations supports the central hypothesis that 
disruption of the neuronal cytoskeleton may represent a common final 
pathway of neuronal injury.
The role of calpain in traumatically induced cytoskeletal injury.
Calpain is a family of calcium dependent proteolytic enzymes. Calpain 
activation is believed to occur when intracellular free calcium levels 
surpass a certain threshold. Substrates for activated calpain include 
cytoskeletal proteins. Using a polyclonal antibody that recognises calpain 
mediated breakdown products (BDPs) of spectrin, the distribution and 
time course of calpain activation following acute subdural haematoma in 
the rat was characterised. A series of experiments demonstrated that 
prolonged activation of calpain occurred following induction of a 
subdural haematoma. Spectrin BDPs were identified predominantly in the 
hemisphere underlying the haematoma, located primarily in the cortex
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which exhibited features of the ischaemic cell process. Calpain mediated 
spectrin breakdown was detected in dendrites and neuronal perikarya as 
early as 2 hours after induction of the haematoma. In the ipsilateral white 
matter, spectrin breakdown was detected in a small proportion of axons 
subjacent to the cortical region of maximal tissue injury. The results 
suggest that calpain may play an important role in the pathobiology of 
traumatic brain injury.
Alterations in the neuronal cvtoskeleton following acute subdural 
haematoma in humans.
Immunohistochemistry was employed to investigate alterations in the 
neuronal cytoskeleton in fatally injured patients sustaining an acute 
subdural haematoma. Post-mortem sections from the superior parietal 
cortex were examined and compared to neurological controls. There was 
loss of MAP 2 immunolabelling in the cortex underlying the haematoma. 
Tau-1 immunoreactivity was increased in some neuronal perikarya 
following acute subdural haematoma. However, the intensity of 
immunoreactivity in both controls and haematoma cases was poor for 
reasons which remain unclear. There was an increase in somato-dendritic 
p - tu b u lin  im m unoreactivity in the cortex after acute subdural 
haematoma. The results from the human post mortem study are similar to 
those obtained in the series of experiments using the rat model of acute 
subdural haematoma. This suggests that the animal model is suitable for 
the analysis of aspects of the pathogenesis of traumatic brain injury.
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Alterations in axolemmal permeability following traumatic brain injury.
Traumatic brain injury can be associated with alterations in the 
axolemma. It is unclear if there exists a spectrum of axolemmal failure 
following the traumatic event or if the passage of macromolecules occurs 
in an "all or none" fashion. The present study used two extracellular 
tracers of different molecular weights to investigate this specific feature. 
In normal conditions these macromolecules are confined to the 
extracellular space by the intact axolemma. Following traumatic injury, 
the axolemma is altered and becomes permeable to macromolecules 
which can then be detected intra-axonally. Anaesthetised, mechanically 
ventilated rats received intrathecal horseradish peroxidase (HRP) or 
microperoxidase (MP), and were then subjected to an impact acceleration 
closed head injury. Animals were perfusion killed at various intervals 
after injury and the brains processed for the visualisation of peroxidase 
activity at both light and electron microscopic level. The results 
demonstrated that both HRP and MP were detectable within injured 
axons at all time points after injury. However, quantitative analysis 
confirmed that HRP demonstrated more reactive axons in the sections 
examined compared to MP. The reason for this is unclear but may be 
related to the biochemical binding properties of MP.
25
PREFACE AND DECLARATION
This thesis primarily represents results from a series of investigations 
which were designed to examine the role of the microtubule component 
of the neuronal cytoskeleton in the pathobiology of acute subdural 
haematoma. The main techniques employed were immunohistochemistry, 
W estern blot analysis and transmission electron microscopy. An 
additional study was carried out to investigate the nature of the altered 
axolemmal permeability which occurs in traumatic brain injury.
Hypothesis to be presented
The central hypothesis is that, in traumatic head injury, the changes that 
take place in the microtubule component of the cytoskeleton are the end- 
product of a final common pathway that is triggered by the influx of 
calcium, through areas of membrane disruption, activating a variety of 
enzymes including calpains.
Investigations were carried out in four broadly defined areas:
1. To examine the microtubule component of the axonal and dendritic 
cytoskeleton in the rat brain following induction of an acute subdural 
haematoma. In addition, to determine the temporal profile of the 
development of cytoskeletal pathology.
26
2. To determine the role of calpain mediated proteolysis in the 
pathogenesis of acute subdural haematoma.
3. To detect alterations in the microtubule component of the neuronal 
cytoskeleton in post mortem tissue from fatally injured patients who 
sustained an acute subdural haematoma.
4. To examine the nature of disruptions in the axolemma following 
traumatic brain injury in the rat impact acceleration model of closed head 
injury.
Results from these studies are presented and discussed separately. In the 
discussion I have attempted to highlight the implications of this work and 
indicate future directions which subsequent investigations may address.
This thesis comprises my own original work and has not been presented 
previously as a thesis in any form. Certain parts of this work involved my 
collaboration with other workers. Western blot analysis and electron 
microscopy were performed in collaboration with Dr Karen Horsburgh 
and Dr William Maxwell respectively. I acknowledge the assistance of 
Professor John T. Povlishock in the interpretation of electron 
micrographs.
The work presented in this thesis was carried out at the W ellcome 
Surgical Institute and Hugh Fraser Neuroscience Laboratories, University 
of Glasgow and The Commonwealth Centre for Brain Injury Research,
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Medical College of Virginia, Richmond, United States of America.
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CHAPTER 1 - INTRODUCTION
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1.1 Head Injury
Head injuries are currently the most important cause of death in young 
adults in the United States of America. Throughout western society a high 
proportion of young chronically disabled individuals become dependent 
on care because of its effects. In contrast to stroke and coronary artery 
disease the incidence of head injury is increasing 1.
In the United Kingdom, one million patients per annum attend hospital 
after sustaining a head injury. Almost half of these are children less than 
15 years old and males outnumber females by more than two to one. The 
majority of cases are the result of falls (41%) or assaults (20%). Road 
traffic accidents account for 13% of all patients attending hospital, but 
approximately one third of all acute cases transferred to neurosurgical 
units and 58% of all deaths in these units. Moreover, head injury accounts 
for 15%-20% of all deaths between the ages of 5 and 35 2.
Over the last 20 years, major advances have been made in the 
management of head injury. Unfortunately these have not been translated 
into widespread improvement in outcome. In spite of improved access to 
better quality intensive care facilities and wider use of computerised axial 
tomography (CAT) scanning, neither the mortality rate or the incidence of 
preventable brain damage identified at postmortem, have decreased more 
than 5-10% over the last 15 years 3-5. Intense research in recent years 
has increased our understanding of the pathophysiology of head injury 
and there are promising indications from experimental studies of benefit
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from a range of neuroprotective drugs^J. However, if this progress is to 
continue, further elucidation of the mechanistic basis of traumatic brain 
injury is essential.
1.2 Traumatic Brain Injury
Brain damage after a head injury can be classified by time course and by 
pattern. From a neuropathological point of view, there are two main 
stages in the development of brain damage after a head i n j u r y Primary 
damage occurs at the moment of injury and takes the form of scalp 
lacerations, fracture of the skull, surface contusions, lacerations of the 
brain, diffuse axonal injury and intracranial haemorrhage. Secondary 
damage ,which is produced by complicating processes that are initiated at 
the moment of injury but do not present clinically for a period of time, 
include ischaemia, raised intracranial pressure, brain swelling and 
hypoxia amongst others 2,9
In recent years the specialised techniques of modem neuroradiology have 
contributed to the classification of traumatic brain injury by providing 
functional correlates of the structural damage identified by CAT scanning 
or at autopsy. Advances made in computerised tomography, magnetic 
resonance imaging and, more recently positron emission tomography, led 
to the introduction and wide acceptance of an alternative classification of 
traumatic brain damage based on the pattern of damage which could be 
either focal of d iffu se ^ ” 12. it must be noted that in many patients the 
most accurate description may be of a multifocal distribution 2.
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The principal types of focal brain damage are contusions on the surface of 
the brain, intracranial haematoma and the various types of brain damage 
secondary to intracranial expanding lesions and a high intracranial 
pressure (Figure 1). With the availability of sophisticated scanning, the 
clinician usually knows that lesions of this type are present during life. 
Diffuse brain damage is more subtle and consists of axonal injury, 
hypoxic brain damage, vascular injury and brain swelling. The clinician 
usually suspects this type of brain damage when faced with an 
unconscious patient who does not have an intracranial haematoma. As a 
result of a comprehensive clinical study on head injuries it became 
apparent that two lesions - diffuse axonal injury and acute subdural 
haematoma - were responsible for two thirds of the deaths, that is, more 
than all other lesions combined 13.
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Figure 1
The inter-relationship of different 
pathophysiological processes responsible for brain 
damage in patients who die after head injury.
1.3 Diffuse Axonal Injury
Damage to axonal pathways in the brain is now recognised as the single 
m ost im portant lesion underlying traum atic brain injury with 
consequences ranging from brief concussion to profound vegetative 
s ta te d  There is also increasing recognition of its importance as an 
initiating or accelerating factor in the development of cognitive decline 
and even Alzheimer's disease in later life 14.
The distinctive clinicopathological entity which is now internationally 
termed, diffuse axonal injury, can be defined as the occurrence of diffuse 
damage to axons in the cerebral hemispheres, in the corpus callosum, in 
the brain stem and, less commonly, the cerebellum resulting from a head 
i n j u r y 8 > 9 , 1 5 - 1 8  Three grades of severity can be identified 8. In grade 1 ,  
abnormalities are limited to histological evidence of axonal damage 
throughout the white matter without there being focal lesions in either 
corpus callosum or in the brain stem. Cases are designated as grade 2 if, 
in addition to widely distributed axonal injury, there is also a focal lesion 
in the corpus callosum. Grade 3 represents the most severe end of the 
spectrum and takes the form of diffuse damage to axons and focal lesions 
in both the corpus callosum and in the brain stem.
The severe end of the spectrum of diffuse axonal injury is characterised 
by a statistically lower incidence of lucid interval, fracture of the skull, 
cerebral contusions, intracranial haematomas, and evidence of a raised 
intracranial pressure, as compared with patients without this type of brain
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damage. There is an increased incidence of gliding contusions and small 
deeply seated intracerebral haematomas and also a higher incidence of 
head injury due to road traffic accidents in comparison to falls
Typically the axonal damage associated with traumatic brain injury is 
scattered throughout the brain and brain stem, in clear distinction to the 
focal contusions and mass lesions long thought to be the major 
complications of the traumatic insult. The diffuse injury to axons can only 
be idenfified microscopically. In patients with severe axonal injury who 
survive for only a short time (days), there are vast numbers of reactive 
axonal swellings sometimes called axonal bulbs or retraction balls It 
is important to appreciate that these terms are not synonyms. Indeed, the 
terminology used in the literature has resulted in confusion in the 
comparison of studies. A current review article has proposed clear 
definitions which should clarify this issue and hopefully avoid future 
confusion For all purposes the term "axonal swelling" refers to focal 
increases in axonal diameter which are still in continuity with the rest of 
the axon at both ends. On the other hand, the terminal increase in axonal 
diameter found after axonal disconnection should be referred to only as 
axonal bulbs. Thus the occurrence of axonal swellings precedes that of 
axonal bulbs in damaged nerve fibres. In this proposal, the term 
"retraction ball" corresponds to "axonal bulb" and its use is largely 
confined to historical perspective.
Axonal bulb formation is essential for a definitive diagnosis of 
irreversible axonal injury, and it is generally accepted that in the human
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brain after head injury, using conventional silver staining methods, a 
survival time of 1 8 - 2 4  hours is required for incontravertib le 
identification^. The axonal bulbs can be seen in sections stained by 
haemotoxylin and eosin as small round eosinophilic masses but are more 
easily seen in sections impregnated with silver. Recently developed 
immunohistochemical techniques are more sensitive in the detection of 
axonal bulb formation in human head injured brain s e c t i o n s 2 0 - 2 2  Using 
an antibody to the p-am yloid precursor protein (p-APP), evidence of 
axonal damage can be seen after a survival of between 2  and 3  
h o u r s 2 2 > 2 3  Histological studies demonstrated that axonal bulbs may be 
seen in only 3 0 %  of cases stained by silver impregnation, whereas if the 
same sections are immunostained using the antibody to P-APP, evidence 
of axonal bulb formation may be identified in nearly 9 2 %  of c a s e s 2 2 .  
Despite these advances, a definitive diagnosis of diffuse axonal injury 
cannot be made in patients who survive for only a short time (1-2 hours) 
after their head injury 24.
Over the course of the past 25 years it has become increasingly clear, to 
both the neurosurgical and neuropathological communities, that in 
patients sustaining mild, moderate and severe forms of traumatic brain 
injury, axonal damage can occur, and based on the number of axons 
involved and their distribution, varying degrees of morbidity can ensue. 
Following upon the initial neuropathological observations 25-28 jt 
became clear that damage to cerebral white matter was an important 
feature of head injured patients. During this period the term "shearing 
injury " was introduced since it was assumed that the forces of injury
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immediately tear axons, causing them to retract and expel a ball of 
axoplasm, forming a retraction ball, the traditional histologic correlate of 
axonal injury. Controversy as to the nature of the brain damage and its 
pathogenesis continued for many years. At various stages it was referred 
to as diffuse damage to the white matter of immediate type 29, diffuse 
white matter shearing injury 30 and inner cerebral trauma 31.
Adams and colleagues more fully characterised the structural features and 
time course of the axonal damage occurring with traumatic brain injury 
and were responsible for clearly defining the concept of diffuse axonal 
injury 8 , 1 6 , 2 9 , 3 2 , 3 3  Through the systematic study of a large population 
of patients who had sustained severe head injury, a direct link between 
the extent of diffuse axonal injury and the ensuing patient morbidity was 
established. This important observation was subsequently expanded upon 
in the laboratory 17. The well controlled subhuman primate model of 
head injury demonstrated that the overall distribution and number of 
damaged axons directly correlated with the morbidity seen in the injured 
animals following angular acceleration injury. Studies conducted in 
humans who had sustained only mild or moderate traumatic brain injury 
also identified the presence of damaged a x o n s ! 5 > 2 5 , 2 7 , 2 8 , 3 4  Although 
reduced in both number and overall anatomical distribution in comparison 
to the severe traumatic state, their very occurrence suggested that axonal 
damage occurs across the spectrum of traumatic injury. This provides 
strong evidence that diffuse axonal injury is part of a clinical continuum 
of diffuse brain damage that clinically ranges from concussion up to and 
including persistent post traumatic coma. More recent findings support
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this hypothesis. Using an antibody to the p-amyloid precursor protein (P- 
APP) axonal damage has been demonstrated in a series of 5 patients who 
died from unrelated causes after a mild head injury 35^
Numerous animal models of traumatic brain injury have been employed
to investigate axonal injury. It is important to appreciate that, to date, only
one animal experimental model precisely replicates the features of the
human condition recognised as diffuse axonal injury. The angular
acceleration model of head injury in the subhuman primate ^  results in
axonal bulb formation in the white matter of the brain which is similar in
distribution to that found in human diffuse axonal injury. Nevertheless,
axonal swellings, as described above, occur in all animal "models of
diffuse axonal injury". However, the distribution of these swellings within
the white matter, differs discretely from that described in the head-injured
patient. Therefore use of the term "diffuse axonal injury" in animal
models in direct comparison with human diffuse axonal injury is not
valid. It is suggested that the term "diffuse traumatic brain injury" should
be used in preference and that a clear statement made that the axonal
injury described in any experimental animal is a model of human diffuse
axonal injury but does not exactly mirror the spatial distribution of
damaged axons found in diffuse axonal injury in the head-injured patient 
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Despite the fact that most researchers now concur that axonal damage is a 
consistent feature of mild, moderate and severe traumatic brain injury 
and, as such, contributes to morbidity, 16,17 no consensus has evolved
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regarding the actual pathogenesis of the observed axonal damage. 
Contemporary studies, conducted in both experimental animals and 
humans, have demonstrated that the pathogenesis of traumatically 
induced axonal damage is more complex than originally posited. In many 
cases it involves evolving intra-axonal changes that lead to progressive 
axonal swelling and detachment over a 12-24 hour period 8,37,38
1.4 Acute Subdural Haematoma
An acute subdural haematoma constitutes one of the "worse case 
scenarios" within the severe head injury spectrum. It is the most common 
mass lesion that complicates severe head trauma and is found in 20-30% 
of patients with severe head injury. The mortality rate for acute subdural 
haematoma exceeds that for any other sub-group of the severely head- 
injured p o p u l a t i o n ^ *  13,39-41 Although between 55% and 70% of 
patients who develop an acute subdural haematoma have a lucid interval 
at some stage in their clinical course, nearly two-thirds will die or be left 
severely disabled such that they are incapable of independent life. This 
occurs despite the fact that surgery is typically performed within a few 
hours of injury 5.
Acute subdural haematoma poses many problems for the neurosurgeon. 
One of these is the clinical paradox in which the outcome for a given 
clinical state appears to be much worse with subdural haematomas than 
with extradural haematoma. The combination of high morbidity and 
mortality despite the presence of a "conscious interval" suggests that
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potentially treatable factors are responsible for much of the ischaemic 
brain damage that occurs in patients with an acute subdural haematoma. 
However, once a subdural haematoma has been surgically evacuated, the 
inadequacy of therapeutic options available to control intra-cranial 
pressure and limit ongoing neurological damage means that these patients 
often present the neurosurgeon with particular difficulties in management. 
For these reasons a major challenge is therefore to elucidate the 
pathophysiologic mechanisms causing ischaemic brain damage and to 
devise strategies to minimise its development 5,39-41
The majority of subdural haematomas are due to disruption of the 
parasagittal bridging veins at the time of injury : however some are 
arterial in origin 9. Most acute subdural haematomas are associated with 
considerable brain damage. Attempts to age haematomas on the basis of 
histological studies have not proved very satisfactory. A working 
classification describes a subdural haematoma as being acute when it is 
composed of clot and blood (usually within 48 hours of injury), subacute 
when there is a mixture of clotted and fluid blood ( developing in between 
2 and 14 days after injury) and chronic when the haematoma is fluid 
(developing more than 14 days after injury) 5.
The most common neuropathological finding in humans with an acute 
subdural haematoma is ischaemic brain damage^.This is distributed 
chiefly in the ipsilateral hemisphere and also in the hippocampus 
bilaterally 32,42 jf  the intracranial pressure is severely raised there may 
be evidence of ischaemic damage in the contralateral cortex^. Acute
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hemispheric swelling, raised intracranial pressure and death are frequent 
sequelae of acute subdural haematoma; yet the majority of patients have 
been conscious at some time after injury. This suggests that secondary 
factors may contribute to the pathology of this condition. At present it is 
unclear what these factors are. Most investigators agree that the aetiology 
of acute subdural haematoma will prove to be multifactorial and related 
to, amongst others, local pressure effects, excessive activation of post 
synaptic receptors and release of toxic substances from the blood itself.
The development of a clinically relevant animal model of acute subdural 
haematoma has allowed some element of the pathophysiology of this 
injury to be clearly elucidated. The rat model of acute subdural 
haematoma demonstrated a consistent zone of focal ischaemic brain 
damage within the hemisphere beneath the subdural haematoma, as is 
found in some humans who die after an acute subdural haem atom a^. 
This zone of histologic cortical infarction corresponded to an area of 
markedly reduced cerebral blood flow
Subsequent studies have tended to focus on the role of excitatory amino 
acids (EAA's) in the mediation of the observed ischaemic damage. 
M icrodialysis techniques demonstrated that the acute subdural 
haematoma is associated with release of extracellular glutamate in the 
underlying cortex, to levels seven times above b a s a l t  in addition, a 
severe reduction in cerebral glucose metabolism was detected in the 
cortex beneath the haematoma and a band of glucose hypermetabolism in 
the peri-ischaemic tissue, surrounding the infarcted tissue, and throughout
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the h ippocam pus^. These reports suggested that glutamate induced 
neuronal damage may be a feature of acute subdural haematoma and 
raised the possibility that this "excitotoxic" process may be amenable to 
therapeutic intervention. Drugs that block the excitotoxic effects of 
glutamate at the N-methyl-D-aspartate (NMDA) receptor have generally 
been effective in reducing the ischaemic brain damage observed in other 
animal models of focal cerebral ischaemia 6,46 Several investigations 
have now demonstrated a consistent neuroprotective effect with NMDA 
antagonists, both in pretreatment and in post treatment paradigms with the 
experimental model of acute subdural haematoma47-50 There is now 
great enthusiasm that the potent neuroprotective effects that have been 
shown for NMDA antagonists drugs in the laboratory can be translated 
into clinical benefit for head injured patients. Clinical trials are either 
underway or p lan n ed ^ .
It is also possible that the release of vasoactive blood components from 
the haematoma initiates pathophysiological events in the underlying 
cortex and leads to ischaemic damage 43,51 This is in accordance with 
the demonstration that the extent of ischaemic damage produced by an 
intracerebral injection of blood was significantly greater than that 
produced by an equivalent volume of inert oil or a m icroballoon^. in a 
closed cranium model of subdural haematoma a zone of ischaemia and 
neuronal cell loss was observed contiguous to the clot whereas an inert 
silicone mass of similar volume had significantly less e ffect, suggesting a 
neurotoxic effect of blood or a blood component. 53 in humans, blood in 
the subarachnoid space causes delayed ischaemia and is toxic to cerebral
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arteries 54. Likewise, the concentration of glutamate in serum is 10 times 
greater than that of extracellular glutamate and in the red blood cells it is 
at least 10 times greater than in serum 55 Therefore, exposure of 
neurones to blood could be associated with glutamate toxicity 56 
Furthermore, a recent investigation suggested that haemoglobin may 
contribute to neuronal loss after cerebral haemorrhage by exacerbating 
excitotoxicity57. Models of sub-arachnoid haemorrhage have investigated 
blood components such as oxyhaemoglobin and lipid peroxides and 
concluded that these may also result in ischaemic c h a n g e s 5 8 > 5 9  However 
a recent study demonstrated that blood in prolonged contact with the 
exposed cortical surface did not result in infarction of the underlying 
neurones 51. This is consistent with experience from the clinical setting 
since it is well recognised that neurosurgical procedures are not 
associated with infarction or neuronal loss at adjacent sites.
It therefore appears likely that the brain's of traumatised patients responds 
in a compromised manner. Perhaps, following traumatic head injury the 
presence of subdural or subarachnoid blood acts synergistically with 
processes initiated by existing insults, such as the mechanical forces of 
injury, raised intracranial pressure, hypoxia or ischaemia, to overwhelm 
the brains's compensatory mechanisms and lead to neuronal cell death. 
There are precedents for this type of synergistic effect in experimental 
traumatic brain injury. The addition of a low level ischaemic insult to a 
sub-threshold mechanical insult potentiated neuronal loss beyond that 
seen with either insult alone 60. Recent work lead to the development of 
a combined fluid percussion brain injury and entorhinal cortical lesion as
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a model for assessing the interaction between neuroexcitation and axonal 
injury. Early results have demonstrated that axonal injury and it's 
attendant deafferentation, when coupled with traumatically induced 
neuroexcitation, produce an enhancement of the morbidity associated 
with traumatic brain injury 61.
At present the role of the neuronal cytoskeleton in the mediation of 
traumatic brain injury is a major focus of investigation. It is recognised 
that, by using multiple research stategies, an insight into the mechanistic 
basis of traumatic brain injury will be gained. This knowledge should 
then allow the development of appropriate therapeutic interventions 
aimed at inhibiting the progression to neuronal cell death. Without such 
agents the prognosis for traumatically brain injured patients will remain 
bleak.
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1.5 The Neuronal Cytoskeleton
Early neuroanatomists soon concluded that the long nerve processes 
contained ' fibrils ' and that these provided the necessary structural 
support 62,63 The era of the cytoskeleton had arrived. In a cross 
sectional view most of the axon is filled with 8-12nm structures, 
neurofilaments, separated from each other by side arm spacers. The axon 
also contains microtubules and microfilaments (Figure 2). Membrane 
bound organelles, including mitochondria, appear to be preferentially 
associated with microtubules and microfilaments. Longitudinal sections 
of the axon reveal arrays of neurofilaments and microtubules as well as 
sidearms that seem to connect cytoskeletal elements to each other and to 
membrane bound vesicles. Essentially, the cytoskeleton consists of 
protein components of the neurone which form the structural elements 
within the cell. It comprises three main elements viz:
a) Microtubules.
b) Neurofilaments.
c) Microfilaments.
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Figure 2
The components of the neuronal cytoskeleton.
Microtuhules
Microtubules (MTs) are a major component of the cytoskeleton in 
nervous tissue and are especially prominent in neuronal processes. They 
play important functional and architectural roles in neurones. The primary 
polypeptides of MTs are alpha and beta tubulins and multiple genes exist 
for both tubulins including brain specific isoforms 64,65 Berth subunits 
have a molecular weight of approximately 50kDa and share considerable 
homology 66,67 w ithin either family, individual subunits diverge from 
each other at less than 10% of amino acid positions 68. For p -  tubulin, 
five isotype clones have been identified and these contribute unique 
functional properties to the cell. Neuronal MTs are small tubules 
approximately 24nm in diameter with walls made up of 12-14 
protofilaments which can be visualised in high resolution electron 
micrographs. In many cases, sidearms can be visualised projecting from 
the surface of the microtubule and these appear to interact with other MTs 
and surrounding structures. As such they constitute a relatively dynamic 
component of the cytoskeleton; a property known as “dynamic 
instability” 69. M T s serve multiple roles in the neurone. In concert with 
actin microfilaments and neurofilaments, they establish and maintain the 
overall internal architecture of the cytoplasm and are a major determinant 
of neuronal size and shape70,71 ^ T s  ajso have a critical role in 
intracellular transport. Video enhanced microscopy has demonstrated that 
the MT arrays in axons serve as tracks along which vesicles and cellular 
organelles are transported from the cell body to the synapse which may 
be up to one metre a w a y ^ 2 .  The process of axoplasmic transport allows a
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whole variety of proteins and organelles to be packaged in the cell soma 
and distributed throughout the neurone. This MT based motility is 
mediated by two families of proteins found in the nervous system; the 
kinesin and cytoplasmic dynein fam ilies^ . Kinesin is a MT activated 
ATPase and it is involved in the anterograde movement of membrane 
bound organelles along the MTs in fast axonal transport^ . Dyneins serve 
as the motor for retrograde axonal transport and may have a role in slow 
axoplasmic transpo rt^ . Disorganisation of the MT component would 
therefore interrupt these vital transport systems. Finally, MTs play an 
important role in neuronal growth and development 64,75
Microtubule Associated Proteins (MAPs')
In addition to tubulin, which is their basic building block, the neuronal 
microtubules also contain large quantities of minor components, the 
microtubule associated proteins (MAPs). There are three properties that 
the MAPs confer on microtubules that may be important viz: MTs are 
stabilised, lengthened and made more rigid in the presence of MAPs 70e 
This is clearly an important contribution to the morphological stability 
and functional properties of microtubules.
M icrotubules are formed in the cell by cycles of assembly and 
disassembly and are composed primarily of tubulin but also contain 
several MAPs which when added back to pure tubulin, promote 
a s s e m b l y 7 6 - 7 8  MAPs are therefore thought to regulate microtubule 
assembly in vivo. The original MAPs isolated were from mammalian
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neurones and named according to the three major size classes of 
polypeptides as defined by molecular weight (MW). These were: MAP 1 
(MW >250kDa), MAP 2 (MW approximately 200kDa) and tau (MW 50- 
7 0 k D a ) 7 6 , 7 9  Recent advances have identified additional MAPs and 
refined the original classes. These are now described with emphasis on 
the main neuronal MAPs.
MAPI
On the basis of electophoretic, biochemical and immunological criteria 
MAP 1 was resolved into three separate proteins, MAP la, MAP lb  and 
MAP lc. Within the nervous system MAP la  (usually called MAP 1) is 
found in neuronal cell bodies, axons, dendrites and glial cells^O MAP lb  
(sometimes called MAP 5), is expressed very early in development of the 
nervous system, suggesting a role in neuronal m orphogenesis^ . It 
continues to be expressed in all regions of the neurone but only attains 
high levels in areas of the adult brain where neuronal differentiation 
continues such as the hippocampus, retinal photoreceptors and olfactory 
s y s t e m 6 4 , 8 1  MAP lc  is the only neuronal MAP with an identified 
function. This MAP is the heavy chain of brain cytoplasmic dynein, a 
protein involved in intracellular transport^ 2. it is not restricted to 
neurones.
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MAP 2
Microtubule associated protein 2 (MAP 2) is a principal protein 
component of microtubules and is consistently most abundant in neuronal 
dendrites and attains only low levels or is undetectable, in axons** 3. As 
such it provides a useful marker of dendrites. It is a high molecular 
weight, heat stable protein doublet that promotes microtubule assembly in 
vitro 79 ,84  an(j may regulate micro tubule interaction with other 
cytoskeletal elements**5>**6. MAP 2 is present only in neurones and is a 
component of the cross bridges between microtubules **7 ancj between 
micro tubules and neurofilaments****. When purified it consists of three 
components **0. These are:MAP 2a (MW 280kDa), MAP 2b (MW 
270kDa) and MAP 2c (MW 70kDa)79. Peptide mapping and monoclonal 
antibody reactivity suggest that MAP 2a and MAP 2b are closely related 
and the term MAP 2 is used to refer to the high molecular weight form 
MAP 2a/b**9. Alternate splicing of transcripts of a single gene gives rise 
to MAP 2 and MAP 2c90. All of these isoforms contain a cluster of 
imperfect amino acid sequences which are also found in tau and are 
thought to be the essential core of the microtubule binding domain of 
MAP 2^1 "93 These components are expressed differentially in that 
MAP 2 is present at low levels in the embryonic brain but becomes the 
major MAP in the adult brain. In contrast, MAP 2c is the major MAP in 
the embryonic brain but is expressed at very low levels in the adult brain, 
persisting mainly in areas of neuronal growth 90.
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Tau
The microtubule associated protein, tau, plays an important role in the 
dynamics of microtubules. Tau is a phosphoprotein and is predominantly 
found in the axonal compartment of neurones where it is able to bind and 
stabilise M T s^ . Purified tau from mammalian brain consists of four to 
six discrete isoforms ranging in molecular mass from 35-65kDa and 
differing by the presence or absence of two types of amino acid 
i n s e r t i o n s ^ , 95 This heterogeneity is generated, at least in part, by 
alternate splicing of a single gene96. All of these isoforms contain a 
cluster of imperfect amino acid sequences which are also found in MAP 2 
and are thought to be the essential core of the microtubule binding 
domain of tau91"93 Phosphorylation of tau, at specific epitopes, has 
marked structural effects leading to a stiffening and elongation of the 
molecule associated with an increased stability of the microtubules^^. 
Conversely, dephosphorylation inhibits this process and may lead to a 
decline in cytoskeletal integrity^.
MAP3
MAP3 is a large protein found in various tissues. In the brain it occurs 
where there are high concentrations of neurofilament rich axons. Despite 
this association it does not appear to be stongly bound to
neurofilaments^S.
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MAP4
MAP4 comprises a family of MAPs distributed ubiquitously in tissues 
and across mammalian species. The function of MAP 4 is unknown but, 
in the brain, it is restricted to glial cells 99.
MAP 2 and tau : Suggested complementary roles in dendrites and axons.
From the above outline it is clear that MAPs have important functions in 
the maintenance of microtubule stability within neurones. It is useful to 
briefly consider MAP 2 and tau together in order to emphasise the 
complementary role these two distinct MAPs have.
MAP 2 and tau are two of the major and most studied microtubule 
associated proteins of the vertebrate nervous system. In neurones, 
immunohistochemistry shows complementary distributions, with tau 
being concentrated in axons 94 and MAP 2 being confined to dendrites 
80. Each protein consists of multiple isoforms that contain three or four 
homologous tandem repeats near the carboxy terminus which are thought 
to constitute microtubule binding domains 92 Electron micrographs 
demonstrate these proteins as lateral projections that appear to cross­
bridge adjacent microtubules. The spacing between adjacent microtubules 
in the presence of tau is about 20nm while that for MAP 2 is about 
lOOnm^S. This suggests that each protein consists of a common 
microtubule binding domain and a projection domain. Since microtubules 
are inherently unstable structures, the stabilising effect of tau and MAP 2
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are likely to be important for the integrity of neuronal functions that 
depend on stable microtubules, such as fast axoplasmic transport.
Neurofilaments
Neurofilaments (NFs) or, intermediate filaments of the nervous system, 
appear in electron micrographs as solid rope like fibrils 8-12nm in 
diameter and are of variable length. They are present in most cell types. 
The primary type of NF is formed from three subunit polypeptides 
collectively called the neurolfilament triplet proteins 100, each coded by 
a separate genelO l. The molecular weight (MW), as estimated by gel 
electrophoresis, for NF subunits vary from 200kDa for the high MW 
subunit (NF-H), 150 kDa for the middle subunit (NF-M) and 68kDa for 
the low MW subunit (NF-L)7M 01. The 68kDa subunit is an assembly 
protein found predominantly in the neurofilament core, and the 150kDa 
and 200kDa subunits are crosslinking proteins found in the connecting 
branches 102 All NF triplet proteins exhibit significant sequence 
homology in the amino terminal, alpha helical domain. The 150kDa and 
200kDa subunits possess highly repeating lysine-serine-proline(LSP) 
sequences, which are heavily phosphorylated and contribute to anomalous 
electophoretic mobilities 103. NFs exhibit an unusual degree of metabolic 
stability, which makes them well suited to maintaining neuronal 
morphology. They also play a critical role in determining axonal calibre 
and slow axoplasmic transport^.
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Microfilaments
Microfilaments are found throughout neurones and glia. Electron 
microscopy demonstrates that they consist of actin subunits arranged like 
two strings of pearls intertwined to form fibrils 4-6nm in diameter. They 
maintain cell shape and are well suited to resist deformation. The full 
extent of their function is unclear but, notably they mediate the 
interaction of the neurone with the surrounding extracellular matrix and 
neighbouring cells 98.
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1.6 The Neuronal Cvtoskelcton in Acute Brain Injury.
Derangements of the neuronal cytoskeleton are undoubtedly important 
pathological consequences of traumatic brain injury. Within the last few 
years laboratory studies have demonstrated that traumatic brain injury can 
produce more widespread alterations in the neuronal cytoskeleton than 
previously recognised. Initial investigations focused on the axonal 
cytoskeleton in diffuse axonal i n j u r y 8 > 3 7  More contemporary studies 
have recognised that the cytoskeleton of dendrites and the neuronal cell 
body are also disrupted by the forces of traumatic injury104,105 The 
functional significance of the observed structural abnormalities remain 
unclear. However, it would seem logical that structural disorganisation of 
the cytoskeleton would result in functional correlates. As such, a greater 
understanding of the mechanisms, which contribute to disruption of the 
cytoskeleton, is essential for the future developments of therapeutic 
strategies which will aim to arrest the progression of changes in the 
cytoskeleton.
As noted previously, traumatic brain injury constitutes a wide range of 
both focal and diffuse pathologies^. It is therefore important to appreciate 
that all animal experimental models have limitations since only certain 
elements of this continuum can be investigated^^. For ease of discussion 
it is convenient to consider the literature relevant to the role of the 
cytoskeleton in traumatic brain injury under two "anatomical "sub­
headings.
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The axonal cytoskeleton in traumatic brain injury
Despite the fact that it is well established that microtubules are the 
principal conduits for fast axoplasmic transport 98 ancj that reactive 
axonal swellings result from an impairment of this process,8 3 7  scant 
attention has been applied to the study of microtubules within the axonal 
cytoskeleton after traumatic brain injury. Rather attention has been 
devoted to the study of the neurofilamentous c omponents^O, 107,108 
Based on the premise that the forces of traumatic injury can either 
mechanically or functionally disturb the cytoskeleton resulting in 
impaired axoplasmic transport, Povlishock and colleagues explored this 
issue using antibodies specific to the three neurofilam ent 
s u b u n i t s 3 7 3 0 7 , 1 0 9 , 1 1 0  As neurofilament accumulation is associated 
with reactive axonal change they reasoned that monoclonal antibodies 
directed at the various neurofilament subunits might provide insight into 
the events leading to reactive change. In this series of experiments animal 
models known to produce consistent axonal injury were employed 106.
Although some mechanistic insight was provided by all three antibodies 
the monoclonal antibody to the 68kDa subunit was the most useful. 
Specifically, within one hour of traumatic brain injury, a highly focal 
increase in the intra-axonal 68kDa subunit was detected, and this was 
most dramatic by two hours post i n j u r y 3 7 , 1 0 7 , 1 0 9  Initially the 68kDa 
immunoreactive neurofilaments paralleled the longitudinal axis of the 
axon, but within the first two hours of injury, they began to withdraw 
from the axolemma and to display an abnormal alignment oblique to the
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longitudinal axis of the axon. With increased survival the degree of 
disorganisation of the 68kDa neurofilaments increased and organelles 
accumulated at the periphery of the axon. This was followed over time by 
continued axonal expansion, lobulation and ultim ately axonal 
disconnection with the formation of a reactive axonal swelling. 
Subsequent studies extended these findings to humans by demonstrating 
that a similar sequence of events occurred with a distinct progression of 
neurofilamentous changes as outlined above 20,108 The implication 
from this series of reports is that the structural disorganisation of the 
axonal cytoskeleton plays an important role in the pathobiology of 
traumatic brain injury. However, the mechanism of neurofilament 
misalignment and how this translated to an impairment of axoplasmic 
transport was unclear.
A major problem in most of the experimental paradigms examined is the 
question of sampling. Although immunohistochemical and ultrastuctural 
abnormalities can be demonstrated within axons, we cannot be certain 
that we are sampling at an initiating site of injury. It could be that the 
most marked disturbances occur upstream or downstream from the actual 
initiating site, resulting in the investigator noting features which are only 
indirectly related to initiating events. This is an important consideration 
and must be borne in mind when comparing the findings from two 
different models.
In an attempt to overcome this problem Povlishock and co-workers 
utilised extracellular tracers on the basis that the site of tracer uptake
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would mark the initiating site of injury 111*112 Ultrastructural analysis 
revealed a complex and unexpected array of disturbances in the 
cytoskeleton. There appeared to be at least two different cytoskeletal 
responses to traumatc brain injury which were related to the severity level 
of the injurious insult. Specifically, following severe injury, in the cat 
model of fluid percussion injury, they detected a concomitant collapse in 
the cytoskeleton as evidenced by increased neurofilament packing, that is, 
a decreased inter-filament distance. This preceded the progressive, yet 
delayed, development of neurofilamentous disarray leading to the 
evolution of reactive axonal swelling as outlined in the previous reports 
from their laboratory. This was a new observation which they had not 
demonstrated previously. This failure was attributed to a problem of 
sam pling m ethodology ^  1. With more mild injuries a different 
cytoskeletal response was displayed. There was misalignment of the 
neurofilaments such that they adopted an abnormal helical pattern lying 
oblique to the longitudinal axis of the axon. In addition, analysis of 
coronal sections indicated that there was loss of microtubules in the 
reactive axons. Further investigations followed and demonstrated that 
these complex changes were neither model or species s p e c i f i c U s i n g  
antibodies against the phosphorylated sidearms of the neurofilaments it 
was demonstrated that the observed compaction of the neurofilaments 
resulted from a loss of the sidearms following injury. A similar 
observation was made in lamprey spinal cord a x o t o m y l l ^ .  Through the 
novel use of antibodies specific for the neurofilament sidearm and rod 
domains these workers confirmed that the neurofilaments lost their side
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arm projections allowing the unmasking of the rod domain in regions of 
cytoskeleton collapse and neurofilament compaction.
Subsequent quantitative analysis and characterisation  of the 
ultrastructural changes occuring in the axonal cytoskeleton suggested that 
there were at least two distinct reactions following traumatic brain 
i n j u r y j n  severe injury, altered axolemmal permeability was 
associated with collapse of the cytoskeleton as evidenced by compaction 
of neurofilaments and loss of microtubules. In contrast, following mild 
injury, there was no evidence of altered axolemmal permeability but the 
neurofilaments were misaligned relative to the longitudinal axis of the 
axon. Both these groups progressed to reactive axonal swelling.
Extensive recent studies designed to investigate the histopathological 
correlates of cytoskeletal derangements demonstrated that there was little 
evidence of axonal involvement within 3 hours of traumatic brain 
injury!04 These workers used the rat model of cortical impact injury 
and examined the cortical samples using quantitative Western blots. They 
detected a significant decrease in the levels of key neurofilament proteins 
(NFL and NFH) and concluded that this constituted evidence of 
disruption of the axonal c y to s k e le to n H o w e v e r , subsequent confocal 
microscopy on the same experimental material detected minimal axonal 
alterations within the c o r t e x  104 This suggested that preferential dendritic 
rather than axonal damage occurs within 3 hours post traumatic brain 
injury. In addition, minimal alterations in axonal NFL(68kDa) subunit 
immunoreactivity were observed in white matter tracts such as the corpus
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callosum following injury and there was no evidence of reactive axonal 
swellings.
The dynamics of the microtubule component of the cytoskeleton are also 
affected by injurious insults. Surprisingly few studies have investigated 
this aspect of the cytoskeleton in traumatic injury. In the guinea pig optic 
nerve traction model of stretch injury, recent studies have provided 
evidence for the loss of microtubules within 15 minutes of injury! 16 
Quantitative analysis demonstrated a significant decrease in the number 
of microtubules in the axoplasm of myelinated fibres and this was 
associated with an increased spacing of the neurofilaments, that is an 
increase in the inter-filament distance. Furthermore, these changes were 
most marked at the nodes of Ranvier suggesting that this specific region 
was most susceptible to stretch injury. In these nodes the axoplasm 
possessed a flocculent substructure between the remaining structurally 
recognisable microtubules and neurofilaments. This morphological 
appearance is consistent with degradation of substrate proteins.
The microtubule associated protein, tau, is altered in axons following 
ischaemic injury. Specifically, focal cerebral ischaemia results in the 
focal accumulations of tau, as detected by the Tau-1 antibody, in the 
white matter tracts of the ipsilateral caudate nucleus and corpus callosum 
in the rat. 130 These accumulations can be demonstrated within 2 hours 
of occlusion of the middle cerebral artery and appear as irregular 
immunostained profiles. Follow up studies also demonstrated alterations 
in tubulin and MAP 5 immunostaining in axons following focal cerebral
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ischaemia in the rati 17. The significance of these findings remains to be 
fully established.
The somato-dendritc cytoskeleton in traumatic brain injury
The first study to demonstrate the loss of a cytoskeletal protein following 
traumatic brain injury examined MAP 2 levels in hippocampal and 
cortical tissue 105. in the rat model of fluid percussion injury they 
reported that moderate traumatic brain injury resulted in a significant 
decrease in the MAP2 protein level in the ipsilateral hippocampus 
compared to the contralateral side. This effect appeared to be regionally 
selective since the MAP 2 decrease did not occur in the cortex. More 
importantly, it suggested that cytoskeletal damage occurs in the somal 
and dendritic compartments following sub-lethal magnitudes of traumatic 
injury.
In more severe brain injury the levels of MAP 2 in the cortex were 
decreased. The cortical impact model produces severe focal cortical 
co n tu sio n s . W ith in  th ree  hours o f in ju ry  q u a lita tiv e  
immunohistochemistry and Western blot analysis detected a substantial 
loss of MAP 2 in the cortex ipsilateral to the site of i n j u r y  104 Moderate 
traumatic injury caused a reduction in cortical and hippocampal MAP 2 
immunoreactivity within 10 minutes of injury and persisted for at least 7 
days post injury! 18 Other investigators demonstrated that these 
disturbances in MAP 2 immunostaining were not model specific. Mild 
focal cortical trauma produced by the weight drop technique resulted in
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decreased M AP 2 im m unoreactivity in the rat cortex and 
hippocampus 1 The loss of MAP 2 immunostaining was most marked 
at the perimeter of the lesion 1-3 days after injury. However, this study 
extended previous work by demonstrating that the reduction in cortical 
MAP 2 immunoreactivity was not observed 21 days after impact. This 
suggests that the pathological processes underlying the loss of MAP 2 
may be reversible.
Quantitative analysis of the effects of severe traumatic brain injury on the 
levels of cytoskeletal proteins have added to the complexity of this topic. 
The rat model of severe lateral cortical impact injury results in an area of 
contusion in the ipsilateral cortex similar to those seen after severe human 
head injury. Quantitative Western blot analysis demonstrated that 
traumatic brain injury caused a significant decrease in the protein levels 
of two prominent neurofilament proteins, NF-L (68kDa) and NF-H 
(200kDa) within 3 hours of injury and this was also observed at all 
survival time points up to 2 weeks post injury H ^.The decrease in the 
68kDa neurofilament subunit was restricted to the site of contusions in 
the ipsilateral cortex with no decrease observed in the contralateral cortex 
or the hippocampus. A decrease in the protein level of the 200kDa 
neurofilament was detected in both cerebral cortices but not in the 
hippocampus. In contrast to earlier qualitative studies (1,6,7,22), these 
investigations suggested that the overall effect of traumatic brain injury 
on the level of the 68kDa neurofilament, throughout the cortex, was 
reduction in the level of the p ro te in ic .  However, this decrease was 
associated with an increase in the presence of lower molecular weight
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immunopositive bands. These protein bands may represent 68kDa 
neurofilament breakdown products produced by the action of proteases on 
the parent 68kDa neurofilament. This particular observation clearly 
complicates the interpretation of the immunohistochemical data which 
demonstrates a focal increase in 68kDa neurofilament subunit in reactive 
axonal swellings, following traumatically induced axonal injury 37,107- 
109. An alternative explanation for this localised increase in 68kDa 
antigenicity may be that it represents the breakdown products of the NF-L 
subunit. Further support for the loss of neurofilament proteins following 
traumatic brain injury was provided by in-vitro studies on mixed 
septohippocampal cultures. Densitometric analysis of immunolabelled 
W estern blots demonstrated that there was a 40% decrease in 
neurofilament immunoreacivity following potassium depolarisation as 
occurs in traumatic brain injury 120
The morphological correlates of these disruptions in the cytoskeleton are 
of importance in determining the relative involvement of axonal and 
dendritic processes in the pathobiology of traumatic brain injury. 
Recently completed investigations used imm unofluorescence and 
confocal microscopy to examine changes in the configuration of axons 
and dendrites within the cortex following traumatic brain injury104,121 
In the same experimental model as used in the initial immunoblotting 
studies, the rat model of cortical impact injury, prominent alterations in 
the immunolabelling of NF-H(200kDa), MAP 2 and NF-L(68kDa) were 
detected in both the ipsilateral and contralateral cortical contusion 
s i te s  104  L ight m icroscopic studies of the NF-H subunit
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immunofluorescence revealed a fragmented appearance of apical 
dendrites within pyramidal neurones layer 3 and 5, as well as a loss of 
fine dendritic arborisation within layer 1. Confocal microscopy detected 
varying degrees of NF-H subunit disassembly represented by a loss of 
linearity, associated with these areas of neurofilament fragmentation. A 
similar pattern of fragmentation was displayed in dendrites showing loss 
of MAP2 immunoreactivity. The NF-L neurofilament subunit (68kDa) 
was altered but not as dramatically as observed with the NF-H 
neurofilament subunit. The decrease in 68kDa immunolabelling after 
injury resulted in less fragmented dendrites. In conclusion, this study 
demonstrated that traumatic brain injury can produce significant 
cytoskeletal derangements in dendrites in the absence of marked axonal 
changes.
Ischaemic brain damage is by far the most common secondary insult in 
traumatically brain injured patients and is detectable in more than 80% of 
fatal cases^A  Disturbances in the neuronal cytoskeleton may be involved 
in the evolution of ischaemic brain damage and alterations in the 
microtubule associated proteins may play an important role.
Morphological studies have demonstrated that the normal linear 
arrangement of the neuronal cytoskeleton is disrupted following even 
brief periods of cerebral ischaemia. Electron microscopy demonstrated 
prompt disintegration of microtubules within histologically defined 
ischaemic areas 122,123 xhis rapid disassembly of microtubules was 
detected within 5 minutes of unilateral occlusion of the carotid artery in
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gerbils. In addition, a differential vulnerability of the microtubule 
components to ischaemia was demonstrated. Specifically, microtubules in 
myelinated axons were more stable than those in dendrites suggesting that 
the structural characteristics of a neuronal process may effect it's 
susceptibility to injurious insults 122.
Numerous investigations have documented alterations in the components 
of the cytoskeleton following ischaemic insults of various types and 
durations. Several studies have indicated that MAP 2 is the most 
ischaemia sensitive component of the cytoskeleton. Even short periods of 
transient global ischaemia (5 minutes) resulted in a loss in MAP 2 
immunoreactivity in the gerbil hippocampus ^ ^ a n d  a decrease in the 
cortical levels of MAP 2 was observed following 72 hours of permanent 
occlusion of the left middle cerebral artery in the rat 125. These changes 
in immunoreactivity are consistent with ultrastructural studies that 
demonstrate alterations in dendritic structure after ischaemia 122 
However, no decrease in MAP 2 levels were detected following cardiac 
arrest for 30 minutes in the rat suggesting that reperfusion injury may 
have a role in the pathophysiology of cytoskeletal derangement! 26. 
Neurofilaments are also degraded in cerebral ischaemia 127.
The localisation and levels of the microtubule associated protein , tau also 
show changes following focal cerebral ischaemia. An early, variable and 
transient increase in perikaryal tau was detected following transient 
global ischaemia in the rat!28. In the cat model, tau immunostaining was 
increased in a proportion of neurones within the ischaemic lesion 129. in
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the rat model there was increased tau immunostaining in axons and some 
neuronal cell bodies throughout the ipsilateral cortex and caudate nucleus 
compared to the corresponding contralateral regions 130 Immunoblotting 
techniques detected a decrease in the cortical levels of the 200kDa 
neurofilament subunit (NF-H), MAP 2 and tubulin following focal 
cerebral ischaemia in the r a t^ ^ .  Other investigations demonstrated a 
decrease in immunolabelling of tubulin, MAP 1 and MAP 2 in the gerbil 
model of transient global isch aem ia^  1*132 j h [ s multiplicity of 
disruption suggests that disturbances in the cytoskeleton may be a key 
feature in the pathogenesis of traumatic brain injury.
The biochemical mechanisms underlying these structural changes in the 
cytoskeleton are a subject of current investigation. In this regard the 
involvement of proteolytic enzymes and excitotoxic amino acids has 
attracted a great deal of research. In particular, the calcium activated 
neutral protease calpain is thought to play an important role in the 
mediation of traumatic brain injury.
1.7 The role of calpain in traumaticallv induced cytoskeletal injury
It is now becoming increasingly clear that traumatically induced brain 
damage cannot be attributed to a single factor, but that several 
mechanisms come into play. A m ultifactorial pathogenesis has 
implications for the pursuit of pharmacological intervention, since there is
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probably no single therapeutic agent which will ameliorate brain damage 
of whatever cause.
A disturbance of ion homeostasis in traumatic brain injury triggers a 
variety of events which can ultimately lead to cellular dysfunction and 
neuronal dam age!33. It has been widely assumed for many years that 
neuronal cell damage is, at least in part, related to loss of cellular calcium 
homeostasis, with an ensuing calcium " overload" 133-135 Sustained 
elevation of intracellular calcium results in the unrestrained activation of 
several calcium-sensitive events. In experimental models of traumatic 
brain injury, marked alterations in total tissue calcium levels and calcium 
fluxes occur in regions of the brain that exhibit subsequent cell loss
136.137 it js suggested that cell calcium "overload" damages cells 
primarily by accelerating lipolysis and proteolysis, and by effecting 
protein phosphorylation through an effect on kinases and phosphatases
133.138 in this series of events the proteolytic degradation of the 
cytoskeleton by the calcium activated protease, calpain, is assumed to 
play a key pathogenetic role. This is consistent with the hypothesis that 
unregulated proteolysis by calpain represents a final common pathway to 
neuronal cell death.
Calpain is a family of calcium-dependent, non-lysosomal, cysteine 
proteases. This enzyme family, also known as calcium-activated neutral 
protease (CANP), is present in most mammalian cells, normally in an 
inactive form. Calpain activation is believed to occur when intracellular 
free calcium levels surpass a certain threshold 139,140 Two forms of
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calpain, which differ in the level of calcium required for activation, have 
been identified in mammalian brain. Calpain I ( or |iM-calpain), activated 
in vitro by micromolar levels of ionic calcium, is located in neuronal cell 
bodies and is less abundant in axons and glia. In contrast, calpain II ( or 
mM-calpain), is activated in vitro by millimolar levels of ionic calcium, 
and is most common in glia and axons 141-143 This difference in 
cellular distribution may reflect a difference in physiological function 
between calpains I and n.
Calpain mediated proteolysis is an attractive candidate to participate in 
degenerative responses because it is activated by calcium and is capable 
of degrading several important intracellular proteins. Among the 
preferred substrates for calpain are cytoskeletal proteins and regulatory 
enzymes. Uncontrolled proteolysis of any, or all, of these proteins could 
have a severe impact on the structural and functional viability of 
neurones. In vitro studies demonstrated that MAP 2, tau, tubulin and 
neurofilaments are susceptible to calpain mediated proteolysis 144-149 
As outlined in the previous section, acute brain injury results in a general 
decrease in cytoskeletal proteins in a wide range of animal experimental 
studies. Overall these investigations suggest that calpain may play an 
important role in the pathological degradation of the cytoskeleton.
A recent report extended these findings by demonstrating that calpain 
activation was a feature of traumatic brain injury 150 Specifically, fluid 
percussion injury in the rat resulted in prolonged calpain mediated 
breakdown of the cytoskeleton. Moreover, this study supported evidence
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obtained from in vitro and in vivo work by suggesting that dendrites are
the most susceptible component of the neuronal cytoskeleton to calpain 
1 0 4 , 1 0 5 , 1 5 1
1.8 The role of the axolemma in the initiation of traumaticallv induced axonal
injury,
For many years it was assumed that the tensile forces of traumatic injury 
sheared axons at the time of injury causing them to retract and expel a 
ball of axoplasm, forming a reactive axonal swelling or retraction ball, the 
traditional histologic correlate of diffuse axonal i n j u r y 2 5 - 2 8 , 3 0  ^ o r e  
contem porary investigations have not supported  this basic 
p r e m i s e ^ , 2 3 , 3 7 , 1 0 8 - 1 1 0  Rather, they have demonstrated that in the 
majority of cases of traumatically induced axonal injury, the process of 
axonal disconnection is not immediate but delayed for 4 - 2 4  hours 
depending on the severity of injury and the species examined. The 
traumatic insult elicits a focal axonal abnormality that leads to the 
impairment of axoplasmic transport with subsequent swelling of the axon 
37. This progresses to separation of the swollen axon into a proximal 
segment in continuity with the sustaining soma and a distal appendage 
which will undergo W allerian degeneration. When, in the above 
described sequence of axonal change, axonal detachment does occur, the 
continued delivery of axoplasmic constituents via anterograde transport 
allows for the continued expansion of the proximal swollen axonal 
segment, which matures into a reactive axonal swelling or retraction ball
of classic description 13,37
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Despite general agreement regarding the occurrence of secondary 
axotomy, that is axotomy occuring at some time after the initial traumatic 
event, there has been little consensus with regard to the pathogenesis of 
the initiating subcellular events involved in this process. The obvious 
question centres on precisely what subcellular event underlies the axon's 
propensity to fail with traumatic brain injury. In this regard, the role of 
the axolemma is a major topic of current investigation.
The axon membrane or axolemma consists of a bilipid membrane and an 
associated submembrane skeleton. This skeletal framework is essentially 
formed by the protein spectrin (also known as fodrin), arranged in a 
pentagonal or hexagonal meshwork lining the interior of the cell 
membrane, and actin, connecting via ankyrin and other components to 
transmembrane proteins. Transmembrane proteins, such as p i-in tegrin  
bind externally to the extracellular matrix and internally via the 
membrane skeleton to the cytoskeleton 152-154
H istorically , two hypotheses have attem pted to explain the 
biochemical/biophysical mechanisms occurring in damaged axons after 
the application of tensile strain/stretch-injury as occurs in non-missile 
head injury. Adams and colleagues, proposed that focal pertubation of the 
axolemma was the crucial initiating event 7 ,15-17 ,155 This was 
associated with increased permeability of the axolemma, allowing the 
influx of extracellular calcium. In the normal situation the intracellular 
concentration of free calcium is rigorously controlled and there is
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normally a steep gradient of the order of 10,000:1 in the concentration of 
calcium between extracellular fluid and axoplasm. The elevation of 
intracellular calcium levels following stretch-injury may activate 
proteolytic enzymes, such as calpain, that cause dissolution and 
subsequent collapse of the cytoskeleton, disrupting axonal transport as 
reflected in the accumulation of membranous organelles and causing the 
pathological disturbances described above. On the other hand, Povlishock 
and colleagues proposed that the physical forces of injury directly 
perturbed the intra-axonal cytoskeleton, as against the axolemma, 
resulting in a series of structural changes causing its disorganisation to 
thereby elicit an impairment of axoplasmic transport 20,37,107,108 The 
concept of an influx of calcium into axons after traumatic brain injury 
was criticised by Povlishock and colleagues for many years. Their main 
contention was that the sequence of cytoskeletal events which they 
observed in various experimental paradigms was inconsistent with a 
proteolytic process. Specifically, they did not detect any evidence of rapid 
dissolution of the cytoskeleton purportedly linked to calcium activated 
proteases.
Fortunately, recent studies have provided considerable insight into each 
of these mechanisms and their potential role in the genesis of the reactive 
axonal change associated with traumatic brain injury.
Observations of traumatically induced axonal abnormalities in the 
majority of experimental models of blunt head injury, without either 
myelin disruption or frank damage to the adjacent neural or glial
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processes suggested that there was no evidence for direct tearing or 
shearing of axons following traumatic injury 109 This was supported 
when freeze-fracture studies, conducted in the early phases of axonal 
injury, failed to demonstrate either immediate disruption of the intemodal 
myelin or early loss of the glial-axonal junctions, suggesting that the 
myelin sheath itself is not immediately damaged by the forces of 
i n j u r y  1^6. At this stage both the above groups, postulated that the forces 
of traumatic injury act first on the axolemma and/or the axoplasm while 
sparing the myelin sheath. Within this proposal, the mechanical forces of 
injury could stretch the axolemma to its biomechanical limits at which 
point it failed and initiated reactive axonal change.
However, in a series of subsequent investigations on both human 20,108 
and animal 107,157 brain tissue, Povlishock and colleagues provided data 
to support an initiating role for the intra-axonal cytoskeleton. Their 
studies revealed a complex sequence of intra-axonal events which 
progressed to reactive axonal change. Specifically, using antibodies 
directed at the neurofilament component of the cytoskeleton they 
observed that there was focal accumulation of the intra-axonal 68 kDa 
subunit (NF-L) within one hour of injury and this increase was dramatic 
by two hours. With increasing time the neurofilam ents became 
disorganised and misaligned relative to the longitudinal axis of the axon. 
There was no loss or dissolution of neurofilaments detected. Overall this 
data was inconsistent with neutral protease mediated degradation of the 
cytoskeleton. Instead the increase in the 68kDa neurofilament subunit 
supported the possibility of a traumatically induced rearrangement of the
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neurofilam ent pool. Again no ultrastructural evidence of direct 
axolemmal disruption was detected in this series of experiments further 
refuting an initiating role for the axolemma. Infolding and distension of 
the axolemma was demonstrated and attributed to the ongoing reactive 
axonal change. These findings suggested that a direct mechanical effect 
upon the cytoskeleton of the axon cylinder was the pivotal event in the 
initiating pathogenesis of axonal injury .
Other approaches suggested that the axolemma was involved in the 
initiation of reactive axonal change. Maxwell et al (1991) used a nerve 
traction model to analyse the morphological changes within damaged 
axons in vivo 1^5 They provided evidence that the initial site of damage 
after a non-disruptive stretch injury is the nodes of Ranvier, some of 
which develop "nodal blebs". These blebs are axolemma limited 
protrusions of the axoplasm into the perinodal space and are most 
numerous within 15 minutes of injury but less so at later intervals. The 
developm ent of nodal blebs correlated with loss of the dense 
undercoating of the axolemma. In damaged axons with nodal blebs the 
neurofilaments were disorganised , deviated from the longitudinal axis of 
the axon and extended into the blebs. In contrast, the microtubules 
maintained their longitudinal arrangement and did not deviate into the 
bleb. Quantitative analysis of this material demonstrated that there was a 
significant loss of m icrotubules and an increased spacing of 
neurofilaments in the axoplasm of nodes with associated nodal blebs. The 
loss of microtubules would disrupt fast axoplasmic transport resulting in 
the focal accumulation of membranous organelles in adjacent paranodal
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regions of the axon to form reactive axonal swellings. In addition, these 
workers provided the first cytochemical evidence to support the idea of 
calcium influx into stretch injured myelinated nerve fibres H 6 . The 
oxalate/pyroantimonate technique for the localisation of calcium, 
demonstrated an increased content of pyroantimonate precipitate within 
nodal blebs which was detectable 15 minutes after a stretch injury. This 
correlated with a reduction in labelling for Ca-ATPase activity on the 
nodal axolem m al58. The node of Ranvier is the specialised region of the 
axolemma in which there are localised groups of Na+ channels , ATPase 
driven pumps for calcium and a Na+/Ca2+ e x c h a n g e r  159. Therefore, loss 
of membrane pump activity in the nodal axolemma might provide a 
mechanism for influx of free calcium into nodes of Ranvier after 
traumatic injury. This evidence supports the hypothesis that the forces of 
traumatic injury result in a focal pertubation of the axolemma with the 
resultant influx of free calcium capable of activating neutral proteases.
Biophysical investigations have utilised novel techniques to analyse the 
axolemma in experimental conditions analagous to non-disruptive axonal 
injury. Following mild stretch-injury a series of constrictions and 
expansions occurs in sciatic nerve fibres from the adult rat. This form 
change is known as beading 160-162 The transformation of the 
essentially cylindrical form of the normal nerve fibre to one that is beaded 
occurs rapidly, within 10-20 seconds on initiation of stretch. Initial 
experimental data suggested that beading is brought about by a 
mechanism related to the axolemma and/or the cytoskeleton 153. The 
tensegrity mechanism suggested that stretch may engage the membrane
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skeleton 163 jn thjs mechanotransduction model, the transmembrane 
protein pl-in tegrin  binds to both the extracellular matrix and the 
cytoskeleton 153. Tension placed on the matrix is signalled through p l-  
integrin to the cytoskeleton with resultant alteration in it’s integrity and 
spatial arrangement. Evidence in favour of this hypothesis was the change 
in stretch resistance of the pl-integrins when cytoskeletal components 
were disrupted 164. However, a recent study indicated that beading does 
not require an interconnected cytoskeleton as envisioned in the tensegrity 
model 36  Moreover, these results also excluded a causal relation or a 
necessary participation of the cytoskeleton. The intriguing conclusion is 
that the axolemma is the initiating site of beading constriction 36  The 
forces of stretch-injury are transm itted to the axolem m a by 
transmembrane proteins resulting in beading constriction. It is worthy of 
speculation that beading may be part of the biological process that is 
described as reactive axonal change in the literature related to 
traumatically induced axonal injury.
Within the last three years the involvement of the axolemma in the 
pathogenesis of axonal injury has become established. The seminal 
observations of Maxwell et al (1993) demonstrated that severe traumatic 
brain injury was capable of direct renting of the axolemma following 
lateral acceleration head injury in non-human primates 165. This study 
was the first to provide ultrastructural evidence which supported the 
concept of axonal shearing in traumatic injury to the brain. The loss of 
axolemmal integrity was associated with rapid dissolution of the axonal 
cytoskeleton. In the axons demonstrating axolemmal renting or
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fragmentation, the fibrous/filamentous organisation of the cytoskeleton 
was replaced by a flocculent precipitate consistent with a rapid 
dissolution of the underlying cytoskeletal proteins. These changes were 
detected within minutes of injury but only occurred in a sub-population of 
fine calibre, thinly myelinated axons after severe injury. These 
morphological changes represented an acute response of axons to injury 
and was termed " primary axotomy" - defined as occurring within 
minutes of injury, in contrast to delayed secondary axotomy which 
developes over a period of hours. In the same experimental material there 
was no evidence of disruption of the axolemma one hour after injury. 
This suggests that the disrupted axonal membrane reseals within an hour 
of injury.
Following this publication, Povlishock and colleagues were forced to 
reconsider their central hypothesis which did not include a role for the 
axolemma in the initiation of traumatically induced axonal injury. On 
reflection, they suggested that direct renting of the axolemma may 
represent the most severe end of a spectrum of axolemmal disruption 111. 
This was a major turning point, in that, for many years this research group 
had advocated that there was no evidence of direct alterations in the 
axolemma following injury in any of the numerous paradigms they had 
investigated. Moreover, they had argued that the pathobiology of 
traumatically induced axonal injury resulted from the direct impairment 
of axoplasmic transport due to the forces of injury disrupting the axonal
cy toskeleton37,107,108
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In a series of experiments designed to investigate this issue, Povlishock 
and colleagues employed the extracellular tracer, horseradish peroxidase, 
to determine if direct alterations in the axolemma were detectable in 
traumatic brain injuries of mild and moderate severity H l» 1 1 2 e This 
novel approach was based on the principle that macromolecular tracers, 
such as horseradish peroxidase, are normally excluded from the axoplasm 
by an intact axolemma. Therefore, detection of intra-axonal peroxidase 
activity would constitute evidence of axolemmal disruption. Furthermore, 
the site of peroxidase activity would delineate the initial site of axonal 
pertubation, allowing insight into the initiating factors involved in the 
pathogenesis of secondary axotomy. Their findings demonstrated that the 
pathobiology of traumatically induced axonal injury was a heterogeneous 
and complex process involving multiple and varied initiating pathologies.
In particular, the severity of the traumatic injury determined subsequent 
events in the axolemma and the cytoskeleton resulting in a differential 
response to the insult. Specifically, following moderate injury, direct 
pertubations of the axolemma reflected in its altered permeability to 
macromolecules were detected m .  This was associated with a rapid 
local compaction of axonal neurofilaments as evidenced by a decrease in 
the inter-filament distance. However, following mild traumatic brain 
injury no evidence of alterations in the axolemma were detected and a 
different set of cytoskeletal abnormalities, with misalignment and axonal 
swelling, were demonstrated. A differential response to injury had 
previously been described in a compression loading model of axonal 
injury 166. With low tensile loading, axons assessed in vitro, show
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axoplasmic disruption independent of any change in axolemmal integrity, 
entirely consistent with those changes described with mild traumatic brain 
injury. With more severe injuries, the same axons revealed axolemmal 
change that correlates with dramatic axoplasmic failure. Subsequent 
studies have extended these findings by demonstrating that these 
alterations in the axolemma and in the cytoskeleton are neither model 1 ^  
or species s p e c i f i c F u r t h e r m o r e ,  following the demonstration of 
traumatically induced alterations in axolemmal perm eability they 
suggested that calcium may be involved in the initiation of cytoskeletal 
events. This apparent contradiction with former views stemmed from the 
fact that they posited that calcium was acting through previously 
unidentified mechanisms. Instead of activating proteolytic enzymes, 
calcium may act less dramatically to alter the neurofilament sidearms, 
causing the neurofilaments to collapse resulting in their increased packing 
density. Conceivably these neurofilament sidearms could be cleaved by 
calcium mediated processes that act on these heavily phosphorylated 
sidearms. The overall conclusion was that there appeared to be at least 
two initiating mechanisms in the pathobiology of reactive axonal change, 
one involving the axolemma and the other involving the cytoskeleton 
directly 1  ^1,112,114
However, it must be emphasised that these important studies consistently 
detected another population of large calibre myelinated fibres that 
demonstrated the features of reactive axonal change without any evidence 
of axolemn\al pertubation reflected in peroxidase passage from the 
extracellular to axoplasmic compartments 111*112. This suggests that
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alteration in axolemmal permeability to macromolecules, is not essential 
for the genesis of reactive axonal change. Alternatively, it also raises the 
possibility that, following injury, the axolemma may be permeable to 
sm aller molecular species capable of evoking changes in the 
cytoskeleton. Macromolecules such as horseradish peroxidase may be too 
large to pass through smaller disruptions in the axolemma with the result 
that the axoplasm remained peroxidase negative despite the presence of 
membrane pertubation.
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CHAPTER 2 - MATERIALS AND METHODS
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2.1 ACUTE SUBDURAL HAEMATOMA IN THE RAT
Animals
All investigations were carried out on adult male Sprague-Dawley rats 
(Harlan Olac., Bicester, Oxon, U.K.) weighing 300-450g. The animals 
were maintained on a 12 hour light: dark cycle and allowed free access to 
food and water prior to experimentation. All animal experimentation was 
carried out under the appropriate Home Office licence.
General Surgical Preparation
The rat was placed in a Perspex chamber and anaesthetised using a 
mixture of 4% halothane, 30% oxygen and 70% nitrous oxide. The 
animal was removed from the chamber and placed supine. A 
tracheostomy was then perfomed and the animal was connected to a 
mechanical ventilator and maintained thereafter with a nitrous 
oxide/oxygen mixture (70%:30%) containing 0.5%-1% halothane. 
Polythene catheters ( Portex: external diameter 0.96mm; internal diameter
0.58mm) were inserted into both femoral arteries , for continuous mean 
arterial blood pressure monitoring (P231D Gould Stratham, Model 2202) 
and blood gas analysis. The left femoral vein was cannulated for 
administration of fluids and the withdrawal of venous blood as required. 
The wounds were closed with nylon sutures. Body temperature was 
monitored throughout the operative procedure by a rectal thermometer,
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and maintained normothermic (37 ± 0.5° C) via a heating blanket 
controlled by the thermometer.
Production of Acute Subdural Haematoma in the rat
The anaesthetised rats were turned prone and mounted in a stereotactic 
frame (Kopf, Clarke Electromedical). A midline scalp incision was made, 
the skin retracted with a self retainer and the coronal and sagittal sutures 
identified. A burr hole 3mm in diameter was drilled 2mm to the left of the 
sagittal suture and 1mm posterior to the coronal suture. Using an 
operating microscope, the dura was incised and a blunt, pre-bent J-shaped 
needle was inserted into the subdural space with the curved tip pulled up 
against the overlying dura. Rapid-curing cyanoacrylate glue was used to 
seal the burr hole and secure the position of the needle. The subdural 
haematoma was created by the injection of 0.4ml of non-heparinised, 
freshly withdrawn autologous venous blood into the subdural space over 
a period of seven minutes. 0.4ml of saline was infused slowly via the 
femoral venous cannula. The needle was then cut and sealed with glue to 
prevent back flow. The scalp wound was sutured with nylon. Control 
animals had insertion of the needle only. Animals were randomly 
allocated to control or lesion groups and allowed to survive for 30 
minutes, 2 hours or 4 hours.
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Physiological Variables
The mean arterial blood pressure (MABP) was monitored continuously 
(P231D Gould Stratham, Model 2202) and maintained at levels above 
90mmHg by adjusting the inspired halothane concentration if required. 
Arterial blood samples were taken before, 30 minutes after and at hourly 
intervals following insertion of the needle into the subdural space. These 
samples were used for the determination of the respiratory status (p(>2, 
p C 02, and pH) by a blood gas analyser ( 238pH/Blood Gas System, Ciba 
Coming). Respiratory volume was adjusted to maintain p C 0 2 between 
34-42mmHg (normocapnia), and adequate arterial oxygenation ( p 0 2 
>100mmHg) throughout. Body temperature was monitored by a rectal 
thermometer and the animals maintained normothermic via a heating 
blanket controlled by the thermometer. Extreme caution was taken to 
avoid any procedure ( e.g. direct heating of the head) which could alter 
artifactually the gradient between deep body temperature and brain 
temperature.
Brain Tissue processing for histology and immunohistochemistrv. 
Transcardiac Perfusion
At the end of the procedure the halothane anaesthesia was deepened and 
the animal placed supine. A midline thoracotomy exposed the heart. A 
needle was inserted via the left ventricle into the ascending aorta and 
clamped in position with a surgical clip. The right atrium was incised and
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ice-cold heparinised saline (5000 units/litre) was infused at a pressure 
equal to the mean arterial blood pressure until the effusate from the right 
atrium was clear of blood. 200mls of 4% paraformaldehyde in 50mM 
sodium phosphate buffer (PAM) was then infused at the same pressure. 
The animal was decapitated, the brain removed and post-fixed in 4% 
paraformaldehyde in phosphate buffered saline at 4° C for 48 hours. After 
this it was cryoprotected for 2-3 days in 30% sucrose in 50mM sodium 
phosphate buffer at 4°C. Following this the brain was frozen in 
isopentane at -42° C for two minutes. 30|im coronal sections were cut in a 
cryostat and stored in cryoprotectant solution (30% glycerol/30% ehylene 
glycol in sodium phosphate buffer) at -20 0 C.
Histology
Brain sections were mounted onto poly-lysine coated slides and stained 
with haemotoxylin and eosin as follows :
1. Air dry the sections.
2. Dehydrate in alcohol 70%-90%-100% each for two minutes.
3. Re-hydrate in alcohol 100%-90%-70% each for two minutes.
4. Wash in distilled water - 1 minute.
5. Haematoxylin - 5 minutes.
6. Wash in distilled water - 3 minutes.
7. Differentiate in acid alcohol (1%  hydrochoric acid in alcohol).
8. Wash in distilled water - 3 minutes.
9. Wash in Scots tap water substitute- 2 minutes.
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10. Wash in distilled water - 3 minutes.
11. Aqueous eosin -3 minutes.
12. Wash in distilled water - 2 minutes.
13. Dehydrate in alcohol 70%-90%-100% each for two minutes.
14. Histoclear - 4 minutes .
Immunohistochemistrv
Free floating tissue sections were rinsed in 50mM phosphate buffered 
saline (PBS) and incubated in PBS containing 0.2% Triton X-100 for 30 
minutes. Endogenous peroxidase activity was blocked by incubating in 
3% hydrogen peroxide for 20 minutes.
Monoclonal antibody immunohistochemistrv
Following two rinses in PBS the sections were incubated for one hour in a 
PBS blocking solution containing 10% normal horse serum and 1% 
bovine serum albumin. Incubation with the primary antibody (Tau-1, 1: 
1000; MAP 2, 1:750; p-tubulin, 1:1000 ), was overnight at 4° C. After 
two rinses with PBS, primary antibody immunostaining was performed 
using a biotinyated horse anti-mouse secondary antibody (1:100) pre­
adsorbed against rat serum for one hour (Vector Laboratories). Sections 
were then incubated with an ABC Vectastain complex for one hour and 
peroxidase activity was visualised with 3,3'-diaminobenzidine (Sigma) as 
the chromogen. Negative controls were included in each experiment 
where the primary antibody was omitted from the procedure. Sections
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were then mounted onto poly-lysine slides, dehydrated, cleared and 
coverslipped in preparation for microscopic examination.
Polyclonal antibody immunohistochemistrv
Following two rinses in PBS the sections were incubated for one hour in a 
PBS blocking solution containing 10% normal goat serum and 0.5% 
bovine serum albumin. Incubation with the primary antibody (1:5000), 
was overnight at 4°C. After two rinses with PBS, primary antibody 
immunostaining was performed using a biotinyated goat anti-rabbit 
secondary antibody (1:100) pre-adsorbed against rat serum for one hour 
(Vector Laboratories). Sections were then incubated with an ABC 
Vectastain complex for one hour and peroxidase activity was visualised 
with 3,3'-diaminobenzidine (Sigma) as the chromogen. Negative controls 
were included in each experiment where the primary antibody was 
omitted from the procedure. Sections were then mounted onto poly-lysine 
slides, dehydrated, cleared and coverslipped in preparation for 
microscopic examination.
Description of the antibodies
The Tau-1 monoclonal antibody recognises a non-phosphorylated epitope 
on tau located between amino acids 192-204. Tau-1 binding to tau in 
axons is increased and, is only detected in neuronal perikarya and glia in 
normal rat brain sections, after dephosphorylation of the tissue 167 The 
MAP 2 monoclonal antibody (clone HM-2; Sigma) reacts with all known
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isoforms of MAP 2, namely MAP 2a, MAP 2b and MAP 2c. In normal 
adult brain it's cellular localisation is differentially distributed in dendrites 
and neuronal cell bodies. Monoclonal anti (5-tubulin (clone no. 2-28-33; 
Sigma) localises (5-tubulin in human and rat tissue providing a specific 
and useful tool in studying the intracellular distribution of tubulin and the 
static and dynamic aspects of the cytoskeleton. The antibody (Ab38) used 
to detect the breakdown products of spectrin specifically generated by 
calpain proteolysis was provided by Smith Kline and Beecham Inc. 
(Harlow, England). The antibody recognises the COOH-terminus of the 
NH2-terminal spectrin fragment. This antibody shows minimal reactivity 
with intact spectrin or with spectrin breakdown products generated by 
proteases other than calpain. The production and characterisation of each 
of the antibodies has been described in detail previously (Tau-1: 94,167? 
MAP 2: 8 0 , P -  tubulin : 168,169 and Ab38 17°).
In preliminary studies, serial dilutions of all antibodies were performed to 
determine the optimum concentration of antibody to be used in the 
definitive investigations.
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Western blots
Preparation of tissue homogenate samples
At 30 minutes or 4hr following the placement of the needle (sham 
operated) or subdural haematoma induction (lesion), the animals were 
decapitated. The brain was rapidly removed and the area of cortex 
underlying the haematoma and corresponding contralateral area of cortex 
dissected out on ice and frozen in liquid nitrogen. Tissue homogenates 
were prepared by homogenising the frozen tissue with a Polytron in ice- 
cold 5mM HEPES buffer pH8 containing 0.32 M sucrose, 5mM 
benzamidine, 2mM P-mercaptoethanol, 3mM EGTA, 0.5mM M gS04, 
10mm sodium vanadate, O.lmM phenylmethylsulfonylflouride, 2(ig/ml 
leupeptin, 5fig/ml pepstatin A, 2|ig/ml aprotinin. The homogenate was 
centrifuged at 10 OOOg for 15minutes at 4°C and the supernatant carefully 
removed. The protein content of the supernatant was determined 
according to the method of Lowry et al. (1951) 1^1. The protein was 
adjusted to a protein concentration of 1 mg/ml. Samples were then 
solubilised with buffer composed of 0.1M sucrose, 3% sodium dodecyl 
sulphate (SDS), 2mMNa2EDTA, 60mMTris, pH6.9 and 1% p- 
mercaptoethanol, 0.05% bromophenol blue. Prior to loading on to the gel, 
samples were heated to 37°C for lOminutes.
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SDS-Polvacrvlamide gel electrophoresis (SDS-PAGE) and protein 
transfer
40|ig protein from ipsilateral and contralateral cortex of sham-operated 
and acute subdural haematoma animals were separated by SDS-PAGE (5- 
20% gradient gel for Tau-1 and p-tubulin; 5-15% gradient gel for MAP2). 
The gels were run overnight at a constant current of 6mA per gel using an 
electrophoresis buffer composed of 190mMglycine, 25mM Tris and
0.1%SDS. After electrophoresis, the proteins were transferred to 
nitrocellulose membranes (Schleicher and Schuell, 0.45jim) at 80V for 
3hours in buffer composed of 190mM glycine, 25m M Tris and 
20%methanol. The extent of transfer and equity of protein loading on the 
gel were checked by staining the gel in a solution containing 0.05% 
comassie brilliant blue R, 50%methanol and 10%acetic acid and 
destaining the gel in the same solution minus the comassie brilliant blue 
R.
Detection of protein bands
After transfer the nitrocellulose blots were incubated in Tris-buffered 
saline, TBS (20mMTris-HCl pH7.5, 0.5M sodium chloride, 0.2%Tween- 
20, TBS-T) containing 3%non-fat dried milk for 2hr at room temperature 
to block non-specific binding sites. The blots were then washed three 
times for ten minutes in TBS-T and incubated overnight at 4°C with 
primary antibodies diluted in TBS-T (Tau-1 1:1000, MAP 2 1:750, p -  
tubulin 1:500). Blots were then washed as before and incubated with
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biotinylated anti-mouse (1:500 in TBS-T, Vector labs.) for lh r at room 
temperature. Following three washes in TBS-T, blots were then incubated 
with streptavidin-alkaline phosphatase (1:1500 in blocking buffer, 
Amersham) for lhour at room temperature. The blots were washed and 
developed using an alkaline phosphatase substrate kit (Bio-Rad).
Measurement of protein bands : Relative optical density.
The resultant protein bands were measured as a relative optical density 
value using an image analyser (MCID) connected to a camera and 
corrected for background. In each case five arbitary points were measured 
within the selected immunoreactive band. The relative optical density 
values from the ipsilateral and contralateral cortices of injured and control 
animals were compared using Student's paired t-test.
Brain Tissue processing for transmission electron microscopy (T.E.M.l
Transcardiac Perfusion
At the end of the procedure the inspired halothane was increased to 3% 
and the animal placed supine. A midline thoracotomy exposed the h e a rt. 
A needle was inserted via the left ventricle into the ascending aorta and 
clamped in position with a surgical clip. The right atrium was incised and 
ice-cold heparinised saline (5000 units/litre) was infused at a pressure 
equal to the mean arterial blood pressure until the effusate from the right 
atrium was clear of blood. At this point 250 mis of 2.5% glutaraldehyde
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in a 0.2M Pipes (piperazine N-N'-bis-2-ethanol sulphonic acid) buffer 
(pH 7.6) was infused over 60 minutes. The animal was then decapitated, 
the brain dissected out and post fixed in 2.5% glutaraldehyde in a 0.2M 
Pipes buffer (pH 7.6) for 48hours at 4° C. Following this stage, the 
cerebral hemispheres were detached from the brain stem and cerebellum 
and cut into 6mm thick coronal slices and stored in the same fixative.
Transmission Electron Microscopy
Three to five l-m m 3 blocks of tissue were removed from the cerebral 
cortex under the acute subdural haematoma and the ipsilateral corpus 
callosum. Control tissue ( sham operated) and naive ( perfusion fixation 
only) was also prepared. Blocks were osmicated in 1 % osmium tetroxide 
in 0.2M Pipes buffer for 1 hour. Rinsed three times in 0.2M Pipes buffer 
and then dehydrated in alcohols and propylene oxide as follows :
1. 70% alcohol for 20 minutes.
2. 90% alcohol for 20 minutes.
3. 100% alcohol for 20 minutes.
4. Rinsed three times in Propylene oxide for 15 minutes each rinse.
Following dehydration the specimens were embedded in Araldite resin 
using epoxy propane as an intermediary. Transverse semithin sections 
were cut from all blocks using a glass knife. Serial thin sections were cut 
on a diamond ultramicrotome from one randomly selected block from 
each animal and stained in 12.5% methanolic uranyl acetate and lead
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citrate for ultrastructural examination on a Philips 301 transmission 
electron microscope.
2.2 ACUTE SIJBDIJRAL HAEMATOMA IN HUMAN POST MORTEM 
TISSUE
Post Mortem Brain Tissue
All cases of fatal head injury had been managed by the Department of 
Neurosurgery, Institute of Neurological Sciences, Southern General 
Hospital, Glasgow and ethical committee approval had been granted for 
the use of this tissue in these studies. Subjects sustaining an acute 
subdural haematoma were identified from autopsy examination. Control 
patients had no known history of neurological or neuropsychiatric 
impairment. All brains in both groups were free from gross tissue 
abnormalities such as tumours and infarcts. The charateristics of control 
and acute subdural haematoma brains are listed in Tables 1 and 2.
Full autopsies were performed on each case. Brains were fixed in 10% 
formol saline for at least three weeks before dissection. Cerebral 
hemispheres were cut in the coronal plane, the cerebellum at right angles 
to the folia, and the brain stem horizontally. Standard blocks of tissue 
were cut from these slices. Comprehensive studies were carried out in 
each case including assessments of the amount of contusional injury, the 
severity of any diffuse axonal injury, the severity of any ischaemic brain
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damage and whether the intracranial pressure had been high during life as 
a result of a supratentorial expanding lesion. A similar number of controls 
matched for age and gender, were also studied.
All autopsies and gross dissection of the brains were performed by the 
Department of Neuropathology, Institute of Neurological Sciences, 
Southern General Hospital, Glasgow.
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Table 1
Clinical and neuropathological details of fatally head injured patients with 
an acute subdural haematoma.
Case
No.
Age Sex Survival Post
mortem
delay
Cause
of
death
Intracranial
haematoma
Ischaemic
brain
•damage
H 33 51 M 12.5d 67h raised ICP Left ASDH 
(E)
Extensive
H 35 62 M 27h 17h raised ICP Left ASDH 
(NE)
Extensive
H 21 41 M 17h 42h raised ICP Right
ASDH(NE)
Minimal
H 34 21 M 216d 67h raised ICP Left ASDH 
(E)
Severe
H 25 52 M 96h 120h raised ICP Left ASDH 
(E)
Extensive
H 27 47 M 60h 69h raised ICP Left ASDH 
(E)
Extensive
Abbreviations used : ASDH: acute subdural haematoma E: evacuated, N: not evacuated,
IC P : intracranial pressure
Table 2
Clinical details of neurological control patients.
Case
No.
Age Sex Survival Post
mortem
delay
Cause 
of death
Head 
Injury or 
intracranial 
haematoma
Other
major
pathologies
N8 64 F Oh 31h I.H.D. No None
N6 68 F 4h 22h I.H.D No None
N4 52 M Oh 63h I.H.D No None
N12 29 F Oh 48h P.T.E. No None
N1 77 F Oh 42h I.H.D. No None
N5 80 F Oh 62h R.A.A.A. No None
N7 71 M Oh 57h I.H.D No None
N il 59 M Oh 45h M.I. No None
N10 62 M Oh 54h P.T.E. No None
Abbreviations used : I.H .D .: ischaemic heart disease,
P .T .E .: pulmonary thromboembolism,
R.A.A.A.: ruptured abdominal aortic aneurysm.
Processing of brain tissue for histology and immunohistochemistrv
The blocks of brain were post fixed in 4% paraformaldehye ( PAM) in a 
sodium phosphate buffer at 4°C for 4 days . After 24 hours the PAM was 
changed and any membranes or blood vessels adherent to the brain tissue 
removed. The blocks were then transferred to 30% sucrose in 50mM 
sodium phosphate buffer at 4° C and cryoprotected for 5 days. Solutions 
were changed as necessary. Following this the block was frozen in 
isopentane at -42°C for two minutes. 30p,m coronal sections from the 
superior sagittal blocks were cut in a cryostat, mounted onto polylysine 
slides and stored at -80°C.
Histology
Human brain tissue sections were stained with haemotoxylin and eosin as 
follow s:
1. Air dry the sections.
2. Dehydrate in alcohol 70%-90%-100% each for two minutes.
3. Re-hydrate in alcohol 100%-90%-70% each for two minutes.
4. Wash in distilled water - 1 minute.
5. Haematoxylin - 5 minutes.
6. Wash in distilled water - 3 minutes.
7. Differentiate in acid alcohol (1%  hydrochoric acid in alcohol).
8. Wash in distilled water - 3 minutes.
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9. Wash in Scots tap water substitute- 2 minutes.
10. Wash in distilled water - 3 minutes.
11. Aqueous eosin -3 minutes.
12. Wash in distilled water - 2 minutes.
13. Dehydrate in alcohol 70%-90%-100% each for two minutes.
14. Histoclear - 4 minutes .
Immunohistochemistrv
The sections were rinsed twice in 50mM phosphate buffered saline 
(PBS) and incubated in PBS containing 0.2% Triton X-100 for 30 
minutes. Endogenous peroxidase activity was blocked by incubating in 
3% hydrogen peroxide in methanol for 20 minutes. Following two rinses 
in PBS the sections were incubated for one hour in a PBS blocking 
solution containing 10% normal horse serum and 1% bovine serum 
albumin (BSA). Incubation with the primary antibody ( Tau-1 , 1: 750; 
MAP 2, 1:750; p-tubulin, 1:750 ) was overnight at 4° C. After two rinses 
with PBS, primary antibody immunostaining was performed using a 
biotinyated horse anti-mouse secondary antibody (1:100) pre-adsorbed 
against rat serum for one hour (Vector Laboratories). Sections were then 
incubated with an ABC Vectastain complex for one hour and peroxidase 
activity was visualised with 3,3'-diaminobenzidine (Sigma) as the 
chromogen. Negative controls were included in each experiment where 
the primary antibody was omitted from the procedure. Sections were then 
dehydrated, cleared and coverslipped in preparation for microscopic 
examination.
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2.3 AXOLEMMAL PERMEABILITY FOLLOWING TRAUMATIC
BRAIN INJURY 
Animals
All investigations were carried out on adult male Sprague-Dawley rats 
(Hilltop Lab Animals Inc., Scottsdale, PA) weighing 350-400g. All 
animals were housed in individual cages in a climate controlled room 
and allowed intake of water and rat chow, ad libitum. All protocols for 
injury and use of animals were approved by the Institutional Animal Care 
and Use Committee.
Surgical Preparation
The rat was placed in a Perspex chamber and anaesthetised using a 
mixture of 4% halothane, 30% oxygen and 70% nitrous oxide. The 
animal was removed from the cham ber and placed supine. A 
tracheostomy was then perfomed and the animal was connected to a 
m echanical ventilator and maintained thereafter with a nitrous 
oxide/oxygen mixture (70%:30%) containing 0.5%-1% halothane. Body 
temperature was monitored throughout the surgical procedure by a rectal 
thermometer, and maintained normothermic ( 37±0.5 °C) via a heating 
blanket controlled by the thermometer.
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Cannulation of the cistema magna and withdrawal of cerebro-spinal fluid 
(CSF).
The anaesthetised rat was placed prone and attached to a stereotactic 
frame (Kopf, Clarke Electromedical). The rats head was positioned in the 
frame to provide optimal flexion of the cervical spine w ithout 
compromising the airway. A 1.5cm midline incision was made from the 
occiput to the posterior tubercle of the atlas and the atlanto-occipital 
membrane identified, and directly visualised, with a combination of blunt 
and sharp dissection. A 25 guage spinal needle was attached to an arm of 
the stereotactic frame and positioned superior to the atlanto-occipital 
membrane. The needle was advanced slowly penetrating the atlanto- 
occipital membrane. The cisterna magna was tapped and 0.05cc of 
cerebro-spinal fluid(CSF) was slowly withdrawn into a tuberculin 
syringe. This CSF was mixed with 5mg of microperoxidase (Sigma 
Chemical Co., St.Louis, MO, USA) or 5mg of horseradish peroxidase 
(Sigma Chemical Co., St.Louis, MO, USA) and the mixture was slowly 
reinfused into the cistema magna from where the tracer could diffuse 
through the CSF compartment to reach the extracellular space. The needle 
was withdrawn and the wound closed with nylon sutures. The animal was 
removed from the stereotactic frame and placed supine on the heating 
blanket. The extracellular tracer was allowed to circulate for thirty 
minutes. During this time the animal was prepared for transfer to the 
injury device. Animals were randomly allocated to control or lesion 
groups.
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Production of the impact acceleration closed head injury in the rat.
A midline scalp incision was performed and the periosteum covering the 
vertex reflected. A stream of air was used to keep the area dry. A stainless 
steel disc, 1cm in diameter and 3mm thick, was fixed to the central 
portion of the skull vault between the coronal and lambdoid sutures with 
dental acrylic. The adhesive was left to dry for five minutes. The animal 
was disconnected from the respirator, transferred to the injury device and 
placed in a prone position on a foam bed of known spring constant ( Type 
E bed manufactured by Foam to Size, Inc., Ashland, Virginia) contained 
within a Plexiglass frame. Two belts secure the rat to the foam bed. The 
lower end of the vertical section of the plexiglass tube was positioned 
directly above the stainless steel disc. The injury was delivered by 
dropping the brass weight (450grammes) from 2 metres through the 
vertical section of the plexiglass tube onto the metallic disc. Rebound 
impact was prevented by sliding the foam bed containing the animal away 
from the tube immediately following the initial impact. The animal was 
then re-connected to the ventilator. No animal was disconnected from the 
ventilator for more than one minute. Post injury observations were made 
for convulsions, haemorrhage or the presence of a skull fracture. Control 
animals were exposed to mock injury with the same temporal course of 
anaesthesia. The metallic disc was removed, the scalp sutured and the 
animal allowed to survive for 5,15, or 60 minutes post injury.
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Brain Tissue Processing for histochemistry and electron microscopy
Transcardiac Perfusion
At the end of the procedure the halothane was increased to 3% and the 
animal placed supine. A midline thoracotomy exposed the heart. A needle 
was inserted via the left ventricle into the ascending aorta and clamped in 
position with a surgical clip. The right atrium was incised and ice-cold 
heparinised saline (5000 units/litre) was infused at 90mmHg until the 
effusate from the right atrium was clear of blood. 700mls of fixative 
containing 2.5% glutaraldehyde and 2% paraformaldehyde in a sodium 
phosphate buffer was then infused at the same pressure over a period of 
one hour. The animal was decapitated and the brain removed taking care 
to preserve the cervical spinal cord. Next, the brainstems were blocked 
sagittally and transferred to the stage of a vibratome, where 50pm serial 
sections were obtained. Alternate serial sections were prepared for the 
histochemical visualisation of the microperoxidase or processing for 
electron microscopy. All sections were stored in a sodium phosphate 
buffer at 4°C.
Histochemistry : The Cohalt-Glucose Oxidase Reaction
Sections selected for peroxidase reaction product visualisation were 
processed using a cobalt-glucose oxidase reaction. The vibratomed 
sections were rinsed three times in a Tris-buffered saline (TRIS) pH 7.6 
and then reacted with 0.5% cobalt chloride in Tris-buffered saline for 10
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minutes. Then three rinses in Tris-buffered saline and two rinses in 0.1M 
sodium phosphate buffer. The sections were then incubated twice for 1 
hour at 37°C with 0.05% diaminobenzidine, 0.2% B-D glucose, 0.04% 
ammonium chloride, and 0.00041% glucose oxidase type II in a 0.1M 
sodium phosphate buffer solution and rinsed three times for 5 minutes in
0 . 1 .  sodium phosphate buffer. Sections were mounted on glass slides, 
dehydrated and cleared with alcohol and xylene for light microscopic 
evaluation.
Transmission Electron Microscopy
The alternate serial sections selected for electron microscopy were 
osmicated in 1% Osmium Tetroxide in a phosphate buffer (0.1M 
Sorensen buffer, pH 1 .2 -13 )  for one hour. Rinsed three times in 0.1M 
sodium phosphate buffer and then dehydrated in alcohols and propylene 
oxide as follow s:
1. 30%, 40%, 50%, 60%, 70% alcohol for 5 minutes in each.
2. 80%, 95%, 95%, 100%, 100% alcohol for 10 minutes each.
3. Rinsed twice in Propylene oxide for 10 minutes each rinse.
4. Rinse once in 100% alcohol/ propylene oxide ( 50:50 mix) for 5 
minutes.
The tissue sections were then placed on an agitator overnight in a 50:50 
mixture of propylene oxide and eponate 12. Following this, the solution 
was changed and the sections were placed in 100% eponate 12 and
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agitated for 4 hours. The sections were then flat embedded in Medcast 
resin on plastic slides ( Thomas Scientific Co.) and incubated overnight at 
60 °C. The next day the plastic slides were separated and the sections 
further incubated at 60 °C for 24-30 hours. These flat embedded materials 
were screened at the light microscopic level and compared with those 
sections cleared for light microscopy.
Regions demonstrating extracellular peroxidase or intraaxonal peroxidase 
influx or both were identified in the cleared sections, and comparable 
regions of the flat embedded materials examined for the presence of the 
peroxidase reaction product. Once those regions dem onstrating 
peroxidase activity were identified, they were cut out and mounted on 
Medcast resin blocks. Thick sections of 1.5|im were cut on an LKB 2128 
ultramicrotome with glass knives. Thin sections were cut with a diamond 
knife ( Diatome), picked up on Formvar-coated slotted grids, and stained 
in 5% uranyl acetate in 50% methanol and 0.3% lead citrate for 
ultrastructural examination on a JEOL 1200 electron microscope.
Quantitative analysis of peroxidase containing axons
Both the horseradish peroxidase (HRP) and the microperoxidase (MP) 
slides were examined under a microscope ( Nikon Inc., xlO). Based upon 
the finding that peroxidase flooded axons occurred mainly in the lateral 
ponto-medullary and cervico-medullary regions of the brain stem, the 
lateral ponto-medullary junction was selected for data analysis. In this 
region, five semi-serial 50}im sections from each animal were randomly
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selected and detailed analysis was carried out to determine the number of 
HRP and MP containing axons per unit area. The counting and area 
measurement were performed with the MCID M4 imaging program 
(Imaging Research Inc., St. Catharines, Ontario, Canada) using a Nikon 
BH-2 microscope (40x with a 2.5x intermediate lens). After the 
microscopic image was digitalised ( Dage MTI Inc., Michigan City, IN.), 
the flooded axons were counted and marked with a circle overlay on the 
image to prevent duplicate counting. The area in which the flooded axons 
were counted corresponded to the area covered by the monitor, 
encompassing 50,000 pm2. Once the values were obtained, the means and 
standard deviation was determined.
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CHAPTER 3 - RESULTS
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3.1 ALTERATIONS IN THE NEURONAL CYTOSKELETON
FOLLOWING ACUTE SUBDURAL HAEMATOMA IN THE RAT.
3.1.1 Physiological variables
At all time points examined there were no significant differences between 
the sham operated and subdural haematoma groups with respect to mean 
arterial blood pressure (MABP), arterial blood gas status or rectal 
temperature (Tables 3a-c). The production of a subdural haematoma 
caused an increase in MABP immediately following the infusion of 
blood (Cushing response). This was a consistent finding and in all 
cases the MABP returned to pre-infusion levels within 15 minutes.
3.1.2 Gross Neuropathology.
In all animals the haematoma was contained within the subdural space 
ipsilateral to the side of injection. It usually extended over much of the 
lateral aspect of the hemisphere, its thickest point measuring some 2-3mm 
in the posterior/parietal region. As a result of the mass effect of this 
haematoma there was deformation of the underlying cerebral hemisphere 
in all animals, the surface of which usually had an obvious concave 
contour.
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Table 3a
Physiological variables during the period of survival after production of an
acute subdural haematoma in the ra t: 30 minutes survival animals.
Sham operated group.
Time after 
insertion of 
needle
Mean arterial 
blood pressure 
(mmHg)
Temperature p02
(mmHg)
pC02
(mmHg)
pH
0 102±9 36.8± 0.3 156 ± 5 41.5 ± 1.3 7.42 ± 0.02
30 mins. 105±10 36.7± 0.1 162 ±9 42.0 ± 0.6 7.4l ± 0.03
Data are presented as mean ± SEM (n=7). Data represents values at the time of insertion 
of the needle into the subdural space and at thiny minutes.
Subdural haematoma group.
tim e after 
production of 
ASDH
Mean arterial 
blood pressure 
(mmHg)
Temperature p02
(mmHg)
pCOl
(mmHg)
pH
0 l64±li 36.7 ± 0.3 ” I47"±7 41.2 ±  1.7 7.39± 0.01
30 mins 106±14 36.9 ±  0.2 15b i  5 40.8 ± 1.1 7.44 ±  0.02
Data are presented as mean ± SEM (n=l 1). Data represents values at the time of 
induction of acute subdural haematoma (ASDH) and at thiny minutes.
Table 3b
Physiological variables during the period of survival after production of an
acute subdural haematoma in the ra t: 2 hour survival animals.
Sham operated group.
Time after 
insertion of 
needle 
(hours).
Mean Arterial 
Blood 
Pressure 
(mmHg)
Temperature p02
(mmHg)
pC02
(mmHg)
pH
0 100± 8 36.9± h i l 4 6 ± $ 42.5 ±1.3 7.41 ±  0.01
0.5 107±4 36.7± 0.1 162 ±7 42.3 ±  0.6 7.43 ±  0.02
1 105± id 36.9dt 0.1 162 ± 8 39.9 ±1.3 7.44 ± 0.01
2 95±4 37.0± 6.1 156 ±8 38.9 ± 0.7 7.41 ± 0.02
Data are presented as mean ± SEM (n=2). Data represents values at the time of 
insertion of the needle into the subdural space and at intervals thereafter.
Subdural haematoma group.
Time after 
production of 
ASDH 
(hours).
Mean Arterial 
Blood pressure 
(mmHg)
Temperature p02
(mmHg)
pC02
(mmHg)
" pH
0 100±6 36.7 ±  0.3 147 ± 7 41.2 ±  1.7 7.39± o.oi
0.5 102±17 36.9 ± 0.2 l5 0 ±  5 46.8 ±  1.1 7.44 ± 0.02
1 101±8 37.2± 6.1 157± 5 42.5± 0.9 7.383: O.oi
2 98±5 36.9 ± 0.1 155 ± 6 41.8 ± 1.0 7.41 ±0.01
Data are presented as mean ± SEM (n=6). Data represents values at the time of 
induction of acute subdural haematoma (ASDH) and at intervals thereafter.
Table 3c
Physiological variables during the period of survival after production of an
acute subdural haematoma in the ra t: 4 hour survival animals.
Sham operated group.
Time after 
insertion of 
needle 
(hours).
Mean Arterial 
Blood 
Pressure 
(mmHg)
Temperature
(°Q
p02
(mmHg)
pC02
(mmHg)
pH
0 105± 08 36.8± 0.1 135 ± 5 43.5 ±1.3 7.44 ± o.oi
0.5 108± 10 36.9± 0.2 152 ±10 42.3 ± 0.9 7.45 ± 0.02
1 106±07 36.9± 0.1 165 ± 8 38.5 ±1.4 7.43 ± 0.01
2 98± 10 37.0± 0.1 166 ±8 38.5 ± 0.8 7.42 ± 0.02
3 101± 11 37.0± 0.1 169 ± 7 40.1 ± 1.0 7.41 ± 0.03
4 1()0±05 57.0 ±  0.2 l 7 l ± 5 41.4 ± 0.5 7.42 ± 0.01
Data are presented as mean ± SEM (n=9). Data represents values at the time of 
insertion of the needle into the subdural space and at intervals thereafter.
Subdural haematoma group.
tune after 
production of 
ASDH 
(hours).
Mean Arterial 
Blood 
Pressure 
(mmHg)
Temperature p04
(mmHg)
pC04
(mmHg)
pH
0 102± 11 35.7 ± 0.4 137 ± 7 ' 41.4 ± 1.5 7.43 ± 0.01
0.5 107±5 36.9 ±0 .1 160 ± 5 39.8 ± 1.1 7.45 ± o.o4
1 102± 7 37.0 ±0.1 16 0±5 38.8 ± 1.0 7.44 ± o.oi
2 58±4 ' 36.5 ±0.1 150 ± 5 40.5 ± 0.9 7.41 ± 0.01
3 94± 8 37.0 ± 0.2 156 ± 4 40.5 ± 1.0 7.42 ± 0.01
4 95±9 36.9 ±0.1 165 ± 5 4 l . 0 ± 0 . 5 7.42 ± 0.02
Data are presented as mean ± SEM (n=15). Data represents values at the time of 
induction of acute subdural haematoma (ASDH) and at intervals thereafter.
Removal of the subdural haematomas revealed a cortical surface that was 
usually free of blood. However, there were one or two instances of small 
amounts of subarachnoid haemorrage and in many instances the 
meningeal vessels immediately beneath the subdural haematoma were 
engorged, in contrast to the remainder of the specimen which was 
essentially bloodless as a result of the perfusion fixation procedure.
Coronal sections of these specimens also revealed that the meningeal and 
intracortical vessels deep to the haematoma, were invariably engorged. 
This gave a pink appearance in contrast to the remainder of the specimen 
which was blanched white.
3.1.3 Neurohistopathologv.
With the exception of the tissue immediately beneath the haematoma the 
brains were well perfused and fixed and free of the histological artefacts,
" dark cell and hydropic cell change" 172 In contrast, the cortex 
beneath the haematoma was engorged and in a few instances a small 
amount of bleeding had occured into the cortex : this occured most often 
at the site of surgical procedure.
The histological appearances seen at 30 minutes, 2 hours and 4 hours 
were similar although more advanced with the longer survival times 
(Figure 3). The principal changes were those of a volume of tissue 
immediately beneath the subdural haematoma that was undergoing 
sequential changes consistent with early infarction.
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Figure 3
Ischaemic brain damage after induction of an acute subdural 
haematoma in the rat.
Coronal sections stained with haematoxylin and eosin 30 
minutes and 4 hours after production of an acute subdural 
haematoma in the rat. Note the region of pallor in the cortex 
underlying the haematoma. In addition, note the mechanical 
effect the haematoma has on the ipsilateral corpus callosum.
30min H+E
The margins of the affected tissue were evident at 30 minutes, as a band 
of tissue that was pale in the H&E stained sections as a consequence of 
loss of eosinophilia of neurones and vascuolation of the neuropil. Such 
changes extended from the superficial layers to the junction between grey 
and white matter and were present to an equal extent at all the margins. 
Medially, the margin of the lesion represented the "boundary" between 
the distributions of the middle and anterior cerebral arteries and laterally 
it was thought to represent the "boundary" between the distributions of 
the middle and posterior cerebral arteries.
At 30 minutes the neurones at the margin of the lesion were contracted, 
rather triangular in shape, and more basophilic in staining than usual, the 
appearances being those of the ischaemic cell process (Figure 4). These 
changes were in marked contrast to those seen in the adjacent normal 
tissue and indeed within the centre of the lesion, the neuronal staining 
properties and the histological appearance of which were entirely normal. 
After 2 hours the changes had evolved to the extent that the boundary was 
now more obvious with clear separation between affected and normal 
tissue. Again the boundary was sharp, measuring no more the 50-100p,m 
in width. At the boundary the neuronal changes had developed to the 
extent that some of them now demonstrated the features of the ischaemic 
cell process with incrustation formation. The vacuolation of the neuropil 
was more pronounced and minimal changes were seen in the astrocytes 
and microglia.
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Figure 4
The histopathological features of the ischaemic cell process 
after production of an acute subdural haematoma in the rat.
Micrograph of the rat cortex stained with haematoxylin and 
eosin 4 hours after production of an acute subdural 
haematoma. The cortex demonstrates features of the 
ischaemic cell process with early infarction, vacuolation of 
the neuropil and swelling of astrocytes.
By 4 hours the lesion had developed further with better definition of its 
boundaries. The ischaemic cell process at the margins of the lesion was 
also better developed. Although changes within the centre of the lesion 
were still minimal there was some variation in the intensity of staining, 
suggesting that early ischaemic changes were also beginning to develop 
within the centre of the lesion.
At none of the time points examined were abnormalities detected other 
than in the cortex immediately beneath the haematoma either within the 
ipsilateral or contralateral hemisphere. The extent and distribution of 
ischaemic brain damage following production of an acute subdural 
haematoma in the rat is indicated in Figure 5.
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Figure 5
The extent and distribution of ischaemic brain damage at 
eight predetermined stereotactic planes through the rat 
brain.
Reproduced with the permission of Mr R.Bullock and 
colleagues (Miller et al., 1990)

3.1.4 Immunohistochemical analysis of the microtubule component of the
neuronal cvtoskeleton following acute subdural haematoma in the rat
In total 24 animals were processed for immunohistochemistry. At each 
time point ( 30 minutes, 2 hours and 4 hours) 6 animals underwent 
induction of an acute subdural haematoma and 2 animals were sham 
operated only.
Tau -1
In control animals ( n= 2) the distribution of Tau-1 immunostaining was 
the same as has been previously described being predominantly localised 
to axons with minimal staining in the neuronal perikarya and glia 94,167
In all animals examined 4 hours after induction of a subdural haematoma 
(n=6) there was an increase in the intensity of Tau -1 immunostaining in 
the neuropil of the ipsilateral cerebral cortex compared to the contralateral 
cortex (Figure 6). A clear line of demarcation, which corresponded to the 
histologically defined boundary of ischaemic damage, was present. The 
enhanced immunolabelling of the neuropil was restricted to tissue within 
this region. A similar effect was detected 2 hours after production of an 
acute subdural haematoma although the increase in immunoreactivity of 
the neuropil was less pronounced than at 4 hours. No clear alteration in 
neuropil immunostaining was present in any of the 30 minutes post 
subdural haematoma( n=6) group. The neuropil of the contralateral
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cortex appeared similar to sham operated cortex throughout the post 
injury period, with no changes in Tau-1 immunoreactivity detected.
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Figure 6
Immunostaining of Tau-1 and MAP 2 in cerebral cortex 4 
hours after production of an acute subdural haematoma.
There is an increase in Tau-1 immunolabelling of the 
neuropil within the histologically defined ischaemic 
territory. A clear line of demarcation (arrows) indicates 
adjacent histologically non-ischaemic cortex underlying the 
haematoma. Note the pronounced loss of MAP 2 
immunoreactivity within the ischaemic region and the well 
defined boundary this forms with the adjacent histologically 
non-ischaemic brain.
MAP2
In all animals and, at every time point examined, characteristic cellular 
changes in Tau-1 immunorectivity were identified within the ipsilateral 
cortex of animals subjected to subdural haematoma compared to the 
contralateral cortex. Specifically, Tau-1 immunoreactivity was increased 
in a proportion of neuronal perikarya within the ischaemic region 
(Figure 7). Although isolated Tau-1 immunopositive perikarya could be 
identified throughout the ipsilateral cortex, these cells were most 
common at the boundary between histologically normal tissue and 
ischaemic tissue. There was no apparent laminar distribution of these 
cells within the cerebral cortex. Quantitative analysis was not 
performed but there was the distinct impression that the number of 
Tau-1 reactive neurones was decreased in the 4 hour group of 
animals compared to the 2 hour group. This decline correlated with 
the observed increase in the number of neurones demonstrating 
abnormal morphology in the corresponding histological sections.
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Figure 7
Immunostaining of Tau-1 in the cerebral cortex after 
induction of an acute subdural haematoma.
Immunostaining of Tau-1 in cerebral cortex in a sham 
operated rat (SHAM) and at 30 minutes, 2 hours and 4 
hours after production of an acute subdural haematoma. 
Note the increase in Tau-1 immunostaining in neuronal 
perikarya and glial cells in the cortex after acute subdural 
haematoma.
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As early as 30 minutes post injury the ipsilateral white matter tracts 
demonstrated disturbances in Tau-1 immunoreactivity compared to the 
contralateral white matter tracts (Figure 8). These changes progressed 
with time being most apparent in the 4 hour group of animals. Typically, 
the intensity of Tau -1 immunostaining was increased in the axons of the 
corpus callosum adjacent to the ischaemic lesion. The altered 
immunoreactivity appeared irregular with a granular effect and was most 
concentrated towards the midline of the brain. This appearance was in 
m arked contrast to the smooth, regular distribution of Tau-1 
immunostaining identified in the white matter tracts from both sham 
operated and contralateral subdural haematoma sections .
Numerous Tau-1 positive glial cells were detected, scattered throughout 
the injured hemisphere. This feature was present as early as 30 minutes 
following production of the subdural haematoma. The Tau-1 reactive 
glial cells were typically small round cells arranged in a linear pattern and 
were predominantly located in the white matter (Figure 8).
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Figure 8
Immunostaining of Tau-1 in myelinated fibre tracts in the 
corpus callosum after induction of an acute subdural 
haematoma.
Immunostaining of Tau-1 in myelinated fibre tracts in the 
corpus callosum in a sham operated rat (SHAM) and at 30 
minutes, 2 hours and 4 hours after production of an acute 
subdural haematoma. Note the progressive disruption in the 
pattern of Tau-1 immunostaining after acute subdural 
haematoma.
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Microtubule associated protein 2 (MAP 2 )
In control animals (n=2) the distribution of MAP 2 immunostaining was 
the same as has been previously described 83. MAP 2 was restricted 
to neurones, being preferentially associated with dendritic processes and 
not detected in axons. The dendrites were arranged in slender elongations 
radiating from the cerebral cortex and were more heavily stained than the 
neuronal cell bodies.
In all of the 4 hour subdural haematoma animals (n=6) there was a 
reduction in MAP 2 immunostaining in the cortex beneath the haematoma 
compared to the contralateral cortex. The area of decreased 
immunolabelling was well delineated with distinct margins and normal 
MAP 2 immunolabelling was maintained lateral to the affected area in the 
ipsilateral cortex (Figure 6). The histologically defined ischaemic lesion 
approximated to the MAP 2 immunonegative cortex. Within this area 
there was prominent loss of dendritic processes in comparison to the 
sham operated animals (Figure 9). Nevertheless, several densely stained, 
distorted dendrites were usually detectable and the occassional neuronal 
perikaryon was strongly immunoreactive. A similar, although less 
advanced, appearance was present in the cortex of animals examined 2 
hours after production of an acute subdural haematoma ( n=6). However 
in this group, the region of immunonegativity was less uniform than after 
4 hours and there was patchy preservation of MAP 2 immunostaining 
within the defined margins of the ischaemic lesion (Figure 9 ) . In 
contrast, 30 minutes post injury (n=6) the distribution and localisation of
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Figure 9
Immunostaining of MAP 2 in the cerebral cortex after 
induction of an acute subdural haematoma.
Immunostaining of MAP 2 in cerebral cortex in a sham 
operated rat (SHAM) and at 30 minutes, 2 hours and 4 
hours after production of an acute subdural haematoma. 
Note the progressive loss of MAP 2 immunostaining in the 
cortex after acute subdural haematoma. In addition, certain 
neuronal perikarya are MAP 2 immunopositive with 
prominent MAP 2 immunolabelled dendritic processes.
MAP 2, as detected by immunohistochemistry, was not effected by the 
subdural haematoma with no obvious alterations in the intensity of the 
cortical MAP 2 immunostaining detected at this time point.
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Of interest, the overall decrease in ipsilateral cortical MAP 2 
immunostaining did not effect all cortical layers to the same extent 
(Figures 10 & 11). Certain neuronal perikarya within the centre of the 
ischaemic lesion exhibited positive immunostaining with prominent 
cell bodies and apical dendrites. These neurones were restricted to 
cortical layers 3 and 5. This effect was most pronounced in animals 
allowed to survive for 2 hours after induction of acute subdural 
haematoma. In these cases, there was a well defined bi-laminar 
arrangement of MAP 2 immunopositive pyramidal neurones with a 
distinct band of decreased immunostaining separating between them.
4 hours post injury the bi-laminar arrangement was not detected and 
there were fewer MAP 2 immunopositive neurones identified in the 
cortex (Figure 10). The remaining MAP 2 labelled pyramidal neurones 
were localised to a single layer of the cortex( layer 3). No clear cellular 
alteration in MAP 2 distribution was detected by immunohistochemistry 
30 minutes after the injury .
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Figure 10
Immunostaining of MAP 2 in the cerebral cortex after 
induction of an acute subdural haematoma.
Immunostaining of MAP 2 in cerebral cortex in a sham 
operated rat (SHAM) and at 2 hours and 4 hours after 
production of an acute subdural haematoma (see following 
page). Note the loss of MAP 2 immunoreactivity within the 
cortex underlying the subdural haematoma. This 
micrograph demonstrates that the loss of MAP 2 
immunolabelling is not uniform throughout the cortex 
following induction of an acute subdural haematoma.
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Figure 11
Laminar pattern of MAP 2 immunostaining following acute 
subdural haematoma.
Immunostaining of MAP 2 in cerebral cortex in a sham 
operated rat (SHAM) and 4 hours after production of an 
acute subdural haematoma. The loss o f MAP 2 
immunolabelling is not uniform throughout the layers of the 
cortex (I-VI). There is some preservation of MAP 2 
immunoreactivity within cortical layers III and V.
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No alterations in MAP 2 immunostaining were detected in the white 
matter tracts of the corpus callosum, at any of the post injury points 
examined. In all cases the control distribution of MAP 2 persisted with no 
immunoreactivity detected in axonal pathways (Figure 12).
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Figure 12
Immunostaining of MAP 2 in myelinated fibre tracts in the 
corpus callosum after induction of an acute subdural 
haematoma.
Immunostaining of MAP 2 in myelinated fibre tracts in the 
corpus callosum in a sham operated rat (SHAM) and at 4 
hours after production of an acute subdural haematoma. 
Note that there are no detectable alterations in MAP 2 
immunostaining after acute subdural haematoma.
ShamMAP2
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p-tuhulin
In control animals ( n=2) the immunohistochemical distribution and 
subcellular localisation of p-tubulin was the same as has been described 
previously. In rat brain, p-tubulin is present throughout and can be 
detected in neurones, glia and astrocytes 173
At all time points examined following induction of an acute subdural 
haematoma, the intensity of P-tubulin immunoreactivity of the neuropil 
was unaltered in the ipsilateral cortex compared to the contralateral 
cortex. No defined margin correlating to the region of histologically 
determined ischaemic brain damage was detected. However, certain 
neuronal perikarya within the centre of the ischaemic area were P~ 
tubulin immunoreactive (Figure 13). These immunopositive cells were 
detected as early as 30 minutes post injury and their number increased 
progressively, becoming most prominent in the 4 hour survival group. 
They were localised to a single layer of the ipsilateral cortex (layer 3) 
with characteristic bandlike laminar distribution (Figure 14). 
Morphologically these cells were pyramidal neurones with densely 
stained cell bodies and long, straight neuronal processes radiating from 
the soma. This localised area of cellular immunoreactivity was not 
detected in any of the sham operated animals or in the contralateral cortex 
of the animals subjected to subdural haematoma.
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Figure 13
Immunostaining of p-tubulin in the cerebral cortex after 
induction of an acute subdural haematoma.
Immunostaining of p-tubulin in cerebral cortex in a sham 
operated rat (SHAM) and at 30 minutes, 2 hours and 4 
hours after production of an acute subdural haematoma. 
Note the increased somato-dendritic P- t ubu l i n  
immunoreactivity within the cortex after acute subdural 
haematoma.
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Figure 14
Laminar pattern of p-tubulin immunostaining following 
acute subdural haematoma.
Immunostaining of P-tubulin in cerebral cortex 4 hours 
after production of an acute subdural haematoma. Note that 
p-tubulin immunolabelling is not uniform throughout the 
layers of the cortex (I-VI). There is pronounced p-tubulin 
immunoreactivity within cortical layer III but less 
immunolabelling in all other layers of the cortex.

In sham operated animals, p-tubulin immunostaining of the white 
matter tracts of the corpus callosum indicated a smooth, regular pattern 
with no areas of focal accumulation . Following subdural haematoma the 
pattern of immunostaining in the contralateral corpus callosum appeared 
to be the same as sham operated tissue with no clear differences detected. 
In contrast, after production of an acute subdural haematoma, the 
ipsilateral corpus callosum demonstrated marked alterations in p-tubulin 
immunostaining with numerous, irregular, granular profiles forming in 
the white matter adjacent to the cortical lesion. This disruption in p -  
tubulin immunoreactivity was most pronounced in the 4 hour injury 
group of animals but was detectable 30 minutes after production of acute 
subdural haematoma. It appeared that the immunostained profiles were 
confined to the axons adjacent to the lesion and did not extend throughout 
the white matter tracts of the corpus callosum (Figure 15).
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Figure 15
Immunostaining of P-tubulin in myelinated fibre tracts in 
the corpus callosum after induction of an acute subdural 
haematoma.
Immunostaining of P-tubulin in myelinated fibre tracts in 
the corpus callosum in a sham operated rat (SHAM) and at 
30 minutes, 2 hours and 4 hours after production of an acute 
subdural haematoma. Note the progressive disruption in the 
pattern of p-tubulin immunostaining after acute subdural 
haematoma.
Tubulin Sham Tubulin 30min
i
if-
W  » j
*'■’ f ' t  * ’j f  I  » , ,,• ‘ f  i C K f . : *  ;■ v' f • ‘ r ; • * • »vV ^ ."S?
*( j  - ^  v ' • I
Tubulin 2hr Tubulin 4h^  T - n r
\
• ’ * *» ♦
t V '  . • -
■ *  v |  0  ^  t* |  * ^  r  ^  m #  J f / y ?  ^  *  * 1
■ 1' • f  -*< *?.£ t j & f  *  - 7 \ V v
* .< , • ,< V*-'  v ** * ' ,  \ r  ' ,1 ‘ '  .  ’ j  *
• . 1  ' y*%  * : . f  &T* ■ * .’ v >■ ■ v ^ .
* * x  V. ■* r V  • 4  f f  .-.r X. >' A
r  - j f l F f v M -  '7 ? . " - * •
"S ■€ ’v \ ~  * 4 ® r * " •*
<  i v > ?>.*<-«. > , r • /  •- j y
C  >*?K s n * .  ’ -  * • ' -  /  i •  r
# f c :  > *  -  • / > * ' '
• % v, * * vr<? \  - *
• : £  .•' : ." v " - ‘
.4 *•“ ‘ k. 4 - -
A v zvl, fJA
. 'P
a
*4
3.1.5 Western blot analysis of the cerebral cortex following acute subdural
haematoma in the rat
In total 20 animals were processed for Western blotting analysis at 
survival times of 30 minutes or 4 hours. In each group five animals had 
induction of an acute subdural haematoma and five animals were sham 
operated.
Tau
In normal adult rat brain Tau-1 recognises five major protein bands 
corresponding to molecular weights between 52-68 kDa. 94 The 
electrophoretic profile of tau was altered in the ipsilateral cortex 
compared to the contralateral cortex of animals subjected to an acute 
subdural haematoma. Within this subgroup, four major protein bands 
were observed instead of the five protein bands detected in the controls 
(sham operated and injured contralateral cortex). These protein bands did 
not correspond exactly to the normal electrophoretic profile of tau. The 
higher molecular weight bands (bands 1 and 2 ) were decreased 
following injury and a protein band, which was not detected in control 
samples, appeared within the range of bands 2 and 3. Further, following 
subdural haematoma induction the profile of band 4 changed and shifted 
to a position of higher molecular weight. These changes were present in 
animals examined at the 30 minute time point but were more pronounced 
in the 4 hour group of injured animals. The electrophoretic profile of tau 
was not altered in the ipsilateral cortex compared to the contralateral
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Figure 16
Western Blot analysis of cortical Tau follow ing acute subdural 
haematoma.
Western Blot analysis of Tau in the left (L) and right (R) cerebral 
hemispheres of sham operated rats (sham) and at 30 minutes or 4 
hours after production of an acute subdural haematoma (haem). 
The positions of 45kDa and 66kDa molecular weight markers are 
indicated. Note the shift in the electrophoretic profile and the 
reduction in the level of Tau in the left cerebral hemisphere at both 
30 mins and 4 hrs following haematoma induction compared to the 
contralateral (R) cerebral hemisphere and both hemispheres of the 
sham operated animals.
cortex of sham operated animals. The contralateral cortex of injured 
animals showed an electrophoretic profile of tau approximating those of 
the sham operated group (Figure 16).
Measurement of tau levels as relative optical density revealed that there 
was a statistically significant reduction in the level of tau , in the 
ipsilateral cortex, compared to the contralateral cortex at both 30 minutes 
(20 %, p < 0.05) and 4 hours (43 %, p < 0.05) following subdural 
haematoma (Figure 17).
138
Ta
u 
Im
m
un
or
ea
ct
iv
ity
30 mins
D  Ipsilateral 
I  Contralateral
Sham Subdural
Operated Haematoma
4 hours
Sham Subdural
Operated Haematoma
Figure 17
Tau immunoreactivity in the cortex following acute 
subdural haematoma.
Tau immunoreactivity in the cerebral cortex in sham 
operated rats and at 30 minutes and 4 hours after 
production of an acute subdural haematoma. Data are 
expressed as mean ± SEM and represent arbitary 
densitometric units. A significant decrease (*p<0.05) in 
Tau immunoreactivity is demonstrated in the ipsilateral 
hemisphere at both time points after production of an 
acute subdural haematoma. n=5 animals per group.
MAP 2
In normal adult rat brain MAP 2 recognises one major protein band, 
corresponding to the isoforms MAP 2a and MAP 2b, with a molecular 
weight of approximately 280 kDa . The electrophoretic profile of MAP 2 
was not altered by the production of an acute subdural haematoma 
(Figure 18).
Measurement of MAP 2 protein levels as relative optical density revealed 
that there was a statistically significant reduction in the level of MAP 2, 
in the ipsilateral cortex, compared to the contralateral cortex at both 30 
minutes (53 %, p < 0.05) and 4 hours (76 %, p <0.05). The level of MAP 
2  in the ipsilateral compared to the contralateral cortex in sham operated 
animals was not significantly altered at 30 minutes or 4 hours (Figure 19).
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Figure 18
Western Blot analysis of cortical MAP 2 following acute subdural 
haematoma.
Western Blot analysis o f MAP 2 in the left (L) and right (R) 
cerebral hemispheres o f sham operated rats (sham) and at 30 
m inutes or 4 hours after production o f an acute subdural 
haematoma (haem). The position of the 280 kDa molecular weight 
marker is indicated. Note the reduction in MAP 2 levels in the left 
(L) cerebral hemisphere at both 30 mins and 4 hrs follow ing  
haematoma induction compared to the contralateral (R) cerebral 
hemisphere and both hemispheres o f the sham operated animals.
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Figure 19
MAP 2 immunoreactivity in the cortex following acute 
subdural haematoma.
MAP 2 immunoreactivity in the cerebral cortex in sham 
operated rats and at 30 minutes and 4 hours after 
production of an acute subdural haematoma. Data are 
expressed as mean ± SEM and represent arbitary 
densitometric units. A significant decrease (*p<0.05) in 
MAP 2 immunoreactivity is demonstrated in the 
ipsilateral hemisphere at both time points after production 
of an acute subdural haematoma. n=5 animals per group.
Tubulin
In normal adult rat brain the monoclonal anti-tubulin antibody used in this 
study recognises a dimer of approximately 50kDa which corresponds to 
a-tubulin  and (5-tubulin . No alteration in the electrophoretic profile of 
tubulin was detected following the production of an subdural haematoma 
(Figure 20). The distribution of protein bands approximated those of the 
sham operated samples ( ipsilateral and contralateral cortex).
Relative optical density measurements demonstrated that the duration of 
time the animal was subjected to an acute subdural haematoma altered 
the level of tubulin detected. 30 minutes after subdural haematoma there 
was no significant difference in the level of tubulin in the ipsilateral 
cortex compared to the contralateral cortex. In contrast, in the 4 hour 
group, both isoforms of tubulin were significantly reduced in the 
ipsilateral cortex compared to the contralateral cortex, after subdural 
haematoma (54% reduction for upper band and 58% reduction for the 
lower band: p < 0.05). See Figure 21.
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Figure 20
Western Blot analysis of cortical tubulin following acute subdural 
haematoma.
Western Blot analysis o f tubulin in the left (L) and right (R) 
cerebral hemispheres o f sham operated rats (sham) and at 30 
minutes or 4 hours after production o f an acute subdural 
haematoma (haem). The position o f the 50 kDa molecular weight 
marker is indicated. Note the reduction in tubulin levels in the left 
(L) cerebral hemisphere at 4 hrs following haematoma induction 
compared to the contralateral (R) cerebral hemisphere and both 
hemispheres of the sham operated animals.
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P-tubulin immunoreactivity in the cortex following acute subdural 
haematoma.
P-tubulin immunoreactivity (upper and lower bands as outlined in 
Western blot analysis) in the cerebral cortex in sham operated rats and at 
30 minutes and 4 hours after production of an acute subdural haematoma. 
Data are expressed as mean ± SEM and represent arbitary densitometric 
units. There is no significant difference in b-tubulin immunoreactivity in 
any of the samples examined 30 minutes after production of an acute
subdural haematoma. A significant decrease (* p<0.05) in p-tubulin 
immunoreactivity is demonstrated in the ipsilateral hemisphere 4 hours 
after production of an acute subdural haematoma. n=5 animals per group.
3.1.6 Transmission Electron Microscopy examination of the neuronal
cvtoskeleton following acute subdural haematoma in the rat.
In total seven animals were processed for transmission electron 
microscopy. Four animals were subjected to an acute subdural 
haematoma and killed by perfusion fixation after 4 hours. Two animals 
were controls ( sham-operated ) and had insertion of the needle only. A 
single animal was perfusion fixed to provide a naive control.
Control animals
The sections from the control ( sham operated and naive) animals had an 
entirely normal ultrastructure (Figures 22 and 23). Within the cerebral 
cortex, the dendritic cytoskeleton was linearly organised with 
microtubules and neurofilaments disposed along the longitudinal axis of 
the dendrite. The nodal, paranodal and intemodal axoplasm had a discrete 
cytoskeleton with microtubules and neurofilaments that formed linear 
arrays parallel to the longitudinal axis. An occassional membranous 
organelle, either smooth endoplasmic reticulum or mitochondrion, 
occurred in the axoplasm but these were always very low in number.
The intemodal myelin sheath was uniform with closely apposed lamellae. 
The internal aspect of the myelin sheath and the external surface of the 
axolemma were always in close relation.
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Figure 22
Ultrastructural analysis of the dendritic cytoskeleton.
A longitudinal thin section of a dendrite in the cerebral 
cortex from a sham operated animal (SHAM) and from an 
experimental animal 4 hours after placement of the 
haematoma. In the sham operated cortex cytoskeletal 
elements are linearly arranged along the long axis of the 
dendrite where microtubules are evenly spaced. In the 
experimental animal, microtubules within the dendritic 
cytoskeleton now follow a helical disposition (arrowheads) 
rather than being linearly organised. However, microtubules 
still lie in parallel within this abnormal pattern.

Experimental animals
A variety of structural abnormalities were observed following production 
of an acute subdural haematoma. Specifically the cytoskeleton was 
disrupted with resultant alterations in its three dimensional configuration.
In the ipsilateral cerebral cortex the dendritic cytoskeleton was also 
altered. Ultrastructural analysis demonstrated misalignment of the 
dendritic microtubules with the formation of an abnormal helically 
orientated pattern rather than the longitudinal arrangement identified in 
the control tissue. The microtubules remained parallel within this 
abnormal pattern (Figure 22).
In transverse sections of myelinated axons in the corpus callosum there 
were reduced numbers of microtubules and a decreased spacing between 
neurofilaments . Microtubules were absent within the axoplasm. The 
neurofilaments appeared compacted, that is, there was a reduced spacing 
between neurofilaments and they tended to lie in the centre of the injured 
axon. No obvious misalignment of the neurofilaments was detected in this 
protocol. Electron microscopy demonstrated dissociation of adjacent 
lamellae the myelin sheath and the occurrence of peri-axonal spaces 
associated with a reduction in axonal transverse diameter. In some axons 
the axoplasm consisted of a diffuse, flocculent precipitate, while in others 
there was a central core of neurofilaments. Aggregates of membranous 
profiles, resembling smooth endoplasmic reticulum, were identified in the 
axoplasm. The mitochondria displayed a disrupted organisation of their
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cristae. Typically these abnormal features occurred in a field containing 
axons demonstrating normal morphology (Figure 23).
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Figure 23
Ultrastructural analysis of the axonal cytoskeleton.
A transverse section of a myelinated fibre from the corpus 
callosum of a sham operated animal (SHAM) and from an 
experimental animal 4 hours after placement of the 
haematoma. The axonal cytoskeleton consists of regularly 
spaced neurofilaments and microtubules all arranged 
parallel to the long axis of the axon. In the experimental 
animal, there are no microtubules present and the 
neurofilaments have a reduced spacing, or are compacted, 
tending to lie in the centre of the axon. Note the presence of 
peri-axonal spaces (*) in the myelinated fibres after 
production of an acute subdural haematoma.

3.2 Immunohistochemical analysis of calpain mediated spectrin breakdown
following acute subdural haematoma in the rat.
In total 24 animals were processed for immunohistochemistry. At each 
time point (30 minutes, 2 hours and 4 hours) 6 animals underwent 
induction of an acute subdural haematoma and 2 animals were sham 
operated only.
Immunohistochemical analysis confirmed that the ipsilateral cortex is the 
main site of calpain mediated breakdown of spectrin following acute 
subdural haematoma (ASDH) in the rat. Spectrin breakdown products 
(BDPs) were confined within the histologically defined ischaemic lesion. 
No immunoreactivity was detected in the contralateral cortex of animals 
subjected to induction of an ASDH. In sham operated animals there was 
increased immunoreactivity demonstrated in the cortex directly beneath 
the site of insertion of the needle. Spectrin BDPs immunostaining was 
only observed in axons examined later than two hours after induction of 
an acute subdural haematoma.
Spectrin breakdown occurred over a large area of the cortex underlying 
the haematoma (Figure 24). Although haematoxylin and eosin histology 
revealed only early ischaemic cell process in the cortex at 30 minutes 
following ASDH, calpain mediated spectrin BDPs were present in 
cortical dendrites in the region that proceeded to exhibit the most marked 
ischaemic cell process changes. Within the cortex, the distribution of 
spectrin BDP immunoreactivity did not change with time. In all cases the
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area of immunoreactivity correlated with the histologically defined 
ischaemic area. However, 2 hours after induction of an ASDH, the 
intensity of the immunoreactivity had increased and this persisted, 
unchanged, in the 4 hour group of animals.
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Figure 24
Calpain mediated spectrin breakdown in the cerebral cortex 
after induction of an acute subdural haematoma.
Immunostaining of calpain mediated breakdown products 
(BDPs) of spectrin in cerebral cortex in a sham operated rat 
(SHAM) and at 30 minutes, 2 hours and 4 hours after 
production of an acute subdural haematoma. Note the 
progressive increase in calpain mediated spectrin 
breakdown in the cortex underlying the haematoma.
SHAM
30miri
4hours
Neuronal perikarya containing spectrin BDPs were detected in the 
ipsilateral cortex 30 minutes after induction of an ASDH (Figure 25).
This was a consistent finding displayed in all animals. These neurones 
became more prominent in the 2 and 4 hour group of animals. 
Examination of the adjacent H&E tissue sections revealed that these 
neurones were confined to cortical layer 4. Immunoreactive dendrites 
were identified in all layers of the cortex and demonstrated various 
degrees of fragmentation. In the 30 minute survival animals the spectrin 
BDP immunolabelled dendrites were in continuity but appeared irregular 
and distorted. By 2 hours these dendrites were fragmented, that is they 
were not continuous, and contained areas of immunonegativity suggesting 
that the whole length of the dendrite was not intact. Immunoreactive 
dendrites increased in both number and in the severity of fragmentation in 
the 4 hour group of animals (Figure 25).
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Figure 25
Calpain mediated spectrin breakdown in neuronal perikarya 
and dendrites following acute subdural haematoma.
Immunostaining of calpain mediated breakdown products 
(BDPs) of spectrin in cerebral cortex in a sham operated rat 
(SHAM) and at 30 minutes, 2 hours and 4 hours after 
production of an acute subdural haematoma. Note the 
progressive increase in calpain mediated spectrin 
breakdown. Proteolytic fragments of spectrin are primarily 
localised in dendrites and neuronal perikarya.
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In all animals , spectrin BDP immunoreactivity was observed along the 
interface with the subcortical white matter. The adjacent cortical tissue 
was labelled in a punctate fashion and there was a well defined boundary 
with the subjacent white matter. There was no definite evidence of 
calpain mediated spectrin BDPs immunoreactivity detected in the white 
matter of any of the animals examined 30 minutes after production of an 
acute subdural haematoma. In contrast, at both 2 hours and 4 hours after 
induction of the acute subdural haematoma, calpain mediated spectrin 
BDPs immunoreactivity was demonstrated in axons underlying the 
haematoma (Figure 26). The immunoreactivity had an irregular punctate 
appearance. In addition, immunopositive oligodendrocytes were detected 
within the white matter of the 4 hour group of injured animals only.
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Figure 26
Calpain mediated spectrin breakdown in myelinated fibre 
tracts in the corpus callosum following acute subdural 
haematoma.
Immunostaining of calpain mediated breakdown products 
(BDPs) of spectrin in myelinated fibre tracts in the corpus 
callosum in a sham operated rat (SHAM) and at 30 minutes, 
2 hours and 4 hours after production of an acute subdural 
haematoma. Note the presence of increased levels of 
calpain mediated spectrin breakdown immunoreactivity in 
the 2 hour and 4 hour group of experimental animals.
Ab38 SHAM Ab38 30min
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3.3 Alterations in the neuronal cvtoskeleton following acute subdural
haematoma in humans
3.3.1 Neurohistopatholo g v
The presence of an acute subdural haematoma resulted in an area of 
ischaemic brain damage in the ipsilateral superior parietal cortex. The 
histologically defined ischaemic tissue, as detected by haemotoxylin and 
eosin, was pale compared to the control brain tissue (Figure 27).
Microscopy of the haemotoxylin and eosin, stained cryostat sections 
taken from the superior parietal lobule reveals both cortex and related 
white matter. Scattered throughout the deeper layers of the cortex are a 
number of contracted neurones, the nuclei of which show condensed 
basophilic chromatin and the cytoplasm of which is eosinophilic having 
lost its' Nissl substance. Many of these neurones are associated with 
swelling and vacuoles in related astrocytes and a number of incrustations 
are seen. Apart from this swelling, reactive cellular changes are not seen 
in either glia or blood vessels. There is some accentuation of these 
changes within layers 5 and 6 but in some areas there are effected 
neurones in layers 4, 5 and 6. The superficial layers appear to be spared. 
The related white matter is normal. There is no evidence of vascular 
occlusion or of infiltration by neurophils.
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Figure 27
The histopathological features of the ischaemic cell process 
after an acute subdural haematoma in humans.
Micrograph of the left superior parietal cortex from a 
patient sustaining an acute subdural haematoma. The cortex 
demonstrates features of the ischaemic cell process with 
contracted neurones containing condensed nuclear 
basophilic chromatin and eosinophillic cytoplasm.
3.3.2 Immunohistochemical analysis of the microtuhule component of the
neuronal cvtoskeleton following acute subdural haematoma in human 
post mortem tissue
Tau-1
The degree of immunolabelling was very faint in all brain sections 
processed for Tau-1 immunhistochemistry. In control cases the 
distribution of tau, as detected by the Tau-1 antibody, was the same as has 
been described previously being preferentially localised in axons and not 
detectable in the neuronal cell bodies. However, the presence of an acute 
subdural haematoma resulted in clear alterations in the localisation of 
Tau-1 within the ischaemic superior parietal cortex (Figure 28). Tau-1 
immunostaining was decreased in the neuropil of all the cases with a 
subdural haematoma. There was no correlation with this observation and 
either the post mortem delay or survival time after injury. Within the 
ischaemic lesion Tau-1 immunoreactivity was faintly increased in some 
scattered neuronal perikarya. However, these were few in number and 
difficult to detect due to the intense loss of neuropil staining. No 
alterations Tau-1 immunoreactivity in the white matter were detected in 
any of the cases examined .
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Figure 28
Immunostaining of Tau-1 in the human cerebral cortex after
an acute subdural haematoma.
Immunostaining of Tau-1 in the human cerebral cortex in a 
neurological control patient (control) and in a patient 
sustaining an acute subdural haematoma (ASDH). Note that 
Tau-1 immunolabelling is faint in both sections. However, 
there is the suggestion of an increase in Tau-1 
immunoreactivity in certain neuronal perikarya following 
acute subdural haematoma.
Control
ASDH
Microtuhule associated protein 2 (MAP 2)
In the control cases MAP 2 was distributed as has been previously 
described being preferentially localised to the somato-dendritic 
compartment. There were alterations in MAP 2 immunostaining in the 
superior parietal cortex after an acute subdural haematoma (Figure 29). In 
these cases, there was a pronounced loss of MAP 2 immunoreactivity 
within the histologically defined ischaemic area in the superior parietal 
cortex. Although there was some variability in the extent of the changes 
detected, all cases examined revealed a decreased labelling of dendrites 
and minimal staining of neuronal cell bodies within the ischaemic area. 
The neuropil was less intensely stained than in the control cortex and 
there were no alterations in MAP 2 immunostaining of axons which 
remained immunonegative. These findings were the same irrespective of 
the survival time or post mortem delay.
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Figure 29
Immunostaining of MAP 2 in the human cerebral cortex
after an acute subdural haematoma.
Immunostaining of MAP 2 in the human cerebral cortex in 
a neurological control patient (control) and in a patient 
sustaining an acute subdural haematoma (ASDH). Note the 
decrease in MAP 2 immunostaining following acute 
subdural haematoma. In addition, certain neuronal perikarya 
are MAP 2 immunopositive with fragmented MAP 2 
immunolabelled dendritic processes.
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p-tubulin
In the control cases p-tubulin was widely distributed being detectable in 
dendrites, axons and in a few neuronal cell bodies. There were numerous 
fine, slender, immunopositive dendrites detected throughout the cortex. 
These processes had a regular arrangement, radiating from the cortical 
surface. In the cases with an acute subdural haematoma there were 
marked alterations in this pattern (Figure 30). Within the histologically 
defined ischaemic area the regular appearance of p-tubulin 
immunostaining was disrupted and multiple, irregular, immunopositive 
profiles were detected. There was also an increased immunostaining of 
neuronal perikarya within the ischaemic area but these were scattered and 
did not form a laminar arrangement. Other elongated neuronal processes 
were more intensely stained than the control cases but were distorted and 
mishapen. The impression was formed that this range of disruption may 
result from differences in the plane of section of the tissue relative to the 
direction of the neuronal processes such that they are detected at different 
angles of projection. No alterations in the subcortical white matter were 
detected in any of the cases examined.
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Figure 30
Immunostaining of p-tubulin in the human cerebral cortex 
after an acute subdural haematoma.
Immunostaining of P-tubulin in the human cerebral cortex 
in a neurological control patient (control) and in a patient 
sustaining an acute subdural haematoma (ASDH). Note the 
increased somato-dendritic p-tubulin immunoreactivity 
within the cortex after an acute subdural haematoma.
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3.4 Alterations in axolemmal permeability following traumatic brain injury
In total 24 animals were used in this study . At each time point examined 
(5 minutes, 15 minutes and 1 hour) six animals were subjected to 
traumatic brain injury and two animals were sham operated only.
3.4.1 Clinical Observations
All animals survived the trauma. Immediately after injury all rats had a 
period of apnea which lasted for 10 to 20 seconds and was associated, in 
the majority of animals, with a generalised convulsion that lasted 15-30 
seconds. These convulsions occurred only once and always immediately 
after trauma. In addition all injured rats developed a decortication flexion 
deformity in their forelimbs. No skull fractures were detected in any of 
the animals.
3.4.2 Neuropathology Examination
All brains were considered to be well perfusion fixed as evidenced by
good neuronal morphology, the absence of intravascular blood and the
lack of cytological artefacts such as " dark cells" or " hydropic cells"
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3.4.3. Gross Neuropathology
In injured animals there was significant sub-arachnoid haemorrhage 
occupying the basal cisterns and cistema magna. The blood extended to 
the sub-arachnoid spaces over the cerebral hemispheres. There was no 
focal brain lesion after injury. Petechial haemorrhages were frequently 
observed in the brain stem and occassionally in the mid-brain.
3.4.4. Neurohistopathologv
Injured neurones were common in the supraventricular areas of the 
cerebral cortex, especially the central portion under the injury site.
In sections stained with haematoxylin and eosin, shrunken 
neurones associated with perineuronal vacuolation were identified in 
animals surviving 1 hour after injury. It was observed that the density of 
damaged neurones decreased towards the periphery of the lesion.
3.4.5 Control animals
Light microscopy
The cleared sections reacted for visualisation of peroxidase activity 
displayed tracer diffusion throughout the basal cisterns. From here, the 
tracer could be seen diffusing directly into the extracellular compartment 
of the ventral brainstem, and along the perivascular sleeves (Figure 31). 
In all cases, the tracer penetrated 1-2 mm into the brainstem parenchyma,
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encompassing some of the fibre systems known to undergo reactive 
change in this animal model, such as the corticospinal tract. Light 
microscopic examination revealed that the peroxidase reaction product 
was confined to the extracellular space, where it was conspicuous in the 
axonal nodal regions as well as the perivascular spaces. No intra-axonal 
peroxidase activity was detected in any of the control animals.
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Figure 31
Axolemmal permeability following traumatic brain injury.
Light micrographs of cleared sections from the ventral 
pontomedullary junction of sham operated animals reveals 
the passage of peroxidase through the interstices of the 
brain parenchyma. Note that horseradish peroxidase (HRP) 
and microperoxidase (MP) both pass through the 
perivascular sleeves (arrowheads) and are confined to the 
extracellular space. After 1 hour of diffusion no signs of 
intraaxonal peroxidase uptake are evident.
SHAM
Electron microscopy
Electron microscopic examination of this material revealed that the 
peroxidase reaction product was confined to the extracellular 
compartment, with all axons demonstrating normal ultrastructural detail. 
The morphological appearance of these axons were similar to those 
described in Figure 23 . Specifically, there was a normal regular 
arrangement of the axonal cytoskeleton with microtubules and 
neurofilaments arranged parallel to the longitudinal axis of the axon.
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3.4.6. Experimental animals
Light microscopy
All animals subjected to an impact acceleration closed head injury, in the 
presence of extracellular microperoxidase (MP) or horseradish peroxidase 
(HRP) demonstrated focal peroxidase uptake at two sites within the 
ventral brainstem (Figures 32, 33, 34). Specifically, scattered axons 
within the pontomedullary and cervicomedullary junctions displayed 
focal inudation with the once extracellularly confined peroxidase. Such 
axons could be seen in relation to other fibres which demonstrated no 
evidence of peroxidase uptake, consistent with the diffuse nature of the 
injury. These peroxidase containing axons were seen at all survival times 
including those animals assessed within 5 minutes of the traumatic 
injury. Despite the presence of their peroxidase content, these axons 
appeared otherwise unaltered at the light microscopy level, with the 
exception that they all displayed microvacuolation scattered throughout 
the peroxidase laden axoplasm . Although intra-axonal peroxidase 
activity could be detected with either tracer it was readily apparent that 
the horseradish peroxidase was detected in more axons than the 
microperoxidase. Quantitative analysis confirmed this impression.
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Figure 32
Axolemmal permeability following traumatic brain injury.
Light micrographs of cleared sections from the ventral 
pontomedullary junction of animals examined 5 minutes 
after induction of traumatic brain injury. Intra-axonal 
peroxidase is demonstrated with horseradish peroxidase 
(HRP) and microperoxidase (MP). Note that these 
peroxidase containing axons are visualised in a field where 
other fibres show no evidence of peroxidase influx. In 
addition, there is a greater uptake of HRP compared to MP.
5min , MP
Figure 33
Axolemmal permeability following traumatic brain injury.
Light micrographs of cleared sections from the ventral 
pontomedullary junction of animals examined 15 minutes 
after induction of traumatic brain injury. The findings 
detected are similar to the group of animals examined 5 
minutes after injury. Intra-axonal peroxidase is 
demonstrated with horseradish peroxidase (HRP) and 
microperoxidase (MP). Note that these peroxidase 
containing axons are visualised in a field where other fibres 
show no evidence of peroxidase influx. In addition, HRP 
demonstrates a greater number of flooded axons compared 
to MP.

Figure 34
Axolemmal permeability following traumatic brain injury.
Light micrographs of cleared sections from the ventral 
pontomedullary junction of animals examined 60 minutes 
after induction of traumatic brain injury. The findings 
detected are similar to the group of animals examined 5 and 
15 minutes minutes after injury. Intra-axonal peroxidase is 
demonstrated with horseradish peroxidase (HRP) and 
microperoxidase (MP). Note that these peroxidase 
containing axons are visualised in a field where other fibres 
show no evidence of peroxidase influx. In addition, HRP 
demonstrates a greater number of flooded axons compared 
to MP.
60min
Electron microscopy
Ultrastructural analysis of the peroxidase-containing axons revealed a 
distinct set of morphological alterations (Figure 35). These were the same 
irrespective of what tracer had been used. The peroxidase reaction was 
confined to a limited segment of the axon cylinder where it dispersed 
throughout the axoplasm . Within 5 minutes of the traumatic event, the 
peroxidase tracer could be seen in the axoplasm where it was identified in 
nodal, paranodal and intemodal regions. In these foci of tracer influx, the 
related neurofilament network appeared dense, with the suggestion that 
the neurofilaments were now more tightly compacted than in the control 
tissue. This alteration was demonstrated at all survival times examined 
(up to 1 hour post injury) and did not change or progress during this 
period.
Local mitochondrial abnormalities were most dramatic at these foci of 
peroxidase activity. The mitochondria appeared swollen with disrupted 
cristae. These abnormal features seen at the electron microscopic level, 
correlated with the microvacuolation seen with light microscopy. 
Typically, these injured axons occurred in a field containing other fibres 
with no detectable intra-axonal peroxidase reaction product. No 
evidence of direct axolemmal renting was observed in any of the animals 
in this series.
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Figure 35
Ultrastructural detection of microperoxidase flooded axons 
following traumatic brain injury.
Electron micrographs from the ventral pontomedullary 
junction of animals examined 5 minutes after induction of 
traumatic brain injury. They demonstrate a 
microperoxidase (MP) flooded axon. The peroxidase 
containing axon (arrows) is seen in a field demonstrating 
other unaltered axonal profiles. Note that the peroxidase 
containing axon cylinder displays a densely packed 
filamentous network and the mitochondria appear dilated.

3.4.7 Ouantatative analysis
As noted above, homologous 50,000|im2 regions from the 
pontomedullary and cervicomedullary junctions were selected and 
subjected to quantitative analysis to determine the number of HRP or MP 
containing axons per unit area. At all survival times statistically fewer 
flooded axons were detected with microperoxidase as the tracer than in 
the corresponding sections utilising horseradish peroxidase (Figure 36).
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Figure 36
Comparison of horseradish peroxidase and 
microperoxidase in the detection of alterations 
in axolemmal permeability following traumatic 
brain injury.
CHAPTER 4 - DISCUSSION
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4.1 A LTERA TIO N S IN THE N EU RO N A L C Y TO SK ELET O N
FOLLOWING ACUTE SIJBDIJRAL HAEMATOMA IN THE RAT.
The role of the cytoskeleton in traumatic brain injury is a controversial 
issue. There is no doubt that cytoskeletal abnormalities are a pathological 
feature of numerous neurological disorders. Equally, there is a strong 
implication that the cytoskeleton has a pivotal role in the pathogenesis of 
these conditions. However, the relative role of structural determinants 
versus concurrent biochemical derangements, as the crucial pathological 
event, remains to be defined. In this discussion the main findings from 
this series of investigations will be considered with emphasis on the 
relative role of structural and biochemical alterations. For ease of 
description the cytoskeletal proteins will be discussed separately. It 
should be noted that the cytoskeleton is a functional unit and the 
biochemical derangements operant in traumatic brain injury may effect all 
it's components.
The principal aim of this investigation was to characterise the effects of 
acute subdural haematoma (ASDH) on the microtubule component of the 
neuronal cytoskeleton. The study was designed to identify morphological 
alterations in the cytoskeleton at three time points in the acute phase of 
injury. In doing so, we hoped to gain an insight into the sequence of 
events occuring immediately after an ASDH. The findings demonstrate 
that alterations in the m icrotubule com ponent of the neuronal 
cytoskeleton occur following ASDH in the rat. In addition, and perhaps 
more importantly, these disturbances were detected within 30 minutes of
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injury and involved both dendrites and axons. This has important 
implications in the design of therapeutic strategies which ultimately aim 
to arrest or reverse the pathological processes involved in this event. The 
data presented is the first systematic study of the cytoskeleton following 
ASDH and provides a basis for future investigations.
4.1.1 The rat model of acute subdural haematoma results in multiple insults to 
the brain
Animal models allow specific aspects of human disease to be 
investigated. They do not mimic the human condition and such an 
assumption is flawed 106,174 The rat model of ASDH results in several 
features analagous to the situation in humans presenting with this lesion 
9,43 These features allow investigation of the pathophysiology of 
ASDH. The main neuropathological abnormality following an ASDH, in 
either the rat model or in humans, is an ischaemic lesion in the ipsilateral 
cortex beneath the haematoma. In addition, the associated mechanical 
displacement of the hemisphere, elevated intra-cranial pressure and 
resultant brain swelling produce a series of insults peculiar to this 
paradigm. Furthermore, the constituents of the blood itself may play an 
important role in the evolution of ischaemic cell damage 43,51,52,57 
Therefore, this model is not a model of pure ischaemia. It is a multi-insult 
model of an important complication of traumatic head injury. The 
multiplicity of injurious processes associated with ASDH suggest that 
several biochemical may co-exist and contribute to the pathogenesis of 
this condition.
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4.1.2 MAP 2 is decreased in the ipsilateral cortex following acute subdural
haematoma in the rat
Acute subdural haematoma (ASDH) results in a decrease in the protein 
level of MAP 2 in the adult rat cortex underlying the haematoma. 
Quantitative Western blot analysis demonstrated that 30 minutes after 
induction of an ASDH there is a 53% reduction in the protein level of 
MAP 2 in the ipsilateral cortex. This progresses to a 76% decrease in 
MAP 2 levels after 4 hours. In animals examined at 2 or 4 hours after 
production of a subdural haematoma there was an associated reduction in 
dendritic density as assessed by immunohistochemistry. Ultrastructural 
examination revealed an abnormal spatial configuration of cortical 
dendrites beneath the haematoma consistent with disruption of the 
dendritic cytoskeleton and in agreement with the altered MAP 2 
immunostaining.
Within the last five years the role of MAP 2 in traumatic brain injury 
(TBI) has been examined and several laboratories have reported findings 
which are in broad agreement with the present study. Although 
differences in severity, between animal models, cause some discrepencies 
in the literature, the overall implication is that the somato-dendritic 
cytoskeleton is sensitive to TBI and that injurious processes initiate 
degradation of MAP 2. The first publication to examine the effect of TBI 
on MAP 2 demonstrated that moderate levels of a midline (central) fluid 
percussion injury in the rat resulted in a significant decrease in 
hippocampal MAP 2 levels but did not effect cortical levels of MAP 2
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105. This study suggested that alterations in the distribution of MAP 2 
can occur in the absence of neuronal cell damage. Other studies have not 
supported this basic premise. Rather it appears that a pronounced loss of 
MAP 2 is associated with degeneration and cell death in cortical 
neurones. MAP 2 immunoreactivity was profoundly diminished in the 
cortex and hippocampus ipsilateral to the site of injury following lateral 
(parasagittal) fluid percussion injury of moderate severity in the rat H 8. 
This alteration was detected within 10 minutes of injury and persisted up 
to 7 days after injury. In this study MAP 2 immunolabelling was virtually 
abolished in the entire injury area which is similar to the appearance of 
MAP 2 following ASDH. Severe cortical impact injury, which produces 
contusions similar to those found in humans after traumatic head injury, 
also caused a loss of MAP 2 protein in the rat cortex within 3 hours of 
injury 151. Consequently, there appears to be a range of MAP 2 loss from 
pronounced loss preceding cell death in zones of severe injury to 
moderate losses in sublethally injured areas probably not destined for cell 
death. Therefore MAP 2 may have a useful role in the evaluation of the 
efficacy of various treatments on attenuating the neuropathological 
sequelae of traumatic brain injury.
It remains to be determined if this general decrease in MAP 2 is 
reversible. A recent report suggested that this was the case in mild TBI. 
In the rat model of mild focal cortical trauma diminished MAP 2 
immunostaining was detected at the perimeter of the lesion up to 3 days 
post injury. However, no loss in immunostaining was detected 21 days 
after injury H 9  Hence, severe TBI may result in cytoskeletal
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abnormalities which cannot be overcome by the cell and may culminate 
in neuronal cell death. Less severe cytoskeletal alterations could be 
repaired although functional changes in the neurone may persist.
The decrease in MAP 2 immunoreactivity could be attributable to several 
factors including the inability to detect the target epitope due to potential 
post-translational changes following traumatic brain injury 175 These 
changes may involve proteolysis since the monoclonal anti-MAP 2 
antibody used in this study (Sigma AP-20) does not detect MAP 2 
breakdown products following traumatic brain injury 105,176 T h u s  the 
loss of MAP 2 in dendritic processes most probably represents significant 
disruption of dendritic morphology and presumably alterations in 
dendritic function. Alternatively, loss of MAP 2 immunolabelling could 
be associated with mechanically broken dendrites, a possibility that 
requires investigation with other morphological techniques including 
Golgi or silver staining.
4.1.3 Laminar arrangement of MAP 2 immunopositive neurones within the 
ipsilateral cortex following acute subdural haematoma. Is there selective 
vulnerability of cortical neurones to acute subdural haematoma ?
Following induction of an acute subdural haematoma (ASDH) MAP 2 
immunostaining showed a laminar distribution in the ipsilateral cortex. 
Despite pronounced MAP 2 loss in the cortex beneath the haematoma, a 
sub-population of pyramidal neurones in layers 3 and 5 were MAP 2 
immunopositive. This feature was present 2 hours post ASDH when there
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was a clearly defined bi-lam inar arrangem ent of preserved 
immunolabelling. In animals examined 4 hours post ASDH a different 
pattern was displayed. Although a proportion of pyramidal neurones 
within layer 3 remained MAP 2 immunopositive, these were decreased in 
number and the definition of the cortical layers was more blurred 
indicating a more pronounced loss of MAP 2 immunoreactivity in the 
cortex.
The reason for this pattern of im m unostaining is uncertain. 
Neuropathological examination of the brain following ASDH indicated 
that neurones within the centre of the ischaemic lesion demonstrated 
minimal changes although the variation in H&E staining suggested that 
early ischaemic changes were taking place. It is possible that these 
neurones are only sub-lethally injured and able to resist the decrease in 
MAP 2 occurring in other neurones which are more severely damaged by 
the insult such as those in the periphery of the histologically defined 
lesion. In this proposal subsequent cell death and degeneration would 
result in loss of MAP 2 immunoreactivity. This is in accord with 
numerous investigations that suggest loss of MAP 2 is a marker of 
impending neuronal cell death 119,132,151,177,178 Unfortunately, the 
histological stain used in this study, is relatively poor in the recognition of 
neuronal death at short survival times within the cortex. Silver 
impregnation of degenerating neurones 179 and immunohistochemical 
labelling of reactive astrocytes with glial fibrillary acidic protein (GFAP) 
180,181 are m0re useful and could provide definite evidence of the
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corelation between MAP 2 loss and neuronal cell death which this study 
suggests.
Further support that MAP 2 loss is a feature of neuronal cell death 
following TBI was provided in a recent publication 151 M ore 
importantly, and of clinical interest, their results were the reciprocal of 
the present study indicating the correctness of our assumption that the 
neurones in cortical layers 3 and 5 are only sub-lethally injured up to 4 
hours after an ASDH. Severe cortical impact injury in the rat, resulted in 
a marked decrease in MAP 2 immunostaining in apical dendrites of 
pyramidal neurones within layers 3 and 5 of the injured cortex 151.. These 
changes in MAP 2 immunolabelling were associated with histological 
evidence of im pending cell death. Taken together, M AP 2 
immunostaining is a useful marker of both cell death and possible 
neuronal viability. It also confirms that strict parallel histological studies 
are essential for the interpretation of immunohistochemical data.
An alternative, and intriguing, explanation could be that there is a 
differential vulnerability of cortical neurones to ASDH. This would have 
clear therapeutic implications designed to arrest or limit neuronal injury 
in this clinically relevant condition. Investigations in animal models of 
cerebral ischaemia suggested the concept of "selective vulnerability" 
131,182-186 Simply stated, this proposes that certain neurones are more 
susceptible to a given insult than others. The physiological basis of this 
remains uncertain but could be related to anatomical factors, cell 
membrane receptor characteristics, electrophysiological or biochemical
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properties. In animal models of ischaemia, selective vulnerability of 
neurones in the hippocampus have been described. Similarly, moderate 
TBI resulted in a decrease in the level of MAP 2 in the hippocampus in 
the absence of alterations in the cortex suggesting that there is a selective 
vulnerability of the hippocampus to traumatic injury 105. Limited 
information is available concerning the selective vulnerability of cortical 
neurones. Transient ischaemia in the gerbil model demonstrated that the 
pyramidal cells in layers 3 and upper layer 6 of the somatosensory cortex 
were the most sensitive to ischaemia, whereas the neurones in layers 2, 4 
and 5 were more resistant to ischaemia 187. This bi-laminar pattern of 
neuronal death developed after even short periods of ischaemia (3-10 
minutes) and was identifiable at post ischaemic survival times of 6 hours 
to one month. Why the layer 3 pyramidal neurones and, to a lesser extent 
the pyramidal neurones in upper layer 6, should be so m uch'm ore 
sensitive to ischaemia than other cortical neurones is unknown. In the 
adult rat, many pyramidal cells in layer 3 are either corticocortical 
projection cells 188 or callosal projection cells 189 an(j some neurones at 
the lower border of layer 5 and the upper part of layer 6 are also callosal 
projection cells 190. Therefore it seems that the MAP 2 immunopositive 
cells identified in the present study, belong to these two classes of 
projecting neurones. However, the current investigation did not 
demonstrate a decrease in MAP 2 immunostaining in layers 3 and 5 
indicating that, in this model, these neurones are either sub-lethally 
injured or able to resist injury. As noted above H&E histology did not 
confirm ischaemic neuronal death and other techniques are required to 
clarify this issue. With regard to possible increased resistance to injury, it
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may be that the blood supply to this region of the cortex offers some 
protection. Layer 4 of the adult rat somatosensory cortex is characterised 
by a richer blood supply than other cortical layers 19 l e Perhaps a blood 
borne factor accounts for the decrease in MAP 2 observed in this layer 
whilst the lower blood supply to layers 3 and 5 account for some degree 
of protection. Laminar differences in NMDA receptor density could also 
explain the observed pattern of MAP 2 loss. Cortical NMDA receptors 
are most numerous in the outer layers (1 and 2) in the adult rat cortex 
192,193 Moreover, glutamate levels are increased in the cortex beneath 
the haematoma to seven times above basal levels 44 Therefore, 
glutamate mediated neuronal death would predominantly effect the outer 
layers with resultant MAP 2 loss.
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4.1.4 Tau-1 is altered in axons, neuronal perikarva and glial cells following
acute subdural haematoma in the rat.
Following acute subdural haematoma (ASDH) disturbances in the level 
and localisation of the microtubule associated protein tau were detected in 
axons, neuronal cell bodies and glial cells. The temporal profile of these 
changes indicate that tau is modified 30 minutes after induction of ASDH 
and these disruptions persisted for up to 4 hours. There was a significant 
decrease in the level of tau protein in the cortex beneath the haematoma 
as detected by relative optical density. This was demonstrated at both 30 
minutes and 4 hours after induction of the ASDH. Irregular 
accumulations of immunostained profiles were detected in axons 
subjacent to the haematoma at all time points examined after injury. At 
least three possible mechanisms may contribute to the observed 
alterations in tau immunostaining induced by ASDH and detected by 
Tau-1 immunostaining. First, tau may be dephosphorylated at one or 
more sites. Second, tau may be degraded and thirdly, there could be 
redistribution of existing tau or synthesis of new protein following 
ASDH. It is likely that a combination of these factors are involved to 
varying degrees.
The combined use of Tau-1 immunohistochemistry and W estern blot 
analysis suggests that tau is dephosphorylated in response to ASDH. 
Specifically, the increased Tau-1 neuropil immunostaining observed in 
the histologically defined lesion is indicative of tau dephosphorylation 
since the epitope recognised by this antibody is masked in it's
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phosphorylated state 167,194 jn addition, the altered electrophoretic 
profile of tau, with the appearance of additional bands, is also consistent 
with a change in the phosphorylation state of the protein 195. Although 
the significance of this alteration remains unclear it is likely that 
disruption of the cytoskeleton will result in dysfunction.
Cerebral ischaemia results in an acute alteration in the phosphorylation of 
many brain proteins by modifying the activity of specific enzymes 196. 
Since phosphorylation of cellular proteins is an important regulating 
mechanism controlling polymerisation of cytoskeletal proteins, changes 
in the phosphorylation status of proteins may contribute to the 
pathogenesis of brain damage 197. Furthermore, since microtubules are 
inherently unstable structures, the stabilising effect of tau is likely to be 
important for the integrity of axons that depend on stable microtubules for 
rapid axonal transport. Ischaem ia induced alterations in the 
phosphorylation of tau could cause modifications in the configuration of 
this cytoskeletal protein and therefore structural abnormalities in the cell. 
For example, tau is a component of the cross bridges between 
microtubules in axons. In the normal state the spacing between adjacent 
microtubules in the presence of tau is about 20nm. However, alterations 
in the phosphorylation of tau reduces the stoichiometry and affinity of 
binding to micro tubules in vitro, possibly contributing to disruption of 
axonal function 91.
Acute subdural haematoma in the rat results in a sevenfold increase in 
extracellular glutamate levels in the cortex underlying the haematoma 44
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Increased Tau-1 immunostainining occurred in response to glutamate 
receptor activation in neuronal cell cultures suggesting that in vivo, 
dephosphorylation of tau similarly may occur following ASDH in this 
model. 198 in ischaemia there is disruption of calcium homeostasis and 
other second messenger systems 199, 200 w ithin the ischaemic lesion, 
the increased Tau-1 immunostaining may result from activation of 
glutamate receptors and subsequent increases in intracellular calcium 
levels which could activate calcium dependent enzymes. In vitro, tau is a 
substrate for many kinases including calcium/calmodulin-dependent 
kinase II(CaM kinase II), protein kinase C, cyclic AMP-dependent 
kinase, casein kinase II and proline directed kinases such as MAP kinase 
201-203 These enzymes can alter the phosphorylation status of tau 
suggesting that the balance of their activities may play an important role 
in the pathogenesis of ASDH. In the rabbit spinal cord ischaemia model 
there was a rapid loss of CaM kinase II activity within 30 minutes of 
ischaemic insult. This enzyme can phosphorylate tau in vitro, causing a 
reduction in it's electrophoretic m obility 204  a  recent study 
demonstrated that loss of CaM kinase II activity and dephosphorylation 
of tau occurred only in the ischaemic segment of the rabbit spinal cord 
205 These workers concluded that loss of CaM kinase II activity and 
dephosphorylation of tau were early markers of ischaemic damage. Of 
interest tau was rephosphorylated following reperfusion of the ischaemic 
segment suggesting that these alterations are not irreversible. Alterations 
in phosphatase 2B immunoreactivity have been reported following 
ischaemia although what these antigenic changes mean in terms of 
phosphatase activity is unclear 206-209 However, given that phosphatase
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2 activities are calcium dependent it is possible that enzyme activity is 
increase in ischaemic tissue. This could provide a mechanism for the 
dephosphorylation of tau.
Recent studies support the hypothesis that phosphorylation status of tau is 
altered following acute brain injury. Six hours of focal cerebral ischaemia 
in the cat induced increased tau immunostaining in a population of 
neurones within the ischaemic lesion as reflected by the appearance of 
Alz-50 immunoreactivity 129. An early, variable and transient increase in 
perikaryal tau, as detected by the Tau-1 antibody, was reported following 
transient global ischaemia in the rat 128 ^  the rat model of focal cerebral 
ischaemia alterations in tau were detected in axons, neuronal cell bodies 
and glial cells. These changes were revealed within 2 hours of permanent 
occlusion of the middle cerebral artery and were still present after 6 
hours. This investigation concluded that dephosphorylation and/or 
degradation of tau may account for the observed alterations in the protein 
1^0 Alterations in tau consistent with dephosphorylation were observed 
following intra-hippocampal injection of the microtubule disrupting agent 
c o l c h i n e ^ l O .  in other paradigms of stress, alterations in the 
phosphorylation status of tau have been reported. Heat shock for 1 hour 
followed by a return to normal temperatures for 6 hours leads to an 
increased phosphorylation of tau in the rat brain 211. in contrast, heat 
shock of the human neuroblastom a cell line LAN induces 
dephosphorylation of tau within 30-60 minutes 212 Uncoupling of 
oxidative phosphorylation, as ocurs in ischaemia, in the rat brain cortical 
slices causes dephosphorylation of tau 213,214 Overall, these studies
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suggest that alterations in tau immunoreactivity is a sensitive indicator of 
stress. Furthermore, the phosphorylation status of this protein is effected 
by the balance of numerous enzymes and this may account for the 
alterations in tau detected following ASDH.
Degradation of tau is likely to be a feature of breakdown of the 
cytoskeleton following ASDH. Quantitative W etern blot analysis 
indicated a significant decrease in the level of tau 30 minutes after 
induction of an ASDH. Cytoskeletal proteins are susceptible to enzymic 
proteolysis which may account for this finding. In particular calcium 
dependent proteases such as calpains have been shown to decrease levels 
of cytoskeletal proteins following cerebral ischaemia. This possible 
mechanism will be discussed in another section.
Although the issue of redistribution or synthesis of tau was not 
specifically  addressed in the present study, increased Tau-1 
immunoreactivity in axons and neuronal cell bodies following ASDH 
could be interpreted to indicate redistribution of existing tau or synthesis 
of new protein. One can speculate that tau is dephosphorylated, 
rephosphorylated to some extent and accumulates in some cell soma in a 
degraded form. Although ASDH results in a profound reduction in 
cerebral blood flow there is not complete ischaemia. In addition, 
histological examination indicated that certain neurones were only sub- 
lethally injured, as at the edge of the ischaemic territory. Taken together 
this suggests that under these conditions there may be some 
rephosphorylation of tau. In this regard, MAP kinase (ERK-2) has been
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shown to be reactivated on reperfusion after transient cerebral ischaemia 
215,216 This kinase can phosphorylate tau on multiple sites. Support for 
the concept of redistribution of tau following ischaemia, is limited to a 
few recent studies. Follow ing transien t g lobal ischaem ia, 
immunoreactivity with the Tau-1 antibody decreased in the neuropil and 
increased in the perikarya in all regions of the rat hippocampus 128. 
However, in the rat model of focal cerebral ischaemia no increase in 
immunostaining of either axons or neuronal perikarya was observed when 
another tau antibody, TP70, was used. This is inconsistent with 
accumulation or synthesis of tau protein 130
For brevity it is suffice to note that increased Tau-1 immunostaining was 
detected in oligodendrocytes within the histologically defined ischaemic 
territoty. Typically these small cells were most numerous in the white 
matter although they could be identified scattered throughout the 
ipsilateral cortex. Increased glial staining for tau was detected following 
focal cerebral ischaemia in the rat 130 and also in human head injured 
tissue. Whether this represents an acute response to injury or an increased 
synthesis of tau is uncertain. However, it does raise the possibility that 
increased tau immunostaining is related in some way to the resistance of 
oligodendrocytes to injury. This topic was not central to the hypothesis of 
this investigation and will not be discussed further.
In conclusion there are numerous factors which may be involved in 
determining the observed alterations in tau following ASDH. Disturbance 
of the normal neurochemical environment of the brain effects various
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enzymes and second messenger systems. In this context, it appears that 
the balance of phosphorylation is an important feature which may be 
central to the involvement of the cytoskeleton in traumatically induced 
brain injury.
197
4.1.5 Alterations in p-tubulin following acute subdural haematoma in the rat
This investigation demonstrated increased p-tubulin immunostaining in a 
defined population of cortical neuronal perikarya underlying the 
haematoma. These immunopositive cells were detected within 30 minutes 
of induction of an ASDH and became more prominent up to 4 hours after 
production of an ASDH. Typically these pyramidal neurones were 
localised to cortical layer 3 and with increasing survival more cell bodies 
were strongly p-tubulin immunostained. Cortical layer 3 is usually the 
least resistant to ischaemic insult suggesting once again that in the rat 
model of ASDH there exist a group of neurones in the centre of the lesion 
which are only sub-lethally injured. However, compared to sham operated 
animals and the contralateral cortex of injured animals there was 
increased immunostaining of these pyramidal neurones. In addition, 
axons in the ipsilateral corpus callosum demonstrated altered P-tubulin 
immunoreactivity with irregular, granular profiles detected at all time 
points examined. However, quantitative Western blot analysis indicated 
that there was a significant decrease in the protein level of both bands 
(high and low molecular weight) at 4 hours after induction of ASDH but 
not after 30 minutes. Overall, the results suggest that P-tubulin is 
modified and/or degraded in the rat model of ASDH. The main 
mechanisms involved are discussed elsewhere in this section and the 
activation of calpains may be responsible for protein degradation. As 
noted previously protein phosphorylation is altered in various forms of 
stress stimuli including ischaemia. This may play a role in the observed 
alterations in p-tubulin although this aspect of the cytoskeleton has not
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attracted much attention in the literature. Severe forebrain ischaemia 
results in decreased phosphorylation of a-tubulin in the rat cortex 217 
This may result in abnormalities in the polymerisation of this cytoskeletal 
protein. In broad agreement with this, 5 minutes of ischaemia in the gerbil 
results in decreased a-tubulin immunostaining in the hippocampus 178. 
The monoclonal antibody employed in the present study was not affected 
by the phosphorylation status of p-tubulin and detects all forms of P- 
tubulin. Further studies could use alkaline phosphatase pretreatment to 
determine the of phosphorylation in the response of p-tubulin in this 
paradigm.
An increased synthesis of p-tubulin following induction of an ASDH 
would seem unlikely, especially at the acute time points the present study 
examined. However, in the light of recent studies, this interesting 
possibility deserves discussion. It may be that there is an initial increase 
in p-tubu lin  expression followed by enzymic degradation. There is 
considerable evidence that mammalian p-tubulin  is phosphorylated 
218,219 i i  is likely that this modification is of great significance in 
modulating the assembly or properties of microtubules. A recent report 
demonstrated that of the seven beta isotypes, the phosphorylated one is 
beta(III), the isotype found almost entirely in neurones 220 Moreover, 
the phosphate on the beta(III) isotype was resistant to a wide variety of 
phosphatases but removal of the phosphate inhibited m icrotubule 
assembly in vitro. However, such an inhibition was not evident when 
microtubule assembly was induced in the absence of microtubule 
associated proteins. Therefore, dephosphorylation of p-tubulin in the
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presence of decreased microtubule associated proteins may result in an 
increased production of microtubules. Although the mechanism involved 
is not known, this could account for the increased P - tu b u lin  
im m unolabelling detected in the ischaemic cortex beneath the 
haematoma.
There is a precedent in the literature indicating that such an increase in 
tubulin synthesis occurs following injury to central nervous system. 
When axons of a peripheral nerve are transected and allowed to regrow, 
tubulin protein levels rise substantially and there is an enhanced 
expression of tubulin mRNAs 221-225 j o  determine if this change 
occurred in the central nervous system environment the retinal ganglion 
cells were examined after cutting the optic nerve 226 An early increase 
in tubulin mRNA was detected in axotomised adult rat retinal ganglion 
cells. This increase, as detected by Northern blot analysis, only lasted for 
1 day before a later decrease. It is suggested that the transient increase in 
tubulin mRNAs may reflect an early regenerative response. It could be 
that following ASDH there is an increased expression of p-tubulin in an 
attempt to increase synthesis of microtubules. The stimulus for this 
process could be a decrease in the levels of micritubule associated 
proteins such as MAP 2 which is known to stim ulate tubulin 
polym erisation 227 xhis requires further investigation but is an 
intriguing possibility in the modulation of the cytoskeleton.
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4.1.6 Ultrastructural alterations in the neuronal cvtoskeleton following acute
subdural haematoma in the rat.
Transmission electron microscopy demonstrated alterations in the 
dendritic and axonal cytoskeleton following acute subdural haematoma 
(ASDH) in the rat. The ultrastructural evidence obtained correlated with 
the alterations in the neuronal cytoskeleton detected w ith 
immunohistochemistry and Western blots. The overall implication is that 
there is marked disruption of both the dendritic and axonal cytoskeleton 
in this model of traumatic brain injury. The ultrastructural evidence 
supports and substantiates the immunohistochemical and immunoblotting 
data. Although ultrastructural analysis was only performed in animals 
allowed to survive 4 hours after production of an ASDH, the early 
alterations detected with immunohistochemical methods suggest that they 
represent morphological disorganisation of the cytoskeleton.
In the cortex underlying the haematoma there was an abnormal 
misalignment of dendritic microtubules. This is consistent with the loss of 
MAP 2 demonstrated in the present investigation. MAP 2 is a component 
of the cross bridges between microtubules and is necessary for the three 
dimensional spatial configuration of the dendrite 64,70,91 Therefore, 
loss of MAP 2 could result in an abnormal arrangem ent of the 
microtubules relative to the longitudinal axis of the dendrite. Perhaps the 
loss of MAP 2 allowed the microtubules to collapse on each other. It is 
likely that this leads to functional abnormalities by impairing fast 
axoplasmic transport. This investigation has demonstrated that ASDH
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results in a significant decrease in protein levels of MAP 2. Furthermore, 
this loss of MAP 2 correlated with the detection of calpain mediated 
spectrin breakdown products in the cortex beneath the haematoma. 
Conceivably, the MAP 2 cross bridges could be cleaved by calpain 
causing the microtubules to collapse and become disorganised.
There was loss of an organised axonal cytoskeleton following ASDH. 
Typically, there were reduced numbers of microtubules within the 
axoplasm which consisted of a diffuse, flocculent precipitate. In addition, 
the neurofilaments appeared compacted, that is, there was a reduced inter­
filament spacing, following ASDH. Previous studies in other animal 
models of traumatic brain injury are in broad agreement with these 
findings. Quantitative analysis demonstrated a significant loss of 
microtubules in myelinated axons following optic nerve traction in the 
guinea pig. In the same material, there was increased spacing of 
neurofilam ents 116 ,228 Povlishock and colleagues described
neurofilament compaction and loss of microtubules in traumatically 
injured axons 111. Moreover, they suggested that loss of the 
neurofilament sidearms allowed the neurofilaments to collapse on one 
another with resultant increased packing. However, this alteration was 
only detected in the more severe forms of injury. Specifically, mild
traumatic brain injury was associated with m isalignm ent o f the
neurofilam ents and not m icrotubule loss and com paction of
neurofilaments H I.T hese morphological abnormalities are not species 
or model specific 112 indicating that they are operant in most forms 
of traumatic brain injury.
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Dissolution of the axoplasm is thought to result from the proteolysis of 
cytoskeletal proteins. Calpain, a calcium activated neutral protease, may 
be involved in this process 170 Our results demonstrated calpain 
mediated spectrin breakdown products in white matter tracts of the brain 
following ASDH but only in animals examined at 2 hours or 4 hours after 
injury. In addition, the immunolabelling was faint. However, it should be 
recognised that the Ab38 antibody detects calpain I (fiM -calpain) 
mediated spectrin breakdown products and is only present in low levels in 
axons 141-143 a  recent report demonstrated calpain I mediated spectrin 
breakdown products within axons following experimental traumatic brain 
injury 150. it should be noted that immunolabelled axons were only 
identified in the region of a direct tear of the corpus callosum suggesting 
local disruptive events may be involved. It is also possible that proteases 
other than calpain cause direct cytoskeletal dissolution. The microtubule 
associated protein, tau is predominantly localised to axons 94. Following 
ASDH, Tau-1 immunostaining was altered in white matter. Since tau is a 
component of the cross bridges between axonal microtubules 91, 
modification of this protein could affect the spatial arrangement of the 
microtubules.
The ultrastructural examination confirmed disruption of both the dendritic 
and axonal cytoskeleton following ASDH in the rat. The precise 
mechanisms involved are uncertain at this stage. That calpain or other 
protease enzymes plays a role seems likely although the exact site of 
proteolysis remains unclear. It is recognised that the projection domains 
of microtubules are essential in the maintainence of normal neuronal
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calibre 64,70,91 This function is served by the microtubule associated 
proteins, MAP 2 and tau, in dendrites and axons respectively. It is 
conceivable that enzymic degradation of these microtubule associated 
proteins is responsible for the disorganisation of the cytoskeleton revealed 
by electron microscopy.
Consideration of mechanisms involved in the alterations in microtubules 
and neurofilaments after traumatic brain injury can only be speculative. 
Nevertheless recent evidence has provided a concensus for initial 
compaction of neurofilaments and loss of microtubules following axonal 
injury 38 ,111 ,112 ,114 ,116  The central hypothesis suggests that 
activation of calpain I and/or calpain II may account for the different 
response of microtubules and neurofilaments to traumatic injury. In this 
proposal calpain I (fiM-calpain) is activated by micromolar increases in 
intracellular free calcium levels following the traumatic insult 147. This 
results in cleavage of the neurofilam ent sidearm s causing the 
neurofilaments to collapse and become compacted 111,112,114 That is, 
there is a reduced interfilament distance but retention of their filamentous 
structure for up to six hours after injury 111»114. Activation of calpain I 
(|iM  calpain) results in post-translational modification of the 150kDa 
neurofilament subunit (NF-M) and may be involved in shaping the 
neurofilament network rather than it's degradation 229,230 This is then 
followed over a period of hours rather than minutes, by neurofilament 
misalignment and disassembly 111,114. Dissolution of neurofilaments 
does not occur until calcium levels are increased to millimolar levels 
capable of activating calpain II 147. Complete loss of neurofilaments
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through activation of calpain II (mM calpain) requires calcium 
concentrations of at least 0.2mM 231
In addition, calpain I (pM-calpain) activation causes rapid dissolution of 
microtubules as evidenced by the loss of microtubules in the axoplasm 
detected in ultrastructural studies. It is assumed that degradation of the 
microtubule associated proteins also occurs by this mechanism. Axonal 
microtubules exist as two subtypes, either so-called cold-labile and cold- 
stable or drug-labile and drug-stable 232-235 Calcium alone is capable of 
precipitous disassembly of cold-labile microtubules 236-239 Cold-stable 
microtubules are resistant to calcium but are depolymerised when calcium 
interacts with calmodulin at physiological concentrations such as occur in 
the brain, where half maximal disassembly of cold-stable microtubules 
occurs in the presence of 1.0 mM calmodulin and 100 mM calcium 235
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4.1.7 The role of the calcium dependent protease calpain in the mediation of
cytoskeletal injury following acute subdural haematoma in the rat.
The present investigation demonstrates that calpain mediated proteolysis 
of spectrin occurs as early as 30 minutes following induction of an acute 
subdural haematoma (ASDH) in the rat and continues for up to 4 hours 
post injury. In addition, immunohistochemical analysis revealed that 
calpain activity predominated in the cortex underlying the haematoma. 
Although spectrin is an integral constituent of the submembrane 
cytoskeleton, this study suggests that calpain may play a role in the 
degradation of the microtubule component of the neuronal cytoskeleton. 
Immunohistochemical observations also provided evidence for the 
cellular localisation of calpain activity after injury. At all survival times 
examined, spectrin breakdown products (BDPs) were detected in 
dendrites and neuronal cell bodies but not in axons. At 2 hours and 4 
hours post induction of ASDH, calpain degraded spectrin was localised in 
dystrophic and fragmented dendritic processes. This suggests that 
dendrites may be particularly vulnerable to calpain mediated proteolysis. 
The only previous study to examine calpain mediated proteolysis of the 
cytoskeleton following traumatic brain injury reported similar findings 
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This investigation has reported early changes in the breakdown of 
spectrin by calpain following experimental brain injury in the rat. Several 
points should be considered when using this data to interpret the time 
course of calpain activation in this model. Calpain activation depends on
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the elevation of intracellular calcium levels above a certain threshold 147 
Previous investigations have reported rapid changes in extracellular 
calcium levels following traumatic brain injury 137,240 However, 
whether these translate to a rapid increase in intracellular levels of 
calcium has not been determined. A recent qualitative study demonstrated 
accumulation of calcium in the axoplasm of the node of Ranvier 
following traction of the optic nerve in the guinea pig H 6 . As noted in 
that report, further quantitative studies are required to provide evidence 
for changes in the concentration of calcium following traumatic brain 
injury. Therefore, it is possible that increased intracellular free calcium 
and subsequent calpain activation are delayed following trauma, perhaps 
due to calcium buffering. An alternative explanation is that acute calpain 
activation may result in a limited spectrin proteolysis below the detection 
threshold for the immunohistochemical protocol.
The cerebral cortex underlying the haematoma displayed the most 
pronounced spectrin breakdown. Histological examination revealed that 
this area also demonstrates the most marked ischaemic cell change. This 
close correspondance suggests that cell populations undergoing calpain 
mediated spectrin breakdown may eventually die. Since we report calpain 
mediated proteolysis as early as 30 minutes after injury it is likely that 
spectrin breakdown occurs prior to, rather than as a consequence of 
neuronal cell death. Studies in experimental models of excitotoxicity and 
cerebral ischaemia support this hypothesis and raise the possibility that 
aspects of calpain mediated pathphysiology are reversible 170, 241-243s 
Indeed within the last few years several investigations have demonstrated
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that calpain inhibitors may have neuroprotective effects in animal models 
of cerebral ischaemia 243-245 Moreover, pretreatment with a synthetic 
calpain inhibitor suppressed the degree of depletion of MAP 2 following 
permanent occlusion of the middle cerebral artery in the rat 244> The 
discovery and refinement of selective inhibitors of calpain remains an 
important goal 246
The vulnerability of dendrites following traumatic brain injury has been 
suggested by decreased levels of cytoskeletal proteins such as 
neurofilam ents and microtubule associated protein 2 (MAP 2) 
105,115,151 in ^  present investigation, the region of decreased MAP 2 
immunostaining in the cortex corresponds closely with the area of 
pronounced calpain mediated spectrin BDPs immunoreactivity. This 
suggests that calpain activation may be responsible, in part, for MAP 2 
proteolysis. However, this relationship was not detected in the 30 minute 
survival animals. In this group there was no observed alterations in MAP 
2 im m unostaining whereas calpain m ediated proteolysis was 
demonstrated. Despite the absence of detected immunohistochemical 
alterations in the distribution of MAP 2, quantitative W estern blot 
analysis revealed a significant decrease in the protein levels of MAP 2 in 
the ipsilateral cortex following ASDH. It is unclear why the 
immunohistochemical protocol failed to detect alerations in MAP 2 
immunolabelling but this may reflect the fact that Western blot analysis 
was the more sensitive technique at this early time point. It is recognised 
that MAP 2 is more susceptible to calpain mediated proteolysis than 
spectrin 146,247 supporting the correctness of this assumption. Overall
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this study supports the hypothesis that calpain activation occurs within 30 
minutes of ASDH and is involved in the degradation of MAP 2. Whether 
other proteases are involved in the proteolysis of MAP 2 requires 
elucidation. As noted in previous sections, a decrease in the protein levels 
of tau and p-tubulin occurred following ASDH in the rat. The 
demonstration of calpain activation in the cortex is consistent with the 
central hypothesis that calpain is involved in the degradation of 
cytoskeletal proteins following traumatic brain injury.
In this study calpain mediated spectrin proteolysis was detected in axons 
but only in those animals examined at 2 hours and 4 hours after induction 
of an acute subdural haematoma. Overall, the intensity of axonal calpain 
mediated spectrin BDPs immunoreactivity was low and restricted to the 
white matter tracts subjacent to the injured cortex. This indicates that the 
observed alterations in Tau-1 and p-tubulin within white matter were not 
entirely due to calpain I activity. This observation is not surprising. 
Axons are believed to contain primarily calpain II rather than calpain I 
necessitaing extremely elevated calcium levels to initiate proteolysis 
142 ,143 ,147  Such non-physiological concentrations of axonal 
intracellular calcium may not occur in this experim ental model. 
Alternatively they may not occur within 4 hours of induction of an 
ASDH. Neither of these points were investigated in the present study. 
Furthermore, the antibody used in this study, Ab38, is specific for the 
breakdown products of calpain I activity 170 _ Future studies will utilise 
antibodies directed at the calpain II BDPs to address this issue. It is 
suffice to conclude that activation of calpain may play a role in the
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mediation of traumatically induced axonal injury following acute
subdural haematoma.
4.1.8 The mechanistic basis of cytoskeletal damage following traumatic brain 
injury,
Although this investigation was not designed to provide definitive 
characterisation of the mechanism(s) involved in cytoskeletal injury after 
traumatic brain injury, several mechanistically relevant observations 
merit discussion.
Recent investigations suggest that NMDA receptor activation has a role 
in mediating calpain induced damage to the cytoskeleton 242,248-250 in 
particular it is proposed that NMDA receptor activation interacts with 
calpain leading to a common final pathway of neuronal injury. There is 
no doubt that the presence of an acute subdural haematoma alters the 
neurochemical environment of the brain. Traumatic brain injury induces 
w idespread membrane depolarisation and excessive release of 
neurotransmitters, including acetylcholine and glutamate 251. in the rat 
model of acute subdural haematoma there is an increase in extracellular 
glutamate to seven times above basal levels in the cortex underlying the 
haematoma 44. The ionophore associated with the N-methyl-D-aspartate 
(NMDA) receptor is permeable to calcium and there is considerable 
evidence that this property contributes to the role of the receptor in 
pathological conditions 138. Calpain has been implicated in a variety of 
NMDA receptor dependent effects and recent investigations have
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suggested that rapid activation of calpain occurs following stimulation of 
NMDA receptors 248  ^ Furthermore, translational suppression of calpain 
reduced NMDA-induced spectrin proteolysis in hippocampal slices 249 
Activation of the NMDA receptor seems to be involved in the observed 
decrease in MAP 2 immunostaining following cerebral ischaemia in the 
gerbil, since pretreatm ent with the NMDA antagonist, MK801 
ameliorates this response 252 Administration of kynurenate, a 
competitive antagonist at non-NMDA receptors and a non-competitive 
antagonist at the NMDA receptor, attenuated MAP 2 loss following 
experimental traumatic brain injury in the rat However, a recent 
study did not support the concept of NMDA receptor mediated calcium 
influx as an important mechanism underlying the loss of MAP 2 
immunolabelling following mild traumatic brain injury in the rat 119
It is also possible that other effects elicited by intense stimulation of 
NMDA receptors interact with calpain activation. Perhaps the most 
obvious example of this would be the generation of free radicals, an effect 
observed to occur following application of NMDA 253, 254 proteins 
damaged by free radicals are reported to be more susceptible to cleavage 
by calpain thereby extending the range of aberrant effects that follow 
stimulation of the pro tease 255
As discussed earlier the phosphorylation status of tau, MAP 2 and tubulin 
effects their structural properties with the inference that this translates 
into functional disturbances. Protein phosphorylation also influences the 
interaction between calpain and cytoskeletal proteins 140, 256 The basis
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for this complex process is that calcium infux through the NMDA 
receptor affects second messenger system s controlling protein 
phosphorylation. Protein kinase C (PKC) and calcium/calmodulin- 
dependent protein kinase II (CaMKII), are also substrates for calpain 257- 
261. Therefore, calpain mediated proteolysis of these regulatory enzymes 
has the potential to alter the degree of phosphorylation of the cytoskeletal 
p ro te in s . Ample biochem ical evidence indicates that M AP 2 
phosphorylation influences it's affinity for microtubules and it's efficacy 
in promoting tubulin polymerisation 262,263 phosphorylation has been 
hypothesised to effect the conformation of the MAP 2 molecule 264 an(j 
seems to determine the susceptibility of the molecule to degradation by 
calpain 147. Recent studies have indicated that protection of MAP 2 
against calpain is dependent on the degree of phosphorylation of MAP 2 
256 ,265  jn contrast, NMDA receptor activation induces rapid 
dephosphorylation of MAP 2 making it more vulnerable to calpainolytic 
degradation 175, Phosphorylation is generally considered to protect 
neurofilament proteins from degradation whereas dephosphorylation 
increases vulnerability of the neurofilaments to calpain mediated 
proteolytic degradation 266 r  has been suggested that the high degree 
of phosphorylation common to the purified NF-H subunit may be 
responsible for it's relative resistance to calpain mediated proteolysis 267
The context in which the above interactions would be operative is still 
unclear. Nevertheless the physiological relevance of these interactions 
and their interplay are likely to underlie the mechanistic basis of 
cytoskeletal disruption. It is worthy of speculation that calpain
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degradation of phosphatases may render the cytoskeleton more 
susceptible to calpain mediated proteolysis. The current investigation 
supports the hypothesis that the phosphorylation status of cytoskeletal 
proteins is altered following traumatic brain injury and that calpain is 
responsible, at least in part, for proteolytic degradation of the 
cytoskeleton.
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4.2 ALTERA TIO N S IN THE N EU RONAL C Y TO SK ELETO N
FOLLOWING ACUTE SUBDURAL HAEMATOMA IN HUMANS.
The results of this study confirmed that alterations in the neuronal 
cytoskeleton can be detected in human post mortem brain tissue 
following traumatic brain injury. In patients sustaining acute subdural 
haematomas there was a loss of MAP 2 immunoreactivity in the cerebral 
cortex underlying the haematoma compared to the control cases. In 
addition, this study demonstrated an increase in Tau-1 immunostaining in 
the somatodendritic compartment and an altered distribution of p-tubulin 
immunolabelling in the parietal cortex beneath the haematoma compared 
to the control cases. Comparison of the results in human postmortem 
material with those in the rat model of acute subdural haematoma indicate 
that the alterations in the microtubule component of the neuronal 
cytoskeleton were similar in both studies. Although the postmortem 
changes were not as extensively characterised in the human as compared 
to the rat brain, the results demonstrate that alterations in the neuronal 
cytoskeleton are a feature of head injured human beings sustaining an 
acute subdural haematoma. This is important in that it indicates that the 
rat model of acute subdural haematoma could be a useful tool in the 
investigation of the pathobiology of traumatic brain injury.
The use of human postmortem tissue presents certain difficulties. There is 
no doubt that it is difficult to correct for every premorbid variable. For 
example, the mechanism of injury can vary within a group of patients 
sustaining an acute subdural haematoma. In addition, factors such as
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associated systemic injuries, coexistent diseases, delays in treatment and 
the nature of treatment can vary greatly. However, since the aim of this 
particular study was to identify alterations in the neuronal cytoskeleton in 
humans and, to compare these with the results obtained in the well 
controlled experimental model, it is reasonable to accept these limitations 
as being inherent to the use of postmortem tissue. Obvious in any 
consideration of a study of this nature is the potential for artifactual 
change. As noted in the Materials and Methods section, considerable 
differences exist in the intervals between death and fixation of brain 
tissue. Although such a variable can contribute to potential erroneous 
evaluations, it is reasonable to accept this because this study was 
essentially a neuropathological comparison between experimental studies, 
in which delays in fixation are not a factor, and human postmortem tissue.
A recent investigation examined the stability of the neuronal cytoskeleton 
during the postmortem interval 268 These workers demonstrated that 
similar cytoskeletal changes occurred in human postmortem tissue and rat 
brain analysed at various postmortem intervals. The main suggestion 
from this study was that alterations in the cytoskeleton detected in 
postmortem tissue were of questionable significance. The reason for this 
appeared to be that the microtubules and microtubule associated proteins 
(MAPs) are not biologically stable after death. Therefore caution is 
required in the interpretation of cytoskeletal alterations in studies using 
human postmortem tissue.
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Overall the results of the present investigations indicate that similar 
alterations in the cytoskeleton can be detected in humans and rats 
following acute subdural haematoma. Despite the difficulties in the use of 
postmortem tissue, this work supports the hypothesis that alterations in 
the neuronal cytoskeleton play a role in the mediation of traumatic brain 
injury.
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4.3 ALTERATIONS IN AXOLEMMAL PERMEABILITY FOLLOWING
TRAUMATIC BRAIN INJURY.
The present study confirmed the results of previous investigations by 
demonstrating that alterations in the axolemma are a feature of 
traumatically induced axonal injury H I  Comparison between two 
extracellular tracers of different molecular size indicated that there was no 
evidence of an increased detection of flooded axons when employing a 
tracer of smaller molecular size. This suggests that in this injury 
paradigm, trans-axolemmal influx of the extracellular tracer is an" all or 
none" phenomenon. That is, there is no evidence of a differential 
permeability change following traumatic brain injury wherein the 
axolemma would first preferentially leak to tracers of smaller molecular 
weights. From this study it appears that when the axolemma fails it does 
so in a non-specific manner.
Ultrastructural tracers serve the important purpose of defining tissue or 
cellular compartments and their interconnecting channels. The ideal tracer 
substance should be (a) nontoxic and physiologically inert, (b) composed 
of uniform particles of known size, (c) immobilised in its in vivo position 
by fixation, (d) capable of being accurately localised when viewed with 
the electron microscope and , (e) demonstrable at low concentration. In 
addition a small molecular size is essential for many applications. For 
example,membrane channels as narrow as 20nm have been demonstrated 
with colloidal lanthanum 269? a tracer smaller than almost all others in 
use. Because of its toxicity, colloidal lanthanum can only be applied to
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fixed rather than living tissue specimens. This complicates and limits the 
interpretations made with this tracer. Clearly there is a need for an 
extracellular tracer of smaller molecuar size which is non-toxic at 
physiological concentrations. Microperoxidase (MP) is such a tracer 
(molecular weight 1900 Daltons, molecular diameter 2nm).
Since the horseradish peroxidase (HRP) method was first applied to the 
peripheral nervous system 270 an(j subsequently to the central nervous 
system 271 it has become one of the most common experimental methods 
for demonstrating neuronal connectivity in the nervous system. HRP has 
a molecular weight of 40, 000 Daltons and a molecular diameter of 5nm. 
In contrast, microperoxidase (MP) is an ultrastructural tracer of low 
molecular weight. The initial investigation which proposed the use of MP 
demonstrated that MP penetrated an extracellular compartment from 
which HRP was excluded 272 xh js finding was consistent with the 
smaller molecular size of MP compared to HRP. On this basis the present 
study was designed.
The investigation was designed to examine a particular aspect of 
axolemmal permeability. Previous studies employed (HRP) as an 
extracellular tracer 111,112,114 xhe use of a macromolecular tracer with 
a molecular weight of 40,000 units has inherent restrictions as oulined 
above. It could be argued that such a molecule may not enter an injured 
axon because it is too large to "pass through "the axolemma. The 
axolemma of an injured axon may be disrupted to allow the passage of 
smaller molecular weight species such as calcium ions as outlined in the
218
previous sections. If there was a differential change in axolemmal 
permeability following traumatic injury then an extracellular tracer of 
smaller molecular weight should detect an increased number of reactive 
axons. This study did not support the concept that such a process was 
operant. Clearly this conclusion can only be made on the assumption that 
HRP and MP have similar properties as related to diffusion and binding 
to intracellular protein. The fact that the extracellular tracer of smaller 
molecular weight (MP) detected significantly less reactive axons than 
HRP suggests that this is not the case. To my knowledge there is no 
relevant literature available on this issue. It is possible that the smaller 
MP molecule does enter an increaed number of reactive axons but does 
not bind to the intracellular proteins and refluxes out of the axon 
rendering it undetectable to our experimental procedure. Therefore, it is 
suffice to note that this study supports the concept that disruption of the 
axolemma following traumatic brain injury is an all or none phenomenon.
The mechanistic basis by which normally excluded molecules gain intra- 
axonal access following traumatic brain injury remain to be elucidated. It 
is unlikely that organic macromolecules are gaining access through ionic 
channels. Furthermore, both tracers examined appeared free in the 
axoplasm as opposed to being bound to the membrane. This free 
appearance indicates that it is unlikely that endocytosis is the underlying 
mechanism of influx. General axolemmal failure, as proposed in 
Wallerian degeneration and ischaemia 273-276 couid be excluded by the 
focal appearance of intra-axonal peroxidase activity and the lack of 
cytoskeletal dissolution. Recent investigations suggest that the
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mechanism of axolemmal permeability is a complex dynamic process and 
may involve attempts by the axon to reseal the disrupted membrane.
Following axotomy extracellular tracers can be detected intra-axonally. 
Several investigations have demonstrated tracer influx after slice axotomy 
277-279 in these studies, the axolemmal permeability is transient and 
usually lasts for up to 30 minutes after axotomy. This "sealing" of the 
axolemma occurs by constriction of the severed tip of the fibre and 
involves a calcium dependent process. An ongoing study by Blight and 
colleagues suggests that the tracer may not enter the axon via the cut end 
of the fibre 280 Using the in vitro model of excised spinal white matter 
these workers applied extracelluar HRP following axotomy. When the 
axons were sliced with a scalpel they were found to reseal and exclude 
further influx of HRP within 30 minutes. In contrast, axons subjected to 
crush injury, where the axon is not severed, maintained their altered 
axolemmal permeability for up to 3 hours. This suggests that the 
mechanics of the axonal injury may effect the nature of axolemmal 
disruption. It is possible that some of the axons are subjected to shear or 
strain forces in the axolemma following a crush injury 281 producing 
alterations in axolemmal permeability similar to those observed in the 
animal model of traumatic brain injury examined in the present study. 
The in vitro model allowed this group to modify the extracellular 
environment and examine the process of axolemmal sealing after an 
injury. Following slice axotomy an extracellular media containing no 
calcium ions impaired resealing of the axolemma such that HRP could 
influx for up to 3 hours after axotomy 280 a  similar disturbance occurs
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after traumatic or crush axotomy indicating that the type of injury has the 
potential to inhibit repair mechanisms within the axon. Blight interprets 
this to suggest that traumatic injury, in this case crush injury, has caused 
the uptake of calcium ions by glia and neurones, resulting in a decrease in 
the concentration of calcium in the extracellular space necessary to 
stimulate axolemma resealing (Blight, personal communication).
The focus of this study was the axolemma and not the associated detailed 
cytoskeletal changes which are documented elsewhere 111,112,114 
Concerning the relationship between these reactive axonal changes and 
alterations in the axolemma, the key question is what factor(s) trigger the 
neurofilament compaction, loss of microtubules and m itochondrial 
dilation following traumatic brain injury. The rapid passage of 
macromolecules and/or smaller molecular species, such as ions, through 
the compomised axolemma could contribute to the ensuing axonal 
damage. The possible role of calcium has attracted a great deal of 
research attention in this regard. In the present study, swollen dilated 
mitochondria were detected in reactive axons within 5 minutes of 
traumatic injury. This may reflect a compensatory reaction to calcium 
influx 282 Mitochondria are known to absorb calcium ions when 
cytoplasmic concentrations are elevated. The increased mitochondrial 
concentration of calcium stimulates dilation or swelling of the organelle 
282-284 That mitochondrial dilation is consistently linked with altered 
axolemmal permeability in the current study, suggests that the 
mitochondria are absorbing excess intra-axonal calcium that has entered 
the axoplasm through the disrupted membrane. In this hypothesis the
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influx of calcium through the axolemma would be capable of altering the 
intra-axonal environment. The associated cytoskeletal changes may 
involve the calcium activated neutral proteases, calpain, which has been 
discussed in a previous section.
Current studies in our laboratory support the hypothesis that calcium is 
involved in the observed cytoskeletal changes (Povlishock, personal 
communication). In a preliminary study, calcium chelators were infused 
intra-thecally in conjunction with HRP. Following experimental traumatic 
brain injury the brains were prepared for ultrastructural analysis. There 
was decreased neurofilament compaction and no mitochondrial dilation in 
the chelator treated animals compared to the non-treated group. Although 
calcium chelators did not provide complete protection, they altered the 
morphology of the HRP permeable axons suggesting that calcium influx 
has an important role in the pathobiology of traumatically induced axonal 
injury.
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